data_1ao8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ao8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.449 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.449 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 13' ' ' ILE . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.41 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 19.5 m-70 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.4 ' CE2' HG22 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.4 HG22 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 96' ' ' ILE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 96' ' ' ILE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.41 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.404 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 15' ' ' LYS . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.403 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 8.8 m-70 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 96' ' ' ILE . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.451 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 96' ' ' ILE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.403 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' CD1' ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 96' ' ' ILE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' CB ' ' CD1' ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.408 ' CG ' HD22 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.42 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 136' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 113' ' ' LEU . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 153' ' ' HIS . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.407 ' CG ' HD22 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.2 m-70 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 96' ' ' ILE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 13' ' ' ILE . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.411 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 46' ' ' TYR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CD1' ' A' ' 103' ' ' PHE . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 153' ' ' HIS . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HG13 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 88' ' ' GLN . 17.1 m-70 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.42 ' CG ' HD22 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD23 ' CG ' ' A' ' 153' ' ' HIS . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 38' ' ' ILE . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 96' ' ' ILE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.406 ' CG ' HD23 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 96' ' ' ILE . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CD2' HD13 ' A' ' 96' ' ' ILE . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.42 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 96' ' ' ILE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 155' ' ' TYR . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 116' ' ' THR . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.409 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 HD23 ' CG ' ' A' ' 153' ' ' HIS . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 10.2 m-70 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.404 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 96' ' ' ILE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.442 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 96' ' ' ILE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 13' ' ' ILE . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE2' HG23 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 HG23 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 96' ' ' ILE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 102' ' ' ILE . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 96' ' ' ILE . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD13 ' CD2' ' A' ' 136' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 113' ' ' LEU . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.449 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.48 -48.3 56.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.507 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 13' ' ' ILE . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.41 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 19.5 m-70 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -73.13 100.7 3.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.47 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.4 ' CE2' HG22 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.4 HG22 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 96' ' ' ILE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -108.37 -41.05 4.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 96' ' ' ILE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.41 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -78.37 -63.94 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.483 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 15' ' ' LYS . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.403 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 8.8 m-70 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -80.94 172.72 13.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . 0.438 ' C4 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 96' ' ' ILE . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 142.46 58.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.463 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 170' ' ' MTX . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 139.42 58.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.542 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.451 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 96' ' ' ILE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.403 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.59 156.92 35.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.473 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' CD1' ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 96' ' ' ILE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' CB ' ' CD1' ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.408 ' CG ' HD22 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -62.06 -178.47 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.479 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 136' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 113' ' ' LEU . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 32.3 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.412 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 153' ' ' HIS . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.407 ' CG ' HD22 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -74.6 -43.1 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.483 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.2 m-70 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 96' ' ' ILE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -103.23 -27.42 12.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.531 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 13' ' ' ILE . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.411 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 46' ' ' TYR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -75.64 -66.82 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.396 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CD1' ' A' ' 103' ' ' PHE . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 153' ' ' HIS . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HG13 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 88' ' ' GLN . 17.1 m-70 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.42 ' CG ' HD22 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -79.65 -28.13 40.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.468 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD23 ' CG ' ' A' ' 153' ' ' HIS . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 38' ' ' ILE . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 96' ' ' ILE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' CG ' HD23 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -73.64 138.01 44.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.707 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 96' ' ' ILE . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CD2' HD13 ' A' ' 96' ' ' ILE . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -72.38 165.31 24.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.462 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.42 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 96' ' ' ILE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 155' ' ' TYR . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 116' ' ' THR . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -102.08 -28.2 12.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.487 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . 0.425 ' C4 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.409 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 HD23 ' CG ' ' A' ' 153' ' ' HIS . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 10.2 m-70 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.404 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -76.65 -49.54 15.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.728 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 96' ' ' ILE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.442 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 ' O ' ' CZ3' ' A' ' 5' ' ' TRP . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -68.05 -64.78 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.486 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 96' ' ' ILE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -73.77 101.59 3.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.49 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 13' ' ' ILE . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE2' HG23 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 HG23 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 96' ' ' ILE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 102' ' ' ILE . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 96' ' ' ILE . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD13 ' CD2' ' A' ' 136' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 113' ' ' LEU . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -70.32 -67.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.546 179.992 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.668 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HB3' HG22 ' A' ' 13' ' ' ILE . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 7' ' ' GLN . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HB2' HD23 ' A' ' 23' ' ' LEU . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.742 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CG2' HG21 ' A' ' 60' ' ' VAL . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 94' ' ' LEU . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CZ ' HG22 ' A' ' 45' ' ' THR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 57' ' ' ARG . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' CB ' HG12 ' A' ' 35' ' ' VAL . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 38' ' ' ILE . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.499 ' O ' ' CE1' ' A' ' 77' ' ' HIS . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 65' ' ' GLN . 87.4 m-70 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 60' ' ' VAL . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' HG21 ' A' ' 40' ' ' VAL . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.538 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 3' ' ' PHE . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 4' ' ' LEU . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.548 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.572 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 148' ' ' ASN . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.499 ' CG ' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.572 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 109' ' ' ASP . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 13' ' ' ILE . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 27' ' ' LEU . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' THR . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.592 ' CG2' HG21 ' A' ' 60' ' ' VAL . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 54' ' ' LEU . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.412 HD12 ' SD ' ' A' ' 39' ' ' MET . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 76' ' ' VAL . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 ' CD2' ' A' ' 106' ' ' PHE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 1' ' ' THR . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 3' ' ' PHE . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.6 ' CB ' HD12 ' A' ' 4' ' ' LEU . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 140' ' ' SER . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 139' ' ' VAL . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' HG23 ' A' ' 152' ' ' THR . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 114' ' ' LEU . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 126' ' ' THR . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD21 ' CG ' ' A' ' 153' ' ' HIS . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB2' HD23 ' A' ' 23' ' ' LEU . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' PRO . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 35' ' ' VAL . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 94' ' ' LEU . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 54' ' ' LEU . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.782 HD12 HG23 ' A' ' 76' ' ' VAL . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.782 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 76' ' ' VAL . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 40' ' ' VAL . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.62 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' HD23 ' A' ' 62' ' ' LEU . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 107' ' ' LYS . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.466 ' HA ' HD13 ' A' ' 13' ' ' ILE . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 131' ' ' LEU . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 129' ' ' ILE . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 140' ' ' SER . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 155' ' ' TYR . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 152' ' ' THR . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 151' ' ' LEU . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.576 ' O ' HD11 ' A' ' 23' ' ' LEU . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 145' ' ' GLU . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.654 ' CG ' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 144' ' ' VAL . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.629 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.461 HG13 HG22 ' A' ' 126' ' ' THR . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.492 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.405 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' HB2' HD23 ' A' ' 23' ' ' LEU . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 24' ' ' PRO . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 35' ' ' VAL . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 3' ' ' PHE . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 4' ' ' LEU . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.629 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.461 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.447 HD11 HD21 ' A' ' 131' ' ' LEU . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 129' ' ' ILE . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 145' ' ' GLU . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' GLU . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.643 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.537 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.59 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 126' ' ' THR . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.4 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.636 HD21 ' ND1' ' A' ' 153' ' ' HIS . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.602 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 34' ' ' THR . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 76' ' ' VAL . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 75' ' ' VAL . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' HG12 ' A' ' 74' ' ' VAL . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 81' ' ' ALA . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 3' ' ' PHE . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.59 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.636 ' ND1' HD21 ' A' ' 23' ' ' LEU . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 126' ' ' THR . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.611 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.605 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 24' ' ' PRO . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.523 ' CE ' HD12 ' A' ' 54' ' ' LEU . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 39' ' ' MET . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD13 ' CG2' ' A' ' 82' ' ' VAL . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 76' ' ' VAL . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 94' ' ' LEU . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 40' ' ' VAL . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' CB ' HD12 ' A' ' 4' ' ' LEU . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 13' ' ' ILE . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.566 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 148' ' ' ASN . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.433 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 143' ' ' THR . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 20' ' ' PRO . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.709 ' HB2' HD23 ' A' ' 23' ' ' LEU . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 86' ' ' ALA . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.709 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 54' ' ' LEU . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 65' ' ' GLN . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 63' ' ' THR . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.485 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 112' ' ' THR . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 110' ' ' VAL . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 3' ' ' PHE . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.606 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 13' ' ' ILE . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.605 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' ARG . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 126' ' ' THR . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.633 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.547 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.601 HD12 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.621 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.481 ' CD2' HD12 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 3' ' ' PHE . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' HB2' HD12 ' A' ' 4' ' ' LEU . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.474 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HE2' HG11 ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.671 HG23 ' HA ' ' A' ' 143' ' ' THR . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.614 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 126' ' ' THR . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' ND1' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' HD12 ' A' ' 27' ' ' LEU . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.707 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 24' ' ' PRO . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.607 ' HD3' HG21 ' A' ' 63' ' ' THR . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' HE1' ' A' ' 49' ' ' PHE . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 54' ' ' LEU . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 76' ' ' VAL . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.676 HD12 HG23 ' A' ' 76' ' ' VAL . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 43' ' ' ARG . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 75' ' ' VAL . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' NE2' ' A' ' 77' ' ' HIS . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG23 HD12 ' A' ' 62' ' ' LEU . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' NE2' HG12 ' A' ' 75' ' ' VAL . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 78' ' ' ASP . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 62' ' ' LEU . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 3' ' ' PHE . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.614 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 152' ' ' THR . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 13' ' ' ILE . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.444 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.495 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.429 HG11 ' HE2' ' A' ' 153' ' ' HIS . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' A' ' 152' ' ' THR . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.621 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.707 ' ND1' HD21 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.608 HG22 ' OE1' ' A' ' 156' ' ' GLU . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.607 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.56 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 20' ' ' PRO . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 26' ' ' ASP . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 27' ' ' LEU . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 24' ' ' PRO . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 34' ' ' THR . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 94' ' ' LEU . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD12 HG23 ' A' ' 76' ' ' VAL . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 HD12 ' A' ' 62' ' ' LEU . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' ASP . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.492 HD11 HG21 ' A' ' 40' ' ' VAL . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 154' ' ' THR . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.596 ' HA ' HG23 ' A' ' 152' ' ' THR . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.492 ' ND1' HD21 ' A' ' 23' ' ' LEU . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 124' ' ' GLY . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.672 HD11 HG22 ' A' ' 126' ' ' THR . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 24' ' ' PRO . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 54' ' ' LEU . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 76' ' ' VAL . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 82' ' ' VAL . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' CD1' HD23 ' A' ' 62' ' ' LEU . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 3' ' ' PHE . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.547 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.672 HG22 HD11 ' A' ' 13' ' ' ILE . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.655 ' HA ' HG23 ' A' ' 154' ' ' THR . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.404 HG11 ' NE2' ' A' ' 153' ' ' HIS . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.692 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.625 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 34' ' ' THR . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.401 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 93' ' ' GLU . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 54' ' ' LEU . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 94' ' ' LEU . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.504 HD12 ' CE ' ' A' ' 39' ' ' MET . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD12 HG23 ' A' ' 76' ' ' VAL . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 HD12 ' A' ' 62' ' ' LEU . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' LEU . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' O ' HD12 ' A' ' 38' ' ' ILE . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 40' ' ' VAL . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.561 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.422 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 62' ' ' LEU . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 13' ' ' ILE . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 140' ' ' SER . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 139' ' ' VAL . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 152' ' ' THR . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 143' ' ' THR . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 114' ' ' LEU . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 20' ' ' PRO . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.736 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 26' ' ' ASP . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.714 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 86' ' ' ALA . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.691 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 35' ' ' VAL . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 76' ' ' VAL . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 62' ' ' LEU . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.563 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.705 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 3' ' ' PHE . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.736 HG22 HD11 ' A' ' 13' ' ' ILE . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.598 ' HA ' HG23 ' A' ' 152' ' ' THR . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.576 ' HB2' HD12 ' A' ' 151' ' ' LEU . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 148' ' ' ASN . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 145' ' ' GLU . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.487 ' CG ' HD21 ' A' ' 23' ' ' LEU . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 143' ' ' THR . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 114' ' ' LEU . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.565 HD11 HG22 ' A' ' 126' ' ' THR . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA2' ' A' ' 14' ' ' GLY . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 26' ' ' ASP . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.627 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 24' ' ' PRO . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.554 ' O ' HG22 ' A' ' 35' ' ' VAL . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 54' ' ' LEU . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CD1' HD11 ' A' ' 54' ' ' LEU . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 49' ' ' PHE . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.84 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 31.5 m80 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' HD12 ' A' ' 129' ' ' ILE . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 3' ' ' PHE . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 4' ' ' LEU . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.565 HG22 HD11 ' A' ' 13' ' ' ILE . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD12 ' HE2' ' A' ' 107' ' ' LYS . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 151' ' ' LEU . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 148' ' ' ASN . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.596 ' CG ' HD21 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 126' ' ' THR . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 24' ' ' PRO . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG2' HG21 ' A' ' 60' ' ' VAL . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.596 HG21 ' CG2' ' A' ' 38' ' ' ILE . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD12 HG23 ' A' ' 76' ' ' VAL . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HD12 ' A' ' 62' ' ' LEU . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 86' ' ' ALA . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' PHE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.484 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 3' ' ' PHE . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.816 HD23 HG22 ' A' ' 157' ' ' VAL . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.404 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 131' ' ' LEU . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 129' ' ' ILE . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 138' ' ' LYS . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' N ' HG22 ' A' ' 137' ' ' THR . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 154' ' ' THR . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 145' ' ' GLU . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.641 ' CG ' HD21 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 154' ' ' THR . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.816 HG22 HD23 ' A' ' 114' ' ' LEU . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB2' HD23 ' A' ' 113' ' ' LEU . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.696 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' CE2' ' A' ' 30' ' ' PHE . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 49' ' ' PHE . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 96' ' ' ILE . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 76' ' ' VAL . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 62' ' ' LEU . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.474 HD13 ' HB ' ' A' ' 40' ' ' VAL . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.588 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 3' ' ' PHE . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HD11 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' CE ' ' A' ' 128' ' ' MET . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HA ' HG23 ' A' ' 152' ' ' THR . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 HG22 ' OE2' ' A' ' 156' ' ' GLU . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' OE2' HG22 ' A' ' 154' ' ' THR . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.734 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 114' ' ' LEU . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 20' ' ' PRO . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 126' ' ' THR . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.599 ' CG ' HD23 ' A' ' 12' ' ' LEU . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD21 ' ND1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.494 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD12 ' CE ' ' A' ' 39' ' ' MET . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.659 HG23 HD12 ' A' ' 62' ' ' LEU . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 78' ' ' ASP . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.624 HG22 ' CE1' ' A' ' 103' ' ' PHE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.706 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 4' ' ' LEU . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.793 HG22 HD11 ' A' ' 13' ' ' ILE . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 140' ' ' SER . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 139' ' ' VAL . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.713 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 152' ' ' THR . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.691 ' ND1' HD21 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 143' ' ' THR . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 114' ' ' LEU . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.664 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 35' ' ' VAL . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE3' HD12 ' A' ' 54' ' ' LEU . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 97' ' ' ALA . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.401 HD12 ' HE3' ' A' ' 39' ' ' MET . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 76' ' ' VAL . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 62' ' ' LEU . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 76' ' ' VAL . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.495 ' CE1' ' CE1' ' A' ' 89' ' ' HIS . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 85' ' ' TYR . 5.8 m80 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.6 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.503 ' CD1' HD23 ' A' ' 62' ' ' LEU . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.6 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.602 HG22 HD11 ' A' ' 13' ' ' ILE . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 23' ' ' LEU . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 126' ' ' THR . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 ' HA2' ' A' ' 14' ' ' GLY . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HB2' HD23 ' A' ' 23' ' ' LEU . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 27' ' ' LEU . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' HG21 ' A' ' 60' ' ' VAL . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 54' ' ' LEU . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 39' ' ' MET . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' HG23 ' A' ' 76' ' ' VAL . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.658 HG21 HG22 ' A' ' 82' ' ' VAL . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' VAL . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 76' ' ' VAL . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.632 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.591 ' CB ' HD12 ' A' ' 4' ' ' LEU . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.787 HG22 HD11 ' A' ' 13' ' ' ILE . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.509 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 94' ' ' LEU . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.705 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 126' ' ' THR . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.612 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' PRO . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.497 HG11 ' OE2' ' A' ' 56' ' ' GLU . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 54' ' ' LEU . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' CE ' ' A' ' 39' ' ' MET . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE2' HG11 ' A' ' 35' ' ' VAL . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD12 HG23 ' A' ' 76' ' ' VAL . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 HD12 ' A' ' 62' ' ' LEU . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 78' ' ' ASP . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HG22 ' A' ' 1' ' ' THR . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.591 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 3' ' ' PHE . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.63 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.705 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.659 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.511 ' CG ' HD21 ' A' ' 23' ' ' LEU . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 143' ' ' THR . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 114' ' ' LEU . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.8 HD12 ' HG2' ' A' ' 127' ' ' LYS . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' O ' HD21 ' A' ' 19' ' ' LEU . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 13' ' ' ILE . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 54' ' ' LEU . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 49' ' ' PHE . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 76' ' ' VAL . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 62' ' ' LEU . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 62' ' ' LEU . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.435 ' CD1' HD23 ' A' ' 62' ' ' LEU . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.604 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 3' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' ' 4' ' ' LEU . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CH2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 153' ' ' HIS . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.8 ' HG2' HD12 ' A' ' 12' ' ' LEU . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' HE2' ' A' ' 153' ' ' HIS . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 116' ' ' THR . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 114' ' ' LEU . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HB3' HG22 ' A' ' 13' ' ' ILE . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 7' ' ' GLN . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HB2' HD23 ' A' ' 23' ' ' LEU . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.742 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CG2' HG21 ' A' ' 60' ' ' VAL . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 94' ' ' LEU . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CZ ' HG22 ' A' ' 45' ' ' THR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 57' ' ' ARG . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' CB ' HG12 ' A' ' 35' ' ' VAL . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 38' ' ' ILE . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.499 ' O ' ' CE1' ' A' ' 77' ' ' HIS . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 65' ' ' GLN . 87.4 m-70 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 60' ' ' VAL . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' HG21 ' A' ' 40' ' ' VAL . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.538 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 3' ' ' PHE . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 4' ' ' LEU . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.548 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.572 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 148' ' ' ASN . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.499 ' CG ' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.572 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.48 -48.3 56.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.507 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 109' ' ' ASP . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 13' ' ' ILE . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD12 ' HM2' ' A' ' 170' ' ' MTX . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 27' ' ' LEU . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' THR . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.592 ' CG2' HG21 ' A' ' 60' ' ' VAL . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 54' ' ' LEU . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.412 HD12 ' SD ' ' A' ' 39' ' ' MET . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 76' ' ' VAL . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 ' CD2' ' A' ' 106' ' ' PHE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 1' ' ' THR . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 3' ' ' PHE . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.6 ' CB ' HD12 ' A' ' 4' ' ' LEU . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 140' ' ' SER . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 139' ' ' VAL . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' HG23 ' A' ' 152' ' ' THR . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -73.13 100.7 3.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.47 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.541 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 114' ' ' LEU . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 126' ' ' THR . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD11 ' C7 ' ' A' ' 170' ' ' MTX . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD21 ' CG ' ' A' ' 153' ' ' HIS . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB2' HD23 ' A' ' 23' ' ' LEU . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' PRO . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 35' ' ' VAL . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 94' ' ' LEU . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 54' ' ' LEU . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.782 HD12 HG23 ' A' ' 76' ' ' VAL . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.782 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 76' ' ' VAL . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 40' ' ' VAL . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.62 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' HD23 ' A' ' 62' ' ' LEU . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 107' ' ' LYS . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.466 ' HA ' HD13 ' A' ' 13' ' ' ILE . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 131' ' ' LEU . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 129' ' ' ILE . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 140' ' ' SER . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 155' ' ' TYR . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 152' ' ' THR . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 151' ' ' LEU . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.576 ' O ' HD11 ' A' ' 23' ' ' LEU . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 145' ' ' GLU . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.654 ' CG ' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 144' ' ' VAL . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -108.37 -41.05 4.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.417 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' NA2' ' A' ' 170' ' ' MTX . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.629 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.461 HG13 HG22 ' A' ' 126' ' ' THR . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.492 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.405 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' HB2' HD23 ' A' ' 23' ' ' LEU . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 24' ' ' PRO . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 35' ' ' VAL . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 3' ' ' PHE . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 4' ' ' LEU . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.629 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.461 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.447 HD11 HD21 ' A' ' 131' ' ' LEU . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 129' ' ' ILE . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 145' ' ' GLU . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' GLU . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.643 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -78.37 -63.94 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.483 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.665 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.537 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.59 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 126' ' ' THR . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.4 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.636 HD21 ' ND1' ' A' ' 153' ' ' HIS . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.602 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 76' ' ' VAL . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 75' ' ' VAL . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' HG12 ' A' ' 74' ' ' VAL . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 81' ' ' ALA . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 3' ' ' PHE . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.636 ' ND1' HD21 ' A' ' 23' ' ' LEU . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -80.94 172.72 13.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.804 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 126' ' ' THR . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.647 HD12 ' HM2' ' A' ' 170' ' ' MTX . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.611 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.605 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 24' ' ' PRO . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.523 ' CE ' HD12 ' A' ' 54' ' ' LEU . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 39' ' ' MET . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD13 ' CG2' ' A' ' 82' ' ' VAL . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 76' ' ' VAL . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 94' ' ' LEU . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 40' ' ' VAL . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' CB ' HD12 ' A' ' 4' ' ' LEU . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 13' ' ' ILE . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.566 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 148' ' ' ASN . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.433 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 143' ' ' THR . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 142.46 58.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.463 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.647 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 20' ' ' PRO . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.709 ' HB2' HD23 ' A' ' 23' ' ' LEU . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 170' ' ' MTX . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 86' ' ' ALA . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.709 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 54' ' ' LEU . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 65' ' ' GLN . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 63' ' ' THR . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.485 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 112' ' ' THR . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 110' ' ' VAL . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 3' ' ' PHE . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.606 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 13' ' ' ILE . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.605 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' ARG . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 139.42 58.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.542 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 126' ' ' THR . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.633 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD21 ' C12' ' A' ' 170' ' ' MTX . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.547 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.601 HD12 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.621 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.481 ' CD2' HD12 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 3' ' ' PHE . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' HB2' HD12 ' A' ' 4' ' ' LEU . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.474 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HE2' HG11 ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.671 HG23 ' HA ' ' A' ' 143' ' ' THR . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.59 156.92 35.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.473 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.511 ' C12' HD21 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.614 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 126' ' ' THR . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' ND1' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' HD12 ' A' ' 27' ' ' LEU . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.707 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 24' ' ' PRO . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.607 ' HD3' HG21 ' A' ' 63' ' ' THR . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' HE1' ' A' ' 49' ' ' PHE . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 54' ' ' LEU . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 76' ' ' VAL . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.676 HD12 HG23 ' A' ' 76' ' ' VAL . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 43' ' ' ARG . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 75' ' ' VAL . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' NE2' ' A' ' 77' ' ' HIS . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG23 HD12 ' A' ' 62' ' ' LEU . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' NE2' HG12 ' A' ' 75' ' ' VAL . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 78' ' ' ASP . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 62' ' ' LEU . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 3' ' ' PHE . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.614 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 152' ' ' THR . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 13' ' ' ILE . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.444 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.495 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.429 HG11 ' HE2' ' A' ' 153' ' ' HIS . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' A' ' 152' ' ' THR . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.621 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.707 ' ND1' HD21 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.608 HG22 ' OE1' ' A' ' 156' ' ' GLU . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -62.06 -178.47 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.479 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.607 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.56 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 20' ' ' PRO . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 26' ' ' ASP . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 27' ' ' LEU . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 24' ' ' PRO . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 34' ' ' THR . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 94' ' ' LEU . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD12 HG23 ' A' ' 76' ' ' VAL . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 HD12 ' A' ' 62' ' ' LEU . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' ASP . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.492 HD11 HG21 ' A' ' 40' ' ' VAL . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 154' ' ' THR . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.596 ' HA ' HG23 ' A' ' 152' ' ' THR . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.492 ' ND1' HD21 ' A' ' 23' ' ' LEU . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 32.3 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.412 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.515 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 124' ' ' GLY . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.672 HD11 HG22 ' A' ' 126' ' ' THR . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.572 HD12 ' HM2' ' A' ' 170' ' ' MTX . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 24' ' ' PRO . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 54' ' ' LEU . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 76' ' ' VAL . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 82' ' ' VAL . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' CD1' HD23 ' A' ' 62' ' ' LEU . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 3' ' ' PHE . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.547 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.672 HG22 HD11 ' A' ' 13' ' ' ILE . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.655 ' HA ' HG23 ' A' ' 154' ' ' THR . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.404 HG11 ' NE2' ' A' ' 153' ' ' HIS . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -74.6 -43.1 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.483 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.572 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD11 ' HM2' ' A' ' 170' ' ' MTX . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.692 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.625 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 34' ' ' THR . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.401 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 93' ' ' GLU . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 54' ' ' LEU . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 94' ' ' LEU . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.504 HD12 ' CE ' ' A' ' 39' ' ' MET . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD12 HG23 ' A' ' 76' ' ' VAL . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 HD12 ' A' ' 62' ' ' LEU . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' LEU . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' O ' HD12 ' A' ' 38' ' ' ILE . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 40' ' ' VAL . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.561 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.422 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 62' ' ' LEU . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 13' ' ' ILE . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 140' ' ' SER . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 139' ' ' VAL . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 152' ' ' THR . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 143' ' ' THR . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 114' ' ' LEU . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -103.23 -27.42 12.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.531 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.473 ' HM2' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 20' ' ' PRO . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.736 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 26' ' ' ASP . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.714 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 86' ' ' ALA . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.691 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 35' ' ' VAL . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 76' ' ' VAL . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 62' ' ' LEU . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.563 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.705 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 3' ' ' PHE . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.736 HG22 HD11 ' A' ' 13' ' ' ILE . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.598 ' HA ' HG23 ' A' ' 152' ' ' THR . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.576 ' HB2' HD12 ' A' ' 151' ' ' LEU . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 148' ' ' ASN . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 145' ' ' GLU . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.487 ' CG ' HD21 ' A' ' 23' ' ' LEU . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 143' ' ' THR . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 114' ' ' LEU . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -75.64 -66.82 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.396 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.565 HD11 HG22 ' A' ' 126' ' ' THR . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HG ' ' HM2' ' A' ' 170' ' ' MTX . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 26' ' ' ASP . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.627 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 24' ' ' PRO . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.554 ' O ' HG22 ' A' ' 35' ' ' VAL . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 54' ' ' LEU . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' HM3' ' A' ' 170' ' ' MTX . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CD1' HD11 ' A' ' 54' ' ' LEU . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 49' ' ' PHE . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 31.5 m80 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' HD12 ' A' ' 129' ' ' ILE . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 3' ' ' PHE . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 4' ' ' LEU . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.565 HG22 HD11 ' A' ' 13' ' ' ILE . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD12 ' HE2' ' A' ' 107' ' ' LYS . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 151' ' ' LEU . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 148' ' ' ASN . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.596 ' CG ' HD21 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -79.65 -28.13 40.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.468 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.513 ' HM3' ' OG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 126' ' ' THR . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 24' ' ' PRO . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG2' HG21 ' A' ' 60' ' ' VAL . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.596 HG21 ' CG2' ' A' ' 38' ' ' ILE . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD12 HG23 ' A' ' 76' ' ' VAL . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HD12 ' A' ' 62' ' ' LEU . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 86' ' ' ALA . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' PHE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.484 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 3' ' ' PHE . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.816 HD23 HG22 ' A' ' 157' ' ' VAL . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.404 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 131' ' ' LEU . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 129' ' ' ILE . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 138' ' ' LYS . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' N ' HG22 ' A' ' 137' ' ' THR . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 154' ' ' THR . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 145' ' ' GLU . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.641 ' CG ' HD21 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 154' ' ' THR . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.816 HG22 HD23 ' A' ' 114' ' ' LEU . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -73.64 138.01 44.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.707 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.46 ' HM2' ' H7 ' ' A' ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB2' HD23 ' A' ' 113' ' ' LEU . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.696 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD12 ' HM2' ' A' ' 170' ' ' MTX . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' CE2' ' A' ' 30' ' ' PHE . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 49' ' ' PHE . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 96' ' ' ILE . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.554 ' OG ' ' HM3' ' A' ' 170' ' ' MTX . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 76' ' ' VAL . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 62' ' ' LEU . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.474 HD13 ' HB ' ' A' ' 40' ' ' VAL . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.588 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 3' ' ' PHE . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HD11 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' CE ' ' A' ' 128' ' ' MET . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HA ' HG23 ' A' ' 152' ' ' THR . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 HG22 ' OE2' ' A' ' 156' ' ' GLU . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' OE2' HG22 ' A' ' 154' ' ' THR . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -72.38 165.31 24.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.462 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.554 ' HM3' ' OG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.734 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 114' ' ' LEU . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 20' ' ' PRO . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 126' ' ' THR . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' CG ' HD23 ' A' ' 12' ' ' LEU . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD21 ' ND1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.494 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD12 ' CE ' ' A' ' 39' ' ' MET . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.659 HG23 HD12 ' A' ' 62' ' ' LEU . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 78' ' ' ASP . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.624 HG22 ' CE1' ' A' ' 103' ' ' PHE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.706 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 4' ' ' LEU . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.793 HG22 HD11 ' A' ' 13' ' ' ILE . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 140' ' ' SER . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 139' ' ' VAL . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.713 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 152' ' ' THR . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.691 ' ND1' HD21 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 143' ' ' THR . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 114' ' ' LEU . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -102.08 -28.2 12.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.487 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.425 ' C4 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.664 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 35' ' ' VAL . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE3' HD12 ' A' ' 54' ' ' LEU . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 97' ' ' ALA . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.401 HD12 ' HE3' ' A' ' 39' ' ' MET . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 76' ' ' VAL . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 62' ' ' LEU . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 76' ' ' VAL . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.495 ' CE1' ' CE1' ' A' ' 89' ' ' HIS . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 85' ' ' TYR . 5.8 m80 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.6 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.503 ' CD1' HD23 ' A' ' 62' ' ' LEU . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.6 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.602 HG22 HD11 ' A' ' 13' ' ' ILE . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 23' ' ' LEU . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -76.65 -49.54 15.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.728 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 126' ' ' THR . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 ' HA2' ' A' ' 14' ' ' GLY . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HB2' HD23 ' A' ' 23' ' ' LEU . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 27' ' ' LEU . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' HG21 ' A' ' 60' ' ' VAL . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 54' ' ' LEU . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 39' ' ' MET . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' HG23 ' A' ' 76' ' ' VAL . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.658 HG21 HG22 ' A' ' 82' ' ' VAL . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' VAL . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 76' ' ' VAL . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.632 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.591 ' CB ' HD12 ' A' ' 4' ' ' LEU . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.787 HG22 HD11 ' A' ' 13' ' ' ILE . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.509 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -68.05 -64.78 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.486 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 94' ' ' LEU . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.705 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 126' ' ' THR . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' C7 ' ' A' ' 170' ' ' MTX . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.612 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' PRO . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG11 ' OE2' ' A' ' 56' ' ' GLU . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 54' ' ' LEU . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' CE ' ' A' ' 39' ' ' MET . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE2' HG11 ' A' ' 35' ' ' VAL . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD12 HG23 ' A' ' 76' ' ' VAL . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 HD12 ' A' ' 62' ' ' LEU . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 78' ' ' ASP . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HG22 ' A' ' 1' ' ' THR . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.591 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 3' ' ' PHE . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.63 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.705 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.659 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.511 ' CG ' HD21 ' A' ' 23' ' ' LEU . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 143' ' ' THR . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -73.77 101.59 3.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.49 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.433 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 114' ' ' LEU . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.8 HD12 ' HG2' ' A' ' 127' ' ' LYS . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' O ' HD21 ' A' ' 19' ' ' LEU . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.825 HD12 ' HM2' ' A' ' 170' ' ' MTX . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.643 ' HB3' ' HM3' ' A' ' 170' ' ' MTX . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 54' ' ' LEU . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 49' ' ' PHE . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 76' ' ' VAL . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 62' ' ' LEU . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 62' ' ' LEU . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.435 ' CD1' HD23 ' A' ' 62' ' ' LEU . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.604 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 3' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' ' 4' ' ' LEU . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CH2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 153' ' ' HIS . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.8 ' HG2' HD12 ' A' ' 12' ' ' LEU . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' HE2' ' A' ' 153' ' ' HIS . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 116' ' ' THR . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 114' ' ' LEU . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -70.32 -67.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.546 179.992 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 170' ' ' MTX . . . . . 0.825 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.668 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HB3' HG22 ' A' ' 13' ' ' ILE . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 7' ' ' GLN . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HB2' HD23 ' A' ' 23' ' ' LEU . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.742 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CG2' HG21 ' A' ' 60' ' ' VAL . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 94' ' ' LEU . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CZ ' HG22 ' A' ' 45' ' ' THR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 57' ' ' ARG . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' CB ' HG12 ' A' ' 35' ' ' VAL . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 38' ' ' ILE . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 60' ' ' VAL . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' HG21 ' A' ' 40' ' ' VAL . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.538 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 3' ' ' PHE . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 4' ' ' LEU . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.548 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.572 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 148' ' ' ASN . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.499 ' CG ' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.572 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 109' ' ' ASP . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 13' ' ' ILE . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 27' ' ' LEU . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 19.5 m-70 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' THR . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.592 ' CG2' HG21 ' A' ' 60' ' ' VAL . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 54' ' ' LEU . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.412 HD12 ' SD ' ' A' ' 39' ' ' MET . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 76' ' ' VAL . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 ' CD2' ' A' ' 106' ' ' PHE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 1' ' ' THR . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 3' ' ' PHE . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.6 ' CB ' HD12 ' A' ' 4' ' ' LEU . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 140' ' ' SER . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 139' ' ' VAL . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' HG23 ' A' ' 152' ' ' THR . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 114' ' ' LEU . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 126' ' ' THR . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD21 ' CG ' ' A' ' 153' ' ' HIS . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB2' HD23 ' A' ' 23' ' ' LEU . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' PRO . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 35' ' ' VAL . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 94' ' ' LEU . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.782 HD12 HG23 ' A' ' 76' ' ' VAL . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.782 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 76' ' ' VAL . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 40' ' ' VAL . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.62 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' HD23 ' A' ' 62' ' ' LEU . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 107' ' ' LYS . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.466 ' HA ' HD13 ' A' ' 13' ' ' ILE . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 131' ' ' LEU . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 129' ' ' ILE . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 140' ' ' SER . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 155' ' ' TYR . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 152' ' ' THR . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 151' ' ' LEU . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.576 ' O ' HD11 ' A' ' 23' ' ' LEU . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 145' ' ' GLU . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.654 ' CG ' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 144' ' ' VAL . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.629 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.461 HG13 HG22 ' A' ' 126' ' ' THR . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.492 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.405 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' HB2' HD23 ' A' ' 23' ' ' LEU . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 24' ' ' PRO . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 35' ' ' VAL . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 3' ' ' PHE . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 4' ' ' LEU . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.629 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.461 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.447 HD11 HD21 ' A' ' 131' ' ' LEU . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 129' ' ' ILE . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 145' ' ' GLU . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' GLU . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.643 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.537 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.59 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 126' ' ' THR . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.4 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.636 HD21 ' ND1' ' A' ' 153' ' ' HIS . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.602 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 34' ' ' THR . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 76' ' ' VAL . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 75' ' ' VAL . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' HG12 ' A' ' 74' ' ' VAL . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 81' ' ' ALA . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 8.8 m-70 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 3' ' ' PHE . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.59 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.636 ' ND1' HD21 ' A' ' 23' ' ' LEU . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 126' ' ' THR . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.611 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.605 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 24' ' ' PRO . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.523 ' CE ' HD12 ' A' ' 54' ' ' LEU . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 39' ' ' MET . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD13 ' CG2' ' A' ' 82' ' ' VAL . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 76' ' ' VAL . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 94' ' ' LEU . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 40' ' ' VAL . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' CB ' HD12 ' A' ' 4' ' ' LEU . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 13' ' ' ILE . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.566 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 148' ' ' ASN . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.433 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 143' ' ' THR . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 20' ' ' PRO . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.709 ' HB2' HD23 ' A' ' 23' ' ' LEU . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 86' ' ' ALA . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.709 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 54' ' ' LEU . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 65' ' ' GLN . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 63' ' ' THR . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.485 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 112' ' ' THR . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 110' ' ' VAL . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 3' ' ' PHE . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.606 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 13' ' ' ILE . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.605 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' ARG . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 126' ' ' THR . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.633 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.547 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' NE2' ' A' ' 33' ' ' GLN . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.793 ' NE2' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.601 HD12 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.621 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.481 ' CD2' HD12 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 3' ' ' PHE . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' HB2' HD12 ' A' ' 4' ' ' LEU . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.474 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HE2' HG11 ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.671 HG23 ' HA ' ' A' ' 143' ' ' THR . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.614 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 126' ' ' THR . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' ND1' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' HD12 ' A' ' 27' ' ' LEU . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.707 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 24' ' ' PRO . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.607 ' HD3' HG21 ' A' ' 63' ' ' THR . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' HE1' ' A' ' 49' ' ' PHE . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 54' ' ' LEU . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 76' ' ' VAL . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.676 HD12 HG23 ' A' ' 76' ' ' VAL . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 43' ' ' ARG . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 75' ' ' VAL . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' NE2' ' A' ' 77' ' ' HIS . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG23 HD12 ' A' ' 62' ' ' LEU . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' NE2' HG12 ' A' ' 75' ' ' VAL . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 78' ' ' ASP . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 62' ' ' LEU . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 3' ' ' PHE . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.614 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 152' ' ' THR . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 13' ' ' ILE . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.444 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.495 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.429 HG11 ' HE2' ' A' ' 153' ' ' HIS . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' A' ' 152' ' ' THR . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.621 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.707 ' ND1' HD21 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.608 HG22 ' OE1' ' A' ' 156' ' ' GLU . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.607 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.56 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 20' ' ' PRO . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 26' ' ' ASP . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 27' ' ' LEU . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 24' ' ' PRO . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 34' ' ' THR . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 94' ' ' LEU . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD12 HG23 ' A' ' 76' ' ' VAL . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 HD12 ' A' ' 62' ' ' LEU . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' ASP . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.492 HD11 HG21 ' A' ' 40' ' ' VAL . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 154' ' ' THR . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.596 ' HA ' HG23 ' A' ' 152' ' ' THR . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.492 ' ND1' HD21 ' A' ' 23' ' ' LEU . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 124' ' ' GLY . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.672 HD11 HG22 ' A' ' 126' ' ' THR . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 24' ' ' PRO . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 54' ' ' LEU . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 76' ' ' VAL . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 82' ' ' VAL . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' CD1' HD23 ' A' ' 62' ' ' LEU . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 3' ' ' PHE . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.547 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.672 HG22 HD11 ' A' ' 13' ' ' ILE . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.655 ' HA ' HG23 ' A' ' 154' ' ' THR . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.404 HG11 ' NE2' ' A' ' 153' ' ' HIS . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.692 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.625 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 34' ' ' THR . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.401 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 93' ' ' GLU . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 54' ' ' LEU . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 94' ' ' LEU . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.504 HD12 ' CE ' ' A' ' 39' ' ' MET . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD12 HG23 ' A' ' 76' ' ' VAL . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 HD12 ' A' ' 62' ' ' LEU . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' LEU . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.2 m-70 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' O ' HD12 ' A' ' 38' ' ' ILE . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 40' ' ' VAL . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.561 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.422 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 62' ' ' LEU . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 13' ' ' ILE . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 140' ' ' SER . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 139' ' ' VAL . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 152' ' ' THR . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 143' ' ' THR . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 114' ' ' LEU . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 20' ' ' PRO . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.736 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 26' ' ' ASP . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.714 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 86' ' ' ALA . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.691 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 35' ' ' VAL . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 76' ' ' VAL . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 62' ' ' LEU . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.563 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.705 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 3' ' ' PHE . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.736 HG22 HD11 ' A' ' 13' ' ' ILE . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.598 ' HA ' HG23 ' A' ' 152' ' ' THR . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.576 ' HB2' HD12 ' A' ' 151' ' ' LEU . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 148' ' ' ASN . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 145' ' ' GLU . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.487 ' CG ' HD21 ' A' ' 23' ' ' LEU . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 143' ' ' THR . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 114' ' ' LEU . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.565 HD11 HG22 ' A' ' 126' ' ' THR . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD23 ' HA2' ' A' ' 14' ' ' GLY . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 26' ' ' ASP . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.627 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 24' ' ' PRO . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.554 ' O ' HG22 ' A' ' 35' ' ' VAL . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 54' ' ' LEU . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CD1' HD11 ' A' ' 54' ' ' LEU . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 49' ' ' PHE . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.84 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 88' ' ' GLN . 17.1 m-70 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' HD12 ' A' ' 129' ' ' ILE . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 3' ' ' PHE . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 4' ' ' LEU . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.565 HG22 HD11 ' A' ' 13' ' ' ILE . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD12 ' HE2' ' A' ' 107' ' ' LYS . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 151' ' ' LEU . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 148' ' ' ASN . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.596 ' CG ' HD21 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 126' ' ' THR . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 24' ' ' PRO . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG2' HG21 ' A' ' 60' ' ' VAL . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.596 HG21 ' CG2' ' A' ' 38' ' ' ILE . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD12 HG23 ' A' ' 76' ' ' VAL . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HD12 ' A' ' 62' ' ' LEU . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 86' ' ' ALA . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' PHE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.484 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 3' ' ' PHE . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.816 HD23 HG22 ' A' ' 157' ' ' VAL . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.404 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 131' ' ' LEU . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 129' ' ' ILE . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 138' ' ' LYS . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' N ' HG22 ' A' ' 137' ' ' THR . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 154' ' ' THR . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 145' ' ' GLU . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.641 ' CG ' HD21 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 154' ' ' THR . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.816 HG22 HD23 ' A' ' 114' ' ' LEU . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB2' HD23 ' A' ' 113' ' ' LEU . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.696 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' CE2' ' A' ' 30' ' ' PHE . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 49' ' ' PHE . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 96' ' ' ILE . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 76' ' ' VAL . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 62' ' ' LEU . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.474 HD13 ' HB ' ' A' ' 40' ' ' VAL . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.588 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 3' ' ' PHE . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HD11 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' CE ' ' A' ' 128' ' ' MET . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HA ' HG23 ' A' ' 152' ' ' THR . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 HG22 ' OE2' ' A' ' 156' ' ' GLU . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' OE2' HG22 ' A' ' 154' ' ' THR . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.734 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 114' ' ' LEU . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 20' ' ' PRO . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 126' ' ' THR . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.599 ' CG ' HD23 ' A' ' 12' ' ' LEU . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.408 ' CD2' ' HD3' ' A' ' 24' ' ' PRO . 37.6 t60 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD21 ' ND1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 22' ' ' HIS . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.494 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD12 ' CE ' ' A' ' 39' ' ' MET . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.659 HG23 HD12 ' A' ' 62' ' ' LEU . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 78' ' ' ASP . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.624 HG22 ' CE1' ' A' ' 103' ' ' PHE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.706 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 4' ' ' LEU . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.793 HG22 HD11 ' A' ' 13' ' ' ILE . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 140' ' ' SER . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 139' ' ' VAL . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.713 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 152' ' ' THR . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.691 ' ND1' HD21 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 143' ' ' THR . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 114' ' ' LEU . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.664 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 35' ' ' VAL . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE3' HD12 ' A' ' 54' ' ' LEU . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 97' ' ' ALA . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.401 HD12 ' HE3' ' A' ' 39' ' ' MET . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 76' ' ' VAL . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 62' ' ' LEU . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 76' ' ' VAL . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 10.2 m-70 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.6 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.503 ' CD1' HD23 ' A' ' 62' ' ' LEU . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.6 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.602 HG22 HD11 ' A' ' 13' ' ' ILE . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 23' ' ' LEU . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 126' ' ' THR . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 ' HA2' ' A' ' 14' ' ' GLY . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HB2' HD23 ' A' ' 23' ' ' LEU . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 27' ' ' LEU . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' HG21 ' A' ' 60' ' ' VAL . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 54' ' ' LEU . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 39' ' ' MET . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' HG23 ' A' ' 76' ' ' VAL . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.658 HG21 HG22 ' A' ' 82' ' ' VAL . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' VAL . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 76' ' ' VAL . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.632 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.591 ' CB ' HD12 ' A' ' 4' ' ' LEU . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.787 HG22 HD11 ' A' ' 13' ' ' ILE . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.509 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 94' ' ' LEU . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.705 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 126' ' ' THR . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.612 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' PRO . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 23.6 m-70 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.497 HG11 ' OE2' ' A' ' 56' ' ' GLU . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 54' ' ' LEU . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' CE ' ' A' ' 39' ' ' MET . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE2' HG11 ' A' ' 35' ' ' VAL . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD12 HG23 ' A' ' 76' ' ' VAL . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 HD12 ' A' ' 62' ' ' LEU . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 78' ' ' ASP . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HG22 ' A' ' 1' ' ' THR . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.591 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 3' ' ' PHE . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.63 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.705 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.659 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.511 ' CG ' HD21 ' A' ' 23' ' ' LEU . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 143' ' ' THR . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 114' ' ' LEU . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.8 HD12 ' HG2' ' A' ' 127' ' ' LYS . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' O ' HD21 ' A' ' 19' ' ' LEU . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 13' ' ' ILE . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 54' ' ' LEU . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 49' ' ' PHE . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 76' ' ' VAL . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 62' ' ' LEU . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 62' ' ' LEU . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.435 ' CD1' HD23 ' A' ' 62' ' ' LEU . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.604 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 3' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' ' 4' ' ' LEU . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 153' ' ' HIS . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.8 ' HG2' HD12 ' A' ' 12' ' ' LEU . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' HE2' ' A' ' 153' ' ' HIS . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 116' ' ' THR . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 114' ' ' LEU . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.74 114.43 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.427 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.38 148.73 40.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.9 tp -158.61 113.04 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.536 -0.727 . . . . 0.0 109.442 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.2 p90 -154.94 165.59 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.733 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.87 132.61 54.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HB3' HG22 ' A' ' 13' ' ' ILE . 1.9 pt20 -137.97 174.68 10.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 109.516 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -117.27 -175.39 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.441 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -57.83 -20.77 38.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.401 -0.812 . . . . 0.0 110.546 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -86.38 -22.71 26.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 110.291 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.85 -13.57 49.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.3 tp -57.55 147.75 25.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.122 -1.222 . . . . 0.0 109.982 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 7' ' ' GLN . 9.5 pt -135.68 27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.714 . . . . 0.0 109.856 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.28 179.93 26.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -158.75 121.74 3.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.915 . . . . 0.0 109.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.66 27.85 14.89 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.58 -0.7 . . . . 0.0 110.066 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.42 -44.14 2.3 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -91.48 161.4 14.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.957 . . . . 0.0 109.394 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.6 mt -77.76 147.03 73.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.624 -0.672 . . . . 0.0 109.312 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -78.49 -37.88 0.63 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.83 3.687 . . . . 0.0 109.874 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -103.72 -173.71 2.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.589 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -140.07 102.05 4.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.642 -0.661 . . . . 0.0 109.359 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -113.87 78.79 4.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.524 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.1 Cg_exo -46.71 -34.42 15.48 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 125.055 3.837 . . . . 0.0 110.184 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -40.18 95.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.67 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HB2' HD23 ' A' ' 23' ' ' LEU . 8.7 t0 -67.59 -29.8 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.72 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 24' ' ' PRO . 14.4 mt -65.16 -31.16 72.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.59 -0.694 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -70.66 -28.66 64.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.546 -0.722 . . . . 0.0 109.642 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -80.21 -30.92 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 109.527 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.77 -42.17 86.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.536 -0.727 . . . . 0.0 109.407 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.742 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.0 ttt180 -63.19 -33.08 74.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.588 -0.695 . . . . 0.0 109.652 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.83 -26.42 44.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.428 -0.795 . . . . 0.0 110.031 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.61 32.92 2.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -150.3 -48.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.45 -0.781 . . . . 0.0 109.769 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.1 m -59.47 125.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.66 -24.41 32.24 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -112.41 -173.7 2.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -1.026 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CG2' HG21 ' A' ' 60' ' ' VAL . 44.1 mt -99.04 125.87 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 ttp -93.22 135.58 34.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.583 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 94' ' ' LEU . 31.4 t -117.47 113.06 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.663 -0.648 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 25.8 m -131.75 154.3 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.511 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.32 -160.83 36.45 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -82.07 -37.78 25.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.986 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -69.17 -30.53 68.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 4.4 m -85.4 -30.58 23.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 26.7 t80 -64.08 -48.05 77.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.49 -22.74 61.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.682 . . . . 0.0 109.945 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 t -62.53 -27.21 69.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.853 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CZ ' HG22 ' A' ' 45' ' ' THR . 15.1 m-85 -70.79 147.71 94.44 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.495 -0.753 . . . . 0.0 109.42 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.26 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.836 3.691 . . . . 0.0 109.758 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -99.44 113.82 26.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.604 -0.685 . . . . 0.0 109.552 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -122.95 143.98 41.91 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.337 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.65 170.97 70.35 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.241 1.127 . . . . 0.0 109.65 -0.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 57' ' ' ARG . 28.9 mt -89.76 116.93 67.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.619 -0.676 . . . . 0.0 109.298 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.12 177.38 8.72 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 124.792 3.662 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' CB ' HG12 ' A' ' 35' ' ' VAL . 8.8 mt-10 80.52 -11.31 1.16 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.006 -0.434 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -163.9 162.64 23.62 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.849 -1.157 . . . . 0.0 109.21 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -70.61 148.1 48.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.34 126.26 52.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 38' ' ' ILE . 36.6 t -122.17 103.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.83 131.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.86 118.74 24.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -144.37 178.59 7.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.562 -0.711 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -101.81 30.54 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.739 . . . . 0.0 109.541 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -114.97 150.07 36.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.46 34.59 5.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.68 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -148.17 31.55 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.648 -0.658 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.42 162.76 15.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -144.0 143.9 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.628 -0.67 . . . . 0.0 109.508 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.5 110.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 109.475 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.0 102.52 10.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.578 -0.701 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.8 -34.7 3.81 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 160.44 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.946 . . . . 0.0 109.498 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -97.8 130.07 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -105.59 113.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.648 -0.657 . . . . 0.0 109.336 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.54 159.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.559 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.34 36.02 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.713 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -149.24 134.47 18.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.65 -41.75 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.31 73.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.608 -0.683 . . . . 0.0 109.435 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 60' ' ' VAL . 31.6 t -64.7 -31.84 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.546 -0.721 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.37 -45.34 60.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.684 . . . . 0.0 109.384 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.11 81.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.64 -0.663 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -68.75 -36.58 78.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.351 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.27 -37.82 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -65.07 -33.98 77.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.584 -0.698 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -27.28 68.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.702 . . . . 0.0 109.698 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -107.09 104.07 50.57 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.534 -0.729 . . . . 0.0 109.305 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.35 -25.46 9.81 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 124.742 3.628 . . . . 0.0 110.116 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.5 26.37 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.801 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.47 160.61 39.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.428 -0.795 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -129.98 154.25 47.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' HG21 ' A' ' 40' ' ' VAL . 7.5 tp -87.76 113.82 23.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.715 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.05 122.46 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.538 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.1 mm -96.14 111.01 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.378 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.23 -46.02 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.608 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.51 -166.32 36.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 -154.12 7.51 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 120.285 -1.715 . . . . 0.0 109.584 -0.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.38 73.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.943 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.625 -0.672 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.35 -36.1 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.704 . . . . 0.0 109.44 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.1 m-85 -62.88 -37.34 86.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 m -64.77 -34.59 78.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.1 78.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 56.5 m-85 -94.83 56.77 2.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.721 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -94.62 -29.37 14.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -98.27 34.13 2.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.535 -0.728 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -163.66 76.92 0.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.49 128.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.776 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 -41.94 3.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -98.12 137.1 37.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.594 -0.692 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 3' ' ' PHE . 15.6 mt -125.97 99.11 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.573 -0.704 . . . . 0.0 109.661 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 4' ' ' LEU . 19.6 mt -90.45 127.56 36.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.265 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -144.74 148.73 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -113.31 105.27 13.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -83.37 122.5 28.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.25 -174.27 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 -43.92 2.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.577 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.2 146.41 47.71 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.4 p -89.01 158.09 18.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -149.83 165.76 31.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.58 145.54 41.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.548 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.73 178.73 48.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.01 -27.86 8.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.925 . . . . 0.0 109.719 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -70.78 123.63 22.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.579 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -128.42 170.05 13.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.1 tpt -91.2 145.34 24.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.584 -0.697 . . . . 0.0 109.73 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.8 pt -64.18 166.21 11.33 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.53 106.68 2.04 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 125.039 3.826 . . . . 0.0 109.966 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 mt -109.45 163.34 13.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -99.29 114.62 27.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -96.67 8.45 44.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -87.44 -28.78 21.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 0.0 109.692 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.26 38.25 1.27 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -145.12 168.84 19.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 m -142.87 143.17 31.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.09 121.36 39.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.62 -30.2 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.56 -0.712 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.46 138.15 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -159.25 111.75 2.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -121.87 121.06 36.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.572 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.3 m -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.586 -0.696 . . . . 0.0 109.468 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 121.85 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.574 -0.704 . . . . 0.0 109.496 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.98 156.28 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.655 . . . . 0.0 109.505 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -167.06 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -63.27 -42.1 99.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.514 -0.741 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.6 m-20 -103.23 166.0 12.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.409 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.34 -29.01 2.64 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 125.176 3.917 . . . . 0.0 109.877 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.93 45.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 148' ' ' ASN . 42.8 mt -96.4 31.17 2.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 109.902 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.1 m -81.54 143.44 32.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.211 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.499 ' CG ' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -140.84 152.29 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.734 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.572 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.3 m -136.09 118.11 15.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -75.62 117.28 17.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.587 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -111.96 140.81 46.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.7 105.51 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 109.581 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 38.8 m95 -98.62 151.19 20.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.679 . . . . 0.0 109.36 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -141.06 153.65 45.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.592 -0.693 . . . . 0.0 109.524 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -71.6 149.0 46.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.593 -0.692 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.48 -48.3 56.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.507 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 109' ' ' ASP . 6.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.73 134.89 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.541 -0.725 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.6 m-85 -90.84 145.7 24.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.711 . . . . 0.0 109.309 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.1 tp -156.49 113.13 3.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.1 p90 -152.54 168.57 25.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.531 -0.731 . . . . 0.0 109.806 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.2 56.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.745 . . . . 0.0 109.439 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 13' ' ' ILE . 11.6 pt20 -143.93 165.09 28.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -105.2 -174.76 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.481 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -62.54 -28.91 70.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.98 -50.46 41.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.613 -0.68 . . . . 0.0 109.578 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.78 -20.09 3.68 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.56 141.14 52.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -1.127 . . . . 0.0 109.925 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.8 pt -111.05 -29.92 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.65 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -165.68 16.47 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -158.59 123.35 4.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.98 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.07 26.77 14.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.15 2.25 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.96 166.23 13.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.98 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD12 ' HM2' ' A' ' 170' ' ' MTX . 9.9 mt -85.9 147.91 46.91 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.558 -0.714 . . . . 0.0 109.44 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.23 -29.65 3.03 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 124.847 3.698 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -111.46 -173.73 2.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.687 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -145.09 101.15 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.91 82.21 6.6 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.33 -32.35 19.63 Favored 'Trans proline' 0 N--CA 1.507 2.266 0 C-N-CA 125.007 3.805 . . . . 0.0 109.909 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 12.8 t70 -62.86 -41.29 99.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.575 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.91 -29.18 70.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 27' ' ' LEU . 70.8 mt -67.0 -32.12 73.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.379 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 19.5 m-70 -64.09 -45.72 87.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.498 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -71.09 -30.45 66.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.521 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' THR . 71.1 t80 -66.23 -40.23 90.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.647 -0.658 . . . . 0.0 109.429 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -66.06 -35.25 80.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 109.521 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.72 63.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.54 -0.725 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -98.78 37.28 1.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.537 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.9 p -146.41 -45.28 0.19 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.56 -0.713 . . . . 0.0 109.571 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.94 119.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.823 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 28.31 24.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.11 -174.84 4.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.516 -0.991 . . . . 0.0 109.376 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.592 ' CG2' HG21 ' A' ' 60' ' ' VAL . 59.6 mt -107.37 102.48 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 54' ' ' LEU . 23.0 ttp -77.45 112.89 14.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -110.97 121.39 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -146.21 162.81 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.621 -0.675 . . . . 0.0 109.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.45 -165.01 40.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -82.64 -29.7 29.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.925 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtt85 -67.57 -41.14 84.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.535 -0.728 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 m -79.94 -32.39 40.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.616 -0.677 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.5 -36.98 84.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -76.71 -22.24 54.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.923 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -62.61 -27.51 69.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -73.21 145.68 86.04 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.748 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -80.15 -55.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.857 3.705 . . . . 0.0 109.893 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -96.84 93.37 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -101.78 139.87 20.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.32 -176.68 16.59 Favored 'Cis proline' 0 N--CA 1.507 2.305 0 O-C-N 123.229 1.121 . . . . 0.0 109.956 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.412 HD12 ' SD ' ' A' ' 39' ' ' MET . 55.0 mt -96.37 113.31 62.25 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.227 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -76.28 174.96 11.97 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 124.659 3.573 . . . . 0.0 110.057 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 62.37 31.73 17.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.759 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -178.52 163.04 1.5 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -87.32 123.15 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -94.61 140.5 29.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.571 -0.705 . . . . 0.0 109.745 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.3 t -142.4 101.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.0 109.291 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -96.94 144.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.555 -0.716 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 76' ' ' VAL . 14.2 tp -129.99 105.95 8.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.595 -0.691 . . . . 0.0 109.374 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 t -132.57 -178.72 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.409 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -112.09 29.93 7.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.705 . . . . 0.0 109.568 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -114.9 113.6 24.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 109.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.96 -5.38 43.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.625 -0.672 . . . . 0.0 110.581 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.56 20.53 18.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.033 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -93.35 85.62 5.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 109.321 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -86.97 107.66 18.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.563 -0.71 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.51 100.41 7.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.689 . . . . 0.0 109.434 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -66.32 129.93 41.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.99 -28.47 14.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.81 141.03 37.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -1.014 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.1 t -86.64 89.4 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -86.31 124.0 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.577 -0.702 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -126.26 -173.17 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.642 -0.661 . . . . 0.0 109.538 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -150.24 36.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -162.54 131.06 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.729 . . . . 0.0 109.619 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -35.64 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.85 81.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.605 -0.685 . . . . 0.0 109.391 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.67 86.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 33.4 t -62.83 -34.82 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 109.428 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -77.08 -33.25 57.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.31 86.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.444 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -64.62 -33.74 76.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.85 60.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.537 -0.727 . . . . 0.0 109.353 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -63.12 -41.91 99.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.516 -0.74 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -69.18 -30.74 69.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -118.31 91.52 41.04 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -77.98 -29.28 4.36 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.031 3.82 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.1 -30.23 71.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.545 -0.722 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.13 138.63 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -101.84 168.69 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.76 135.45 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.584 -0.698 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -126.71 123.77 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 ' CD2' ' A' ' 106' ' ' PHE . 41.0 mm -98.48 123.06 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.346 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.79 -27.91 10.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.798 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.19 -171.05 33.93 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.61 -159.16 9.18 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 120.33 -1.689 . . . . 0.0 109.493 0.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.25 89.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.955 . . . . 0.0 109.523 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -63.26 -35.55 80.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -70.91 -35.65 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.2 m-85 -63.82 -35.2 79.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 109.459 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 m -73.31 -31.43 64.01 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.61 -0.681 . . . . 0.0 109.586 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.79 91.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.709 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' CD2' HD12 ' A' ' 96' ' ' ILE . 63.2 m-85 -94.88 52.13 1.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.429 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.1 tptp -90.95 -30.0 17.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -75.09 -30.24 60.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.743 . . . . 0.0 109.649 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 1' ' ' THR . 0.9 OUTLIER -109.92 67.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -132.88 129.56 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.49 -0.756 . . . . 0.0 109.397 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -133.76 -64.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.613 -0.68 . . . . 0.0 109.406 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -79.43 109.08 13.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.568 -0.708 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 3' ' ' PHE . 18.1 mt -101.85 93.95 5.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.64 -0.663 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.6 ' CB ' HD12 ' A' ' 4' ' ' LEU . 9.0 mt -88.89 122.07 31.89 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -132.17 137.74 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 m -100.01 96.69 7.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.153 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -75.6 119.23 19.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.0 109.68 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.5 176.25 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.586 -0.696 . . . . 0.0 109.457 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.74 -42.9 4.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 141.41 36.74 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -89.02 156.86 18.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.965 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -148.85 162.92 38.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.637 -0.664 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.81 153.51 31.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.78 -175.71 46.37 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.6 -31.35 7.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.988 . . . . 0.0 109.572 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -71.39 104.11 3.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -111.5 165.03 12.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.1 tpt -85.77 146.55 26.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 0.0 109.421 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.9 pt -63.55 165.44 11.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.618 -0.676 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.96 99.59 1.2 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 125.095 3.863 . . . . 0.0 109.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.71 149.01 21.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.12 107.13 18.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.402 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -89.55 8.37 31.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.587 -0.696 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.21 -30.84 20.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.27 35.81 1.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.635 -0.666 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -142.59 167.56 21.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -142.65 152.24 42.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -102.94 137.74 40.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 109.44 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 140' ' ' SER . 25.8 m -128.94 -42.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.575 -0.703 . . . . 0.0 109.658 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 139' ' ' VAL . 3.4 m -112.61 137.44 50.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -0.758 . . . . 0.0 109.468 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -156.09 107.16 2.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -100.48 123.26 44.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.685 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -94.77 139.36 31.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.59 -0.694 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 t -141.55 128.3 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.556 -0.715 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' HG23 ' A' ' 152' ' ' THR . 44.8 mt-10 -110.36 131.79 54.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -89.22 -171.26 3.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.0 p -63.06 -35.51 80.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.71 162.5 19.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.645 -0.66 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.33 -29.46 2.46 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.178 3.919 . . . . 0.0 109.794 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.53 -23.27 46.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.893 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.4 mt -96.72 31.46 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.6 m -86.45 149.19 25.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -146.49 156.51 43.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.0 109.71 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.5 m -141.15 115.67 9.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.696 . . . . 0.0 109.445 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.13 108.27 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.78 131.75 50.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -109.53 109.81 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -104.5 131.47 51.85 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.665 -0.647 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -116.78 160.06 21.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.597 -0.689 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -76.6 155.58 33.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.694 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -73.13 100.7 3.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.47 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.541 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.9 115.2 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.493 -0.755 . . . . 0.0 109.819 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.1 m-85 -76.61 142.83 40.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.65 . . . . 0.0 109.328 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 114' ' ' LEU . 4.7 tp -154.92 105.32 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -143.57 167.33 22.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.517 -0.74 . . . . 0.0 109.686 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.31 135.23 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.352 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 172.66 13.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.675 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -115.87 -172.94 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.546 -0.721 . . . . 0.0 109.384 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -61.91 -28.19 69.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 109.9 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.96 -42.74 76.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.43 33.2 1.97 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.4 tp -96.3 158.26 15.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.952 . . . . 0.0 109.328 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 126' ' ' THR . 31.9 pt -145.72 28.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 109.629 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.61 176.18 22.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -163.58 114.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.647 -0.913 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.02 28.91 18.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.3 -44.06 2.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -93.97 162.99 13.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.565 -0.962 . . . . 0.0 109.31 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD11 ' C7 ' ' A' ' 170' ' ' MTX . 18.7 mt -74.68 153.37 87.34 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.707 . . . . 0.0 109.42 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.4 Cg_endo -80.17 -40.92 0.2 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 124.983 3.789 . . . . 0.0 109.871 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.8 p90 -101.46 -175.84 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -137.52 98.88 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.561 -0.712 . . . . 0.0 109.232 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD21 ' CG ' ' A' ' 153' ' ' HIS . 5.5 tp -115.31 82.62 9.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.524 -0.735 . . . . 0.0 109.708 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.1 Cg_exo -47.32 -36.29 22.56 Favored 'Trans proline' 0 N--CA 1.506 2.221 0 C-N-CA 124.965 3.777 . . . . 0.0 109.905 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.05 -42.24 97.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.703 -0.623 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB2' HD23 ' A' ' 23' ' ' LEU . 20.2 t0 -61.36 -29.43 69.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.588 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' PRO . 34.9 mt -69.37 -31.45 69.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.585 -0.697 . . . . 0.0 109.446 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -68.61 -37.45 79.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -69.17 -31.43 70.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 53.9 t80 -62.81 -39.08 93.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.6 -0.687 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 35' ' ' VAL . 42.7 ttt-85 -64.92 -30.88 71.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.82 -29.97 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -103.1 41.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.527 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.0 p -149.99 -46.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -61.31 127.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.45 66.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -148.71 -178.99 6.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.956 . . . . 0.0 109.494 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.8 mt -101.47 121.45 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.608 -0.682 . . . . 0.0 109.402 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.8 ttp -97.62 103.55 15.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.535 -0.728 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 94' ' ' LEU . 33.2 t -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -139.89 167.64 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.31 -166.47 41.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -80.43 -41.92 23.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.956 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -61.6 -29.57 70.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.577 -0.702 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -86.87 -30.55 21.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.87 -33.6 76.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -84.69 -22.84 29.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.637 -0.664 . . . . 0.0 109.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.5 m -62.66 -29.04 70.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 109.802 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.07 154.85 67.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -80.67 -60.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.986 3.79 . . . . 0.0 109.816 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -104.92 106.27 16.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -102.88 140.71 21.32 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.291 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.19 -173.64 12.71 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 O-C-N 123.154 1.081 . . . . 0.0 109.878 -0.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.1 mt -100.51 116.27 64.5 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -78.14 174.53 12.33 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.713 3.609 . . . . 0.0 110.036 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.14 32.58 20.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 110.112 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -178.49 165.24 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.606 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -91.05 120.66 32.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.95 128.21 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.547 -0.721 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -139.72 96.74 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.525 -0.734 . . . . 0.0 109.332 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.78 151.29 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.782 HD12 HG23 ' A' ' 76' ' ' VAL . 10.1 tp -132.22 114.14 14.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.679 -0.638 . . . . 0.0 109.297 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -129.82 176.35 8.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.492 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.9 32.82 5.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.543 -0.723 . . . . 0.0 109.313 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -138.51 143.52 39.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.604 -0.685 . . . . 0.0 109.423 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.77 29.44 3.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.359 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.47 -36.04 4.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.559 -0.713 . . . . 0.0 109.556 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -62.86 114.1 3.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.586 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -126.99 106.69 9.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.42 140.58 29.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -91.01 116.82 29.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.579 -0.7 . . . . 0.0 109.554 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.0 -43.44 1.7 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.79 157.68 18.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.951 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 t -99.86 113.5 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.605 -0.684 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.07 119.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.782 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -99.6 179.2 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.561 -0.712 . . . . 0.0 109.496 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -149.88 36.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.416 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t0 -170.55 127.19 0.78 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.23 -34.87 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 -34.04 77.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.508 -0.745 . . . . 0.0 109.52 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.02 -36.01 72.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 76' ' ' VAL . 32.3 t -62.75 -30.94 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 109.587 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -72.85 -38.52 67.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.615 -0.678 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.64 74.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.618 -0.676 . . . . 0.0 109.473 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.12 -29.55 69.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.04 62.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.705 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -62.32 -44.01 97.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.62 -0.675 . . . . 0.0 109.59 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -61.99 -27.75 69.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.689 . . . . 0.0 109.672 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -113.33 97.16 42.24 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.49 -44.94 0.14 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 124.951 3.767 . . . . 0.0 109.965 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.66 -38.18 89.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.728 . . . . 0.0 109.547 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.2 149.18 21.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.595 -0.691 . . . . 0.0 109.366 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -115.71 179.44 3.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 40' ' ' VAL . 15.8 tp -101.05 126.59 47.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.579 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -119.78 132.36 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.9 mm -109.62 117.04 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.62 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -103.34 -25.96 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.83 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.25 -171.42 30.17 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 -157.01 9.94 Favored Glycine 0 N--CA 1.5 2.918 0 O-C-N 120.34 -1.682 . . . . 0.0 109.628 0.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.96 74.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.607 -0.937 . . . . 0.0 109.615 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.37 -33.34 75.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.459 -0.776 . . . . 0.0 109.567 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' HD23 ' A' ' 62' ' ' LEU . 41.9 mm -77.18 -36.81 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.472 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.9 m-85 -64.61 -41.8 95.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.554 -0.716 . . . . 0.0 109.445 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 m -62.8 -32.93 74.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.504 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.07 83.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -98.15 47.47 1.0 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.559 -0.713 . . . . 0.0 109.373 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.3 tppp? -78.29 -45.76 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.609 -0.682 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.74 -31.67 35.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.603 -0.685 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.8 58.33 4.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 107' ' ' LYS . 8.0 p -137.18 141.58 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.64 -69.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.579 -0.701 . . . . 0.0 109.386 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 m -81.89 119.79 24.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.3 mt -107.81 96.97 6.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.8 mt -88.58 125.48 34.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.673 -0.642 . . . . 0.0 109.298 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 p -138.68 138.45 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.615 -0.678 . . . . 0.0 109.688 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.3 m -102.21 96.75 7.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.66 . . . . 0.0 109.235 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -75.93 126.34 30.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.616 -0.677 . . . . 0.0 109.616 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.79 -175.27 3.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.633 -0.667 . . . . 0.0 109.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.47 -41.78 2.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.483 -0.761 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.27 138.76 41.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 p -82.81 147.51 28.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.658 -0.907 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.64 156.78 44.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.615 -0.678 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -118.52 151.01 38.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.48 -166.68 35.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.95 -33.26 6.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.566 -0.961 . . . . 0.0 109.568 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -73.44 127.16 31.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -135.99 154.61 51.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.485 -0.759 . . . . 0.0 109.466 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.466 ' HA ' HD13 ' A' ' 13' ' ' ILE . 12.7 tpt -73.02 149.17 43.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 131' ' ' LEU . 11.1 pt -74.0 165.95 48.78 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.669 -0.644 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.55 102.1 1.38 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 125.073 3.849 . . . . 0.0 109.861 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 129' ' ' ILE . 13.3 mt -103.89 156.04 18.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.76 128.1 32.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.55 -27.16 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.596 -0.69 . . . . 0.0 109.73 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.33 -27.29 67.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.475 -0.766 . . . . 0.0 109.893 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -97.96 35.4 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.44 -0.788 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -153.09 147.85 26.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.9 m -131.47 147.31 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.569 -0.707 . . . . 0.0 109.267 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -90.18 144.81 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.532 -0.73 . . . . 0.0 109.423 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 140' ' ' SER . 28.9 m -124.85 -40.91 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.628 -0.67 . . . . 0.0 109.591 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -127.95 147.46 50.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.557 -0.715 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -153.8 102.85 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -88.87 123.53 33.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.4 m -101.24 122.85 44.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 155' ' ' TYR . 30.5 t -123.62 123.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.545 -0.722 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 152' ' ' THR . 32.0 mt-10 -98.32 135.16 40.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.61 -174.98 3.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.648 . . . . 0.0 109.546 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 p -62.88 -32.87 74.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.634 -0.666 . . . . 0.0 109.585 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 151' ' ' LEU . 64.2 m-80 -106.66 165.61 12.61 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.83 -35.51 0.73 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.06 3.84 . . . . 0.0 109.732 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.12 -27.73 59.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.615 -0.678 . . . . 0.0 109.609 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.576 ' O ' HD11 ' A' ' 23' ' ' LEU . 32.9 mt -86.37 8.58 21.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.435 -0.79 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 145' ' ' GLU . 4.0 m -70.64 146.18 50.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.049 -1.032 . . . . 0.0 109.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.654 ' CG ' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -148.03 153.98 39.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.576 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.4 m -131.57 119.85 22.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.637 -0.664 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 144' ' ' VAL . 75.4 m-85 -77.08 102.38 6.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.557 -0.714 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -92.08 128.84 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.34 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.2 t -109.43 97.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.663 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -90.81 147.94 22.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.651 -0.656 . . . . 0.0 109.36 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.98 156.95 47.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.682 . . . . 0.0 109.468 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -67.78 147.07 53.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.583 -0.698 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -108.37 -41.05 4.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.573 -0.704 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.417 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.54 115.76 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -72.32 141.0 48.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.69 -0.631 . . . . 0.0 109.403 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 114' ' ' LEU . 10.1 tp -148.16 112.1 5.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 109.475 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.9 p90 -151.32 153.98 35.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.737 . . . . 0.0 109.812 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' NA2' ' A' ' 170' ' ' MTX . . . -106.79 127.02 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.72 168.14 20.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 109.611 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -115.13 -173.85 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.8 -28.22 69.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -42.45 70.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.581 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.18 31.49 2.63 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.629 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.1 tp -98.51 149.68 22.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.926 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.461 HG13 HG22 ' A' ' 126' ' ' THR . 26.5 pt -140.08 30.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 109.676 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.31 167.9 14.4 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -158.33 118.75 3.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.608 -0.936 . . . . 0.0 109.59 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.84 26.76 13.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.227 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.53 -44.04 2.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -90.23 162.54 15.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.986 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.2 mt -79.13 152.36 76.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.731 . . . . 0.0 109.441 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.492 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.8 Cg_endo -80.3 -33.88 0.93 Allowed 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 125.014 3.809 . . . . 0.0 109.919 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.405 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 15.8 p90 -112.9 -179.34 3.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -132.19 100.33 4.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.2 tp -113.79 100.09 51.46 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.6 Cg_endo -74.29 -29.72 9.25 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 124.753 3.635 . . . . 0.0 109.819 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.46 -32.1 72.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' HB2' HD23 ' A' ' 23' ' ' LEU . 10.5 t70 -70.58 -29.58 66.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 24' ' ' PRO . 30.1 mt -62.06 -33.43 74.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.46 -0.775 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -67.59 -39.55 84.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.683 . . . . 0.0 109.381 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -73.51 -30.59 63.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.588 -0.695 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.5 t80 -69.77 -35.7 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.696 . . . . 0.0 109.509 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 35' ' ' VAL . 14.6 ttp180 -68.37 -42.09 79.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.79 66.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.703 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -97.17 36.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 0.0 109.676 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.8 p -150.07 -46.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.407 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.2 m -62.0 126.63 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.599 -0.688 . . . . 0.0 109.65 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 29.65 32.75 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -157.25 -179.08 7.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.545 -0.973 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.24 108.62 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.59 -0.694 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 45.9 ttp -89.16 117.66 28.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.54 -0.725 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.0 119.19 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.4 m -135.77 147.2 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 109.518 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -169.37 42.35 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -71.65 -29.51 64.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.947 . . . . 0.0 109.632 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -72.18 -30.68 65.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.538 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.5 m -93.19 -30.57 15.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.693 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 21.6 t80 -66.53 -37.17 84.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.496 -0.753 . . . . 0.0 109.561 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.76 -25.67 59.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.975 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -62.59 -28.92 70.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.682 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.14 148.64 97.67 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.4 -58.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 124.894 3.729 . . . . 0.0 109.86 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.43 99.41 8.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.358 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 3.0 mtm180 -98.58 141.19 22.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.83 176.46 35.21 Favored 'Cis proline' 0 N--CA 1.507 2.311 0 O-C-N 123.165 1.087 . . . . 0.0 109.775 -0.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.7 mt -91.62 126.55 53.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.325 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.4 174.02 12.45 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.731 3.62 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 tp10 61.22 29.95 18.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.554 -0.716 . . . . 0.0 109.702 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -177.55 168.02 2.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.736 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.94 127.87 44.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.682 -0.637 . . . . 0.0 109.346 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -101.79 129.86 48.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.57 -0.707 . . . . 0.0 109.651 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -126.22 96.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.74 124.54 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.534 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -115.07 105.94 13.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.657 -0.652 . . . . 0.0 109.324 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -141.39 -177.94 5.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -112.53 31.04 6.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.539 -0.726 . . . . 0.0 109.327 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.91 124.28 52.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.66 -5.24 58.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.543 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.73 18.88 21.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.112 -0.992 . . . . 0.0 110.11 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.59 94.33 8.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.93 107.65 18.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.61 19.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.605 -0.684 . . . . 0.0 109.453 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.38 138.83 40.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.679 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.89 -34.83 5.49 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -107.47 163.41 13.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.986 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 t -103.13 97.6 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.97 113.22 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -107.37 173.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -149.91 33.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -160.86 126.89 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.2 t -62.49 -35.88 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 109.495 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 -32.39 72.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.432 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.1 84.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.632 -0.667 . . . . 0.0 109.406 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.19 -30.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.602 -0.686 . . . . 0.0 109.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.86 -32.48 35.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.31 90.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.46 -40.41 93.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.467 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.84 72.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.639 -0.663 . . . . 0.0 109.416 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -64.07 -34.53 78.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.546 -0.721 . . . . 0.0 109.403 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -75.56 -28.57 59.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.1 m-70 -102.98 107.28 54.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.467 -0.771 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.23 -26.47 5.08 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.877 3.718 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -96.6 26.25 4.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.808 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -144.37 119.75 10.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.476 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.02 -179.08 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.593 -0.692 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -107.9 132.62 53.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.695 . . . . 0.0 109.366 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.2 mm -108.04 122.73 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.603 -0.686 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.06 -27.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.736 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 151.94 -173.04 31.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.73 -152.76 10.11 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 120.342 -1.681 . . . . 0.0 109.672 0.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.02 79.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.96 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.28 -29.51 70.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.56 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -80.02 -38.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -62.65 -40.36 96.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.579 -0.7 . . . . 0.0 109.528 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.78 -33.69 75.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.55 -0.719 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.53 -42.05 87.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.23 40.29 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -81.92 -29.4 32.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -98.61 31.4 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.721 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -160.93 77.1 0.57 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -161.01 147.23 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.389 -0.819 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.86 -55.21 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.584 -0.697 . . . . 0.0 109.328 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 m -86.75 121.19 28.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.691 -0.63 . . . . 0.0 109.362 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 3' ' ' PHE . 23.5 mt -109.71 104.85 13.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 4' ' ' LEU . 11.4 mt -95.18 131.16 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.7 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -149.61 147.79 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 109.649 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 m -106.98 114.66 28.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.635 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mtt-85 -87.95 115.81 25.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.97 166.63 12.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.626 -0.671 . . . . 0.0 109.384 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.84 -38.75 5.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.98 142.4 39.69 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -84.82 156.72 21.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.966 . . . . 0.0 109.403 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -149.94 166.56 29.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.532 -0.73 . . . . 0.0 109.664 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -124.2 144.48 49.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.626 -0.671 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.629 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -178.19 -177.9 47.24 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.72 -31.36 7.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.93 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.461 HG22 HG13 ' A' ' 13' ' ' ILE . 2.0 m -70.9 128.68 36.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -139.05 156.19 47.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.503 -0.748 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.8 tpt -79.65 147.63 31.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.447 HD11 HD21 ' A' ' 131' ' ' LEU . 7.9 pt -67.76 163.53 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.539 -0.726 . . . . 0.0 109.532 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.49 118.05 3.5 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 125.222 3.948 . . . . 0.0 109.869 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 129' ' ' ILE . 14.9 mt -118.24 179.94 3.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -102.65 126.09 49.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -101.46 -26.57 13.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.54 -0.725 . . . . 0.0 109.685 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.34 -26.07 66.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.411 -0.806 . . . . 0.0 109.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.02 30.59 3.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -150.21 129.1 12.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 m -103.58 152.82 21.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -87.56 114.5 24.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.606 -0.684 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.0 t -83.78 -56.24 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -128.25 167.64 16.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.518 -0.738 . . . . 0.0 109.579 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -165.98 97.43 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.47 129.35 34.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.695 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -99.71 131.24 45.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.682 -0.636 . . . . 0.0 109.393 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 145' ' ' GLU . 29.0 t -132.06 158.34 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.603 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.5 pp20? -141.26 158.55 43.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.6 -0.688 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.48 -166.84 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.599 -0.688 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.7 p -63.09 -30.84 71.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.5 -0.75 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -109.54 165.94 11.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.97 -32.46 1.45 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 125.056 3.837 . . . . 0.0 109.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.53 65.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.55 -9.81 58.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.63 -0.669 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' GLU . 6.5 m -58.41 141.79 50.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.141 -0.974 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 25.7 p-80 -144.78 164.13 31.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.537 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.643 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -142.64 115.83 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.56 135.18 48.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -124.82 132.44 53.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.603 -0.686 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.1 t -117.73 98.3 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.628 -0.67 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -91.28 160.41 15.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.561 -0.712 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -146.65 154.36 41.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -68.23 141.77 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.685 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -78.37 -63.94 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.698 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.483 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.665 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.3 124.6 24.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.521 -0.737 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.537 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.0 m-85 -86.59 125.07 33.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.63 -0.669 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.59 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.2 tp -139.27 114.32 9.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.605 -0.684 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.4 p90 -150.42 160.38 43.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.486 -0.759 . . . . 0.0 109.831 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 145.66 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.27 163.36 40.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -112.13 -172.37 2.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -61.07 -28.52 69.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -71.97 -42.18 66.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.545 -0.722 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.94 29.78 2.96 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.5 tp -99.03 129.99 45.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.978 . . . . 0.0 109.308 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 126' ' ' THR . 28.7 pt -104.4 -29.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.7 178.87 33.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 30.3 ttpt -155.14 117.83 4.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.567 -0.96 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 1.1 m-20 59.11 27.07 15.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.502 -0.749 . . . . 0.0 109.9 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.31 16.14 69.88 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.4 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 19.4 p80 -150.24 153.95 37.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.3 mt -72.94 144.49 85.37 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.7 Cg_endo -79.85 -38.39 0.37 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.849 3.699 . . . . 0.0 109.9 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.3 p90 -96.64 178.28 5.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -132.21 91.69 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.618 -0.676 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.636 HD21 ' ND1' ' A' ' 153' ' ' HIS . 9.7 tp -115.64 111.71 43.57 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.587 -0.695 . . . . 0.0 109.521 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.7 -29.34 3.63 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.805 3.67 . . . . 0.0 109.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.93 -38.09 89.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.602 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t70 -72.48 -30.54 64.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.6 mt -62.28 -31.34 71.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -66.59 -33.78 76.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.74 -32.82 71.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 48.6 t80 -69.56 -42.03 75.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -66.67 -31.11 71.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.41 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.45 -30.48 64.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.564 -0.71 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -101.59 39.45 1.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.664 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -146.87 -45.41 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 109.659 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.42 130.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.402 -0.811 . . . . 0.0 109.729 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 30.52 59.34 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -153.14 -179.07 7.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.25 99.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.33 121.07 25.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.657 -0.652 . . . . 0.0 109.603 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 t -104.88 125.38 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.72 160.53 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.04 -158.57 34.61 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.914 . . . . 0.0 109.509 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -65.1 -40.54 94.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -69.44 -36.86 77.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.719 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 40.4 t80 -64.04 -39.27 93.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.538 -0.726 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -79.35 -24.26 42.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.623 -0.673 . . . . 0.0 109.984 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 t -62.64 -28.93 70.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.816 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.9 m-85 -66.86 154.11 92.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.48 -59.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.041 3.827 . . . . 0.0 109.837 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.81 112.26 25.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.68 . . . . 0.0 109.352 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -118.27 142.22 30.86 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.73 156.32 80.69 Favored 'Cis proline' 0 N--CA 1.509 2.387 0 O-C-N 123.22 1.116 . . . . 0.0 109.751 -0.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.68 125.85 91.02 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 109.328 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.41 170.03 17.91 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.697 3.598 . . . . 0.0 109.993 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.01 29.75 19.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.615 -0.678 . . . . 0.0 109.752 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.29 144.7 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.599 -0.688 . . . . 0.0 109.58 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 m -84.55 123.16 30.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.46 136.82 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -127.43 106.04 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.565 -0.709 . . . . 0.0 109.486 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.9 t -86.97 109.95 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 76' ' ' VAL . 8.5 tp -98.41 104.79 16.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.443 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -136.25 166.61 23.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.61 -0.681 . . . . 0.0 109.398 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -99.69 35.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -139.33 131.73 28.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.714 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -98.73 29.16 3.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.56 -0.713 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -110.46 -31.07 7.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.322 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -62.68 107.17 0.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.11 117.25 28.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.588 -0.695 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -89.95 133.86 34.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -99.98 93.9 6.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.69 . . . . 0.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.19 9.45 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -96.01 162.14 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.593 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 75' ' ' VAL . 29.4 t -93.49 159.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' HG12 ' A' ' 74' ' ' VAL . 30.3 t -127.5 132.44 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.411 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -130.66 159.15 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.713 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -136.95 37.18 2.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 81' ' ' ALA . 10.5 p-10 -176.15 136.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.695 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.84 -29.59 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.66 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.68 90.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . . . -71.53 -38.33 71.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.585 -0.697 . . . . 0.0 109.37 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -63.13 -34.98 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.7 -33.12 47.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.665 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.02 85.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.718 . . . . 0.0 109.447 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.46 -36.72 71.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.52 -37.83 50.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.636 -0.665 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -67.63 -34.08 76.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.578 -0.701 . . . . 0.0 109.463 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.56 -29.39 63.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.605 -0.684 . . . . 0.0 109.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 8.8 m-70 -109.59 80.34 1.57 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.704 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.12 -43.37 57.7 Favored 'Trans proline' 0 N--CA 1.505 2.159 0 C-N-CA 124.625 3.55 . . . . 0.0 109.788 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.94 -33.35 75.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.606 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -89.95 131.59 35.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.561 -0.712 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -101.34 171.18 7.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.697 . . . . 0.0 109.462 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.0 tp -102.25 134.28 45.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.46 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -123.44 140.43 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.0 109.446 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.7 mm -112.35 114.12 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.698 . . . . 0.0 109.367 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.88 -43.08 6.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.48 -174.05 34.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.57 5.83 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.342 -1.681 . . . . 0.0 109.701 -0.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.32 -29.89 69.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.613 -0.934 . . . . 0.0 109.546 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.83 -30.32 70.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.536 -0.727 . . . . 0.0 109.598 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.8 mm -85.05 -36.52 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.349 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -64.91 -31.64 72.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.64 -0.663 . . . . 0.0 109.408 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.4 m -74.02 -33.31 63.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.657 -0.652 . . . . 0.0 109.583 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.78 -44.09 86.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 109.629 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -105.94 38.25 2.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.54 -0.725 . . . . 0.0 109.52 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -77.81 -31.51 51.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.704 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.42 36.18 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.497 -0.752 . . . . 0.0 109.468 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -157.27 51.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -135.33 150.86 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.7 -45.83 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.665 -0.647 . . . . 0.0 109.387 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -95.56 123.37 39.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 3' ' ' PHE . 39.7 mt -110.26 99.0 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.7 mt -95.81 125.25 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 109.285 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -140.65 146.84 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.73 . . . . 0.0 109.649 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -110.44 112.52 24.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -86.42 131.23 34.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.716 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.09 -176.5 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.51 -42.38 2.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.671 -0.643 . . . . 0.0 109.474 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.67 148.1 49.63 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.2 t -89.24 147.64 24.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.947 . . . . 0.0 109.483 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -148.51 140.38 23.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -110.52 143.52 40.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.54 -0.725 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.79 -164.81 22.01 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -113.75 -36.5 4.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.635 -0.92 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 5.2 m -76.63 120.54 21.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.547 -0.72 . . . . 0.0 109.557 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -128.87 163.73 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.5 tpt -80.29 145.22 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.27 165.62 37.58 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.694 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.77 106.65 1.84 Allowed 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 125.127 3.885 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -106.74 155.82 19.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.584 -0.698 . . . . 0.0 109.434 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -85.48 108.18 17.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.595 -0.69 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -87.59 8.24 26.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -29.6 36.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -96.8 40.2 1.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.486 -0.759 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -152.23 157.73 41.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -139.73 148.52 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -87.15 126.99 35.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.534 -0.729 . . . . 0.0 109.427 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.27 -30.39 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 0.0 109.575 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 t -131.35 154.72 48.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.3 t -169.72 116.42 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.469 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -117.75 129.13 55.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -92.99 135.96 33.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.628 -0.67 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -131.68 135.12 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.574 -0.704 . . . . 0.0 109.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -124.67 137.1 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.587 -0.695 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.08 -168.66 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.558 -0.714 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.3 p -63.4 -32.82 74.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.13 160.54 25.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.739 . . . . 0.0 109.505 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.04 -34.16 0.95 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.146 3.897 . . . . 0.0 109.795 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.76 -21.4 62.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 109.979 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 68.5 mt -96.35 33.83 1.71 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 0.0 109.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.3 m -93.13 135.83 33.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.516 -0.74 . . . . 0.0 109.164 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.636 ' ND1' HD21 ' A' ' 23' ' ' LEU . 30.0 p-80 -140.52 159.74 41.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.483 -0.761 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 143' ' ' THR . 28.8 m -140.23 121.13 14.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -72.3 133.93 45.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.611 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -128.19 111.24 13.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.639 . . . . 0.0 109.348 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -95.91 96.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.376 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -86.86 143.87 27.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.483 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -132.41 156.05 47.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -88.7 148.91 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -80.94 172.72 13.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.536 -0.727 . . . . 0.0 109.439 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.804 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.39 116.71 3.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -76.23 140.97 41.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.657 -0.652 . . . . 0.0 109.336 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.5 tp -152.59 114.57 4.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.469 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.6 p90 -154.05 162.36 41.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.593 -0.692 . . . . 0.0 109.729 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.08 133.03 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -140.65 173.87 11.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.78 -173.29 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -66.5 -29.31 69.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -0.761 . . . . 0.0 109.74 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -70.34 -36.04 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.39 27.86 4.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 124' ' ' GLY . 7.5 tp -99.3 134.52 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.57 -0.959 . . . . 0.0 109.45 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 126' ' ' THR . 24.0 pt -104.53 -28.95 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.611 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.78 -170.79 28.15 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -158.58 114.42 2.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.956 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.07 27.25 16.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.524 -0.735 . . . . 0.0 109.962 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.85 -44.19 2.23 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -89.81 161.79 15.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.973 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.647 HD12 ' HM2' ' A' ' 170' ' ' MTX . 11.0 mt -84.92 151.28 57.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.626 -0.671 . . . . 0.0 109.543 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.67 -27.79 3.83 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.978 3.786 . . . . 0.0 110.06 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.0 p90 -112.42 -174.71 2.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.673 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -139.41 102.28 4.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.8 tp -117.43 101.08 52.9 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.644 -0.66 . . . . 0.0 109.556 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.611 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.7 Cg_endo -76.0 -28.85 7.24 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.811 3.674 . . . . 0.0 109.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.98 -36.14 79.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.512 -0.743 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.605 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.1 t0 -67.6 -29.65 69.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 24' ' ' PRO . 22.2 mt -60.88 -35.02 75.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.495 -0.753 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -73.28 -33.71 65.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.446 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.2 t80 -68.76 -40.21 79.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.501 -0.749 . . . . 0.0 109.487 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -65.9 -30.01 70.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.537 -0.727 . . . . 0.0 109.443 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -31.02 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.507 -0.745 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -99.78 38.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.655 -0.653 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.7 p -148.7 -45.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.593 -0.692 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.42 131.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.771 . . . . 0.0 109.733 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.34 58.73 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -154.11 -178.84 7.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.975 . . . . 0.0 109.339 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.79 116.64 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.532 -0.73 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.523 ' CE ' HD12 ' A' ' 54' ' ' LEU . 37.3 ttp -88.52 124.12 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.542 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -108.22 126.73 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -144.01 162.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.17 -168.4 43.68 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -33.47 47.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.966 . . . . 0.0 109.321 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -71.55 -41.64 68.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.541 -0.725 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -72.62 -30.74 64.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.667 -0.645 . . . . 0.0 109.493 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -62.87 -57.65 10.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.707 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -63.43 -21.39 66.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.6 -0.687 . . . . 0.0 109.998 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.1 t -62.7 -31.54 72.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.51 149.11 98.51 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.698 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.87 -57.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 124.795 3.663 . . . . 0.0 109.863 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -99.77 106.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 109.382 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -115.72 141.45 27.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.9 Cg_endo -81.49 174.53 45.23 Favored 'Cis proline' 0 N--CA 1.508 2.327 0 O-C-N 123.223 1.117 . . . . 0.0 109.775 -0.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 39' ' ' MET . 96.7 mt -84.88 121.65 74.39 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.51 169.92 17.89 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 124.797 3.665 . . . . 0.0 110.019 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 61.35 26.28 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 109.861 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -178.73 151.59 0.56 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -80.57 155.66 26.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -127.55 139.05 53.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.556 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.01 120.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 t -104.22 122.33 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.575 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD13 ' CG2' ' A' ' 82' ' ' VAL . 22.5 tp -116.08 86.57 2.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.636 -0.665 . . . . 0.0 109.403 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -117.17 -13.6 10.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.344 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.6 t60 62.31 42.72 8.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.444 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -127.85 105.29 8.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.419 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.58 72.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.731 . . . . 0.0 109.474 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -164.92 -48.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 109.431 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -68.02 112.21 4.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.695 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -122.02 111.93 17.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.56 48.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.65 -0.657 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.69 134.11 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.66 10.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -115.39 160.0 20.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.55 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 t -131.9 116.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -107.71 -178.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -149.35 36.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.695 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 17.9 t70 -170.74 138.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -62.9 -37.19 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.79 88.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.583 -0.698 . . . . 0.0 109.507 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.68 78.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.618 -0.676 . . . . 0.0 109.454 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 76' ' ' VAL . 41.6 t -63.22 -35.23 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.611 -0.68 . . . . 0.0 109.372 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -74.85 -35.07 62.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.16 80.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.516 -0.74 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.49 -36.82 83.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.581 -0.7 . . . . 0.0 109.396 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -31.1 63.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 109.388 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.88 -41.7 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.83 -30.86 71.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.64 -0.662 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -116.55 92.41 37.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.532 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -77.58 -29.03 4.92 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.935 3.757 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.528 -0.732 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -91.22 161.12 15.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.76 160.94 20.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.625 -0.672 . . . . 0.0 109.409 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 94' ' ' LEU . 12.6 tp -93.72 112.67 24.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 109.49 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 t -110.32 128.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.648 -0.657 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 40' ' ' VAL . 36.0 mm -101.66 127.78 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.574 -0.704 . . . . 0.0 109.338 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -110.36 -27.88 8.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 109.827 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.98 -170.61 34.32 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.95 -155.78 16.16 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 120.283 -1.716 . . . . 0.0 109.566 0.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.0 86.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.956 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -63.89 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.19 -38.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.56 -40.01 95.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.689 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.7 m -62.12 -34.57 76.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.94 86.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -102.0 40.16 1.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.598 -0.689 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -80.69 -30.68 36.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.693 . . . . 0.0 109.496 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -98.8 33.34 2.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -157.87 73.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.692 . . . . 0.0 109.396 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -162.76 136.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.66 -41.58 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -98.43 121.4 40.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.308 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 10.5 mt -111.1 100.34 9.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.692 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' CB ' HD12 ' A' ' 4' ' ' LEU . 48.4 mt -92.1 125.54 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.1 p -143.38 139.29 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.748 . . . . 0.0 109.607 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 m -103.96 102.78 12.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -78.83 129.88 35.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.652 . . . . 0.0 109.606 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.35 -177.52 3.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.33 -42.6 3.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.51 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.41 142.16 42.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.3 p -86.09 154.79 21.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.97 . . . . 0.0 109.465 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -149.98 158.55 44.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.635 -0.666 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.85 152.56 32.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.736 . . . . 0.0 109.435 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 176.83 -174.73 47.27 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.35 -34.85 5.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.544 -0.974 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 13' ' ' ILE . 2.1 m -70.95 115.12 9.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -128.59 165.09 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.601 -0.687 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -84.91 146.93 27.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.8 pt -65.17 163.69 29.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.93 99.15 1.09 Allowed 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 125.142 3.894 . . . . 0.0 109.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mp -92.0 171.96 8.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.601 -0.687 . . . . 0.0 109.474 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -97.99 114.63 26.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -97.16 8.29 44.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.543 -0.723 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.07 -30.03 28.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.981 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.61 32.66 3.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -143.75 140.18 29.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.8 m -131.29 138.94 49.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.682 . . . . 0.0 109.359 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -67.49 138.06 56.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.598 -0.688 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.37 -35.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.72 . . . . 0.0 109.299 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -146.59 138.68 24.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 109.419 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -146.36 164.47 32.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -156.47 119.06 4.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.566 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.2 m -86.34 122.61 30.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.58 -0.7 . . . . 0.0 109.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.48 122.75 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.88 152.71 18.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -117.15 -173.41 2.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.616 -0.678 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -63.27 -41.48 99.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.409 ' HB2' HD12 ' A' ' 151' ' ' LEU . 3.1 m120 -101.44 164.73 15.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.06 -29.66 2.53 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.107 3.871 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.86 -19.55 44.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 148' ' ' ASN . 70.7 mt -95.94 27.34 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 146.93 30.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.428 -0.795 . . . . 0.0 109.161 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.433 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.4 p-80 -148.11 155.54 41.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.905 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 143' ' ' THR . 52.1 m -137.73 118.98 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.67 -0.644 . . . . 0.0 109.284 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -74.24 119.29 18.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.578 -0.701 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.33 131.76 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -115.54 100.36 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.603 -0.686 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.9 m95 -92.44 149.34 21.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.539 -0.726 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -135.49 156.99 48.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -89.76 103.89 16.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.69 . . . . 0.0 109.467 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 142.46 58.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.463 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.647 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.51 119.9 2.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.1 m-85 -72.02 147.37 46.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.677 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -156.78 112.3 2.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.7 p90 -155.96 157.59 36.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.605 -0.684 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.85 132.99 53.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.216 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.31 171.04 15.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.512 -0.743 . . . . 0.0 109.727 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -111.87 -173.46 2.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.686 . . . . 0.0 109.439 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.1 -29.11 70.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.689 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.68 -40.44 69.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.739 . . . . 0.0 109.502 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.87 32.27 2.49 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 20' ' ' PRO . 7.9 tp -94.24 137.46 33.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.981 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -113.52 -32.12 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.76 178.31 30.78 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -162.73 118.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.663 -0.904 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.38 26.83 12.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.536 -0.728 . . . . 0.0 110.087 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.2 -44.26 2.33 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -95.35 174.05 7.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -1.022 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.34 155.49 48.9 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.554 -0.716 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.5 Cg_endo -80.55 -40.47 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.045 3.83 . . . . 0.0 110.038 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -95.56 -174.24 3.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.612 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -144.57 89.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.599 -0.688 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.2 tp -114.39 113.38 45.77 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.46 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -78.36 -28.98 4.16 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 124.755 3.637 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.0 -34.15 77.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -0.762 . . . . 0.0 109.466 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.709 ' HB2' HD23 ' A' ' 23' ' ' LEU . 23.5 t0 -70.89 -32.34 69.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.39 -35.09 79.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.668 -0.645 . . . . 0.0 109.34 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -65.25 -39.55 92.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -70.72 -32.93 70.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 170' ' ' MTX . 50.7 t80 -68.28 -35.71 78.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.402 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -75.98 -30.25 58.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.85 65.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.557 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -98.94 38.1 1.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.432 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 p -150.04 -44.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.3 m -59.62 118.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.882 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.28 13.65 55.5 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -172.25 3.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.312 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 86' ' ' ALA . 39.6 mt -107.57 118.48 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.9 ttp -92.7 112.76 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.633 -0.667 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -94.99 130.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.384 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.8 m -147.08 160.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.66 -0.65 . . . . 0.0 109.59 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.01 -165.28 40.02 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -82.05 -36.26 27.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.572 -0.957 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -30.16 68.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.476 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -84.9 -32.67 23.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -63.14 -39.75 95.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -73.83 -23.83 59.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.3 t -62.64 -28.55 69.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 109.709 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.32 153.32 92.85 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.523 -0.736 . . . . 0.0 109.407 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.65 -60.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 125.024 3.816 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -106.87 101.34 10.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.683 -0.636 . . . . 0.0 109.296 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -98.15 138.6 20.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.582 -0.699 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.709 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 10.8 Cg_endo -82.69 -175.88 15.64 Favored 'Cis proline' 0 N--CA 1.507 2.279 0 O-C-N 123.232 1.122 . . . . 0.0 109.852 -0.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 54' ' ' LEU . 83.2 mt -98.48 126.59 38.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.708 . . . . 0.0 109.271 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.54 170.75 16.76 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 124.749 3.632 . . . . 0.0 110.066 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 61.39 27.43 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.901 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -178.36 158.39 1.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 109.549 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 m -91.97 138.68 31.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -112.38 135.61 52.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 109.584 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.46 122.7 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.42 121.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.52 -0.737 . . . . 0.0 109.622 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 tp -111.65 86.34 2.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.543 -0.723 . . . . 0.0 109.282 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 65' ' ' GLN . 4.1 t -114.77 -16.63 11.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.653 . . . . 0.0 110.243 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 m80 59.53 37.95 22.57 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.295 -0.878 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 63' ' ' THR . 7.2 tt0 -129.86 105.74 8.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.659 . . . . 0.0 109.432 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -72.52 65.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.59 -0.694 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -157.22 -47.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.393 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.44 113.18 5.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.684 . . . . 0.0 109.534 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.3 148.24 26.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.53 -0.731 . . . . 0.0 109.409 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.17 112.45 6.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.482 -0.761 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.04 129.5 34.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.41 -36.19 4.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -101.32 151.98 21.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.965 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.26 121.35 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.399 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.0 121.83 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -112.96 166.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.522 -0.736 . . . . 0.0 109.43 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -144.41 30.27 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -156.24 129.08 7.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.617 -0.677 . . . . 0.0 109.522 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.02 -38.85 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 109.58 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.79 81.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.1 93.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.76 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.728 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -79.67 -45.29 19.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.77 -28.47 69.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.546 -0.721 . . . . 0.0 109.756 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -62.22 -66.9 0.47 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.505 -0.747 . . . . 0.0 109.458 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -60.8 -29.39 69.43 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -62.5 -28.13 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.683 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -80.44 -30.14 37.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 109.769 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -116.55 77.15 7.79 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.493 -0.754 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -47.03 -32.58 13.34 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 125.104 3.869 . . . . 0.0 110.064 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.68 -32.36 73.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.572 -0.705 . . . . 0.0 109.436 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.08 136.66 32.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -99.85 -174.41 2.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.48 112.34 13.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.573 -0.705 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -110.53 147.67 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.533 -0.729 . . . . 0.0 109.305 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.485 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.5 mm -114.61 125.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.16 -28.31 10.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.68 -168.29 32.75 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.1 -155.1 7.6 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 120.294 -1.709 . . . . 0.0 109.559 -0.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.52 -33.32 75.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.944 . . . . 0.0 109.558 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -68.23 -32.55 72.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.8 mm -72.98 -37.96 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.474 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 96' ' ' ILE . 19.5 m-85 -61.95 -38.46 88.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.6 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 m -65.46 -31.73 72.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.738 . . . . 0.0 109.419 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.63 -45.33 79.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -101.44 36.96 1.89 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.594 -0.692 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -80.87 -33.81 34.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.69 36.08 1.57 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -161.03 72.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 109.316 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 112' ' ' THR . 8.3 p -164.23 136.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 0.0 109.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -123.22 23.08 9.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 109.692 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 110' ' ' VAL . 10.7 m -159.59 111.61 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.173 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 3' ' ' PHE . 74.2 mt -104.6 100.95 10.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.606 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.3 mt -91.15 123.92 34.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.715 . . . . 0.0 109.139 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -142.71 143.78 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.758 . . . . 0.0 109.865 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -106.15 102.09 11.53 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -77.96 123.19 26.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.06 166.29 11.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.689 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -100.02 -37.4 9.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.57 147.82 47.5 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 t -94.82 152.47 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.972 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -150.0 147.67 28.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.7 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -116.7 151.29 36.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.59 -0.694 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.58 -141.14 3.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.73 -45.4 0.81 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 13' ' ' ILE . 1.8 m -71.2 112.28 7.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.635 -0.665 . . . . 0.0 109.479 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -121.6 167.39 12.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -84.75 145.45 27.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 pt -63.56 165.67 11.25 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.559 -0.713 . . . . 0.0 109.374 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.44 96.03 1.06 Allowed 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 125.035 3.824 . . . . 0.0 109.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.62 178.68 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.628 -0.67 . . . . 0.0 109.394 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -110.79 123.62 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.375 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -100.27 -28.25 13.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.63 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.72 -25.37 66.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 109.976 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -96.66 35.59 1.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.431 -0.793 . . . . 0.0 109.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -152.77 157.65 41.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.778 . . . . 0.0 109.318 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -119.0 148.36 43.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.543 -0.723 . . . . 0.0 109.415 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -88.2 125.3 34.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.685 . . . . 0.0 109.311 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 t -103.14 -49.06 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 t -126.34 157.74 37.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.3 t -170.04 86.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.659 -0.65 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 11.2 ttt180 -96.72 134.15 40.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.578 -0.701 . . . . 0.0 109.577 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 24.2 m -102.9 124.53 48.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 t -118.34 126.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.639 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -90.1 149.3 22.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.316 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -172.82 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.5 p -66.45 -34.27 77.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.605 -0.684 . . . . 0.0 109.595 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -113.1 137.5 21.96 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.62 -37.47 63.72 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 124.571 3.514 . . . . 0.0 109.694 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -19.81 61.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.652 -0.655 . . . . 0.0 110.243 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.84 18.67 7.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 19.6 m -76.53 138.13 40.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 109.291 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.605 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.3 p-80 -138.46 155.24 48.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 109.674 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' ARG . 32.0 m -135.43 116.71 14.54 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.667 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -76.29 111.59 11.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.59 127.25 55.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.69 89.33 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.691 -0.63 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 60.9 m95 -81.17 138.38 35.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.579 -0.7 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.58 147.94 52.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.521 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -74.48 119.07 18.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 139.42 58.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.58 -0.7 . . . . 0.0 109.434 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.542 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.8 128.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.716 . . . . 0.0 109.62 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.7 m-85 -74.85 158.05 34.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.4 tp -161.46 107.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.45 -0.781 . . . . 0.0 109.655 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.3 p90 -151.95 161.58 42.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.55 -0.719 . . . . 0.0 109.714 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.17 132.28 55.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.558 -0.714 . . . . 0.0 109.413 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.82 168.52 19.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -113.11 -174.27 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.82 -28.32 68.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.75 . . . . 0.0 109.786 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.69 -51.32 23.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 109.594 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.88 3.82 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.23 141.78 49.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.221 -1.164 . . . . 0.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 126' ' ' THR . 33.7 pt -112.81 -31.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.684 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.98 -165.99 13.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -159.64 112.38 2.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.929 . . . . 0.0 109.631 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 57.81 29.06 16.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 109.981 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.11 2.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -91.18 156.68 17.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.931 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.0 mt -74.61 148.06 85.12 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.553 -0.717 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -78.33 -39.69 0.41 Allowed 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 124.848 3.699 . . . . 0.0 109.947 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 26.4 p90 -99.28 -175.4 3.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.675 . . . . 0.0 109.581 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -130.72 108.49 9.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.548 -0.72 . . . . 0.0 109.38 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 26' ' ' ASP . 5.6 tp -122.92 96.38 45.13 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.651 -0.655 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.6 Cg_endo -71.59 -28.44 17.44 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.67 3.58 . . . . 0.0 109.864 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -69.96 -31.33 68.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.633 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.1 t0 -73.53 -29.85 62.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 0.0 109.447 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD21 ' C12' ' A' ' 170' ' ' MTX . 14.2 mt -59.79 -32.06 70.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 0.0 109.753 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -70.99 -30.81 67.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.664 -0.647 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -78.23 -39.77 39.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -59.1 -28.16 66.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 110.083 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.547 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.7 ttp180 -77.77 -27.89 50.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' NE2' ' A' ' 33' ' ' GLN . . . -70.67 -39.71 73.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 109.717 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.793 ' NE2' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mp0 -94.34 43.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.776 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -150.15 -53.52 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.407 -0.808 . . . . 0.0 109.589 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.05 116.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 -27.01 22.2 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -104.53 -178.95 3.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.511 -0.994 . . . . 0.0 109.626 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.13 127.68 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.9 ttp -97.94 101.31 12.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.705 . . . . 0.0 109.549 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.7 t -91.2 125.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.641 . . . . 0.0 109.392 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.3 m -147.74 165.55 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.703 -0.623 . . . . 0.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.24 -165.72 39.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mtm105 -80.24 -39.04 29.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.578 -0.954 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -63.12 -35.57 80.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.605 -0.684 . . . . 0.0 109.549 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 m -80.05 -31.71 39.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 42.9 t80 -62.73 -41.17 99.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.591 -0.693 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -70.89 -24.62 62.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.633 -0.667 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -62.79 -29.41 70.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 34.4 m-85 -64.38 156.74 75.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -81.36 -60.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.088 3.859 . . . . 0.0 109.722 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 112.95 25.13 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -107.4 141.66 23.45 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.611 -0.681 . . . . 0.0 109.468 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -81.92 174.5 44.25 Favored 'Cis proline' 0 N--CA 1.507 2.297 0 O-C-N 123.232 1.122 . . . . 0.0 109.757 -0.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 81.0 mt -88.48 117.61 68.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.5 176.95 9.05 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.755 3.637 . . . . 0.0 110.007 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 61.63 26.07 15.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.585 -0.697 . . . . 0.0 109.863 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -178.96 177.94 0.79 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.445 -0.785 . . . . 0.0 109.449 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -104.13 149.72 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.601 -0.687 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -128.2 134.19 48.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.68 . . . . 0.0 109.544 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.12 104.17 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.602 -0.687 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -87.71 126.38 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.601 HD12 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -108.17 101.36 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -128.05 159.84 33.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -98.08 37.53 1.42 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.44 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -133.66 137.59 45.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.26 34.23 2.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -141.91 33.42 1.57 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -91.68 148.59 22.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.555 -0.716 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -110.44 110.63 21.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.687 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.78 90.09 2.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.562 -0.711 . . . . 0.0 109.474 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.47 126.1 31.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.5 -36.38 4.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.96 178.74 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.989 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -112.84 117.78 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 t -95.43 108.43 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.549 -0.719 . . . . 0.0 109.413 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -103.74 172.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.594 -0.692 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -149.06 33.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 12.5 t70 -173.53 136.74 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.443 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.69 -32.16 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.69 -35.68 81.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.456 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.3 69.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.42 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -63.75 -30.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.448 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.89 -31.6 22.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.34 71.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.601 -0.687 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -73.49 -34.54 65.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.545 -0.722 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.06 -32.22 39.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -66.17 -28.35 68.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.679 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.71 -31.29 57.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.749 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -116.0 76.83 6.53 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.51 -39.02 16.85 Favored 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 125.161 3.907 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.28 -34.15 77.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -90.15 122.26 32.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.714 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.0 -175.62 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.15 132.57 52.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.489 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -120.71 113.46 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.1 mm -92.35 120.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.461 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.621 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.3 -30.41 8.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.572 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.77 -172.31 31.84 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.37 -159.8 9.52 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.289 -1.713 . . . . 0.0 109.554 0.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.98 71.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.961 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -63.92 -34.09 77.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.713 . . . . 0.0 109.405 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.19 -36.46 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.646 -0.659 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.6 m-85 -63.77 -41.73 97.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.64 -0.662 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -63.23 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.663 -0.648 . . . . 0.0 109.693 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.33 76.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.481 ' CD2' HD12 ' A' ' 96' ' ' ILE . 77.3 m-85 -100.56 41.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.492 -0.755 . . . . 0.0 109.587 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -93.34 -33.39 13.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 109.486 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.79 -29.9 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -114.97 70.23 0.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.554 -0.716 . . . . 0.0 109.321 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -133.09 139.83 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 109.416 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.05 -70.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.604 -0.685 . . . . 0.0 109.331 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.7 m -72.17 119.44 16.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.271 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 3' ' ' PHE . 21.5 mt -112.13 98.54 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' HB2' HD12 ' A' ' 4' ' ' LEU . 12.0 mt -90.54 123.8 34.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.263 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.7 p -143.18 148.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.476 -0.765 . . . . 0.0 109.601 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.0 m -107.27 106.01 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.674 -0.641 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -81.45 116.89 21.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.666 -0.646 . . . . 0.0 109.5 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.78 176.14 6.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.54 -37.44 5.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.704 . . . . 0.0 109.469 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.36 150.67 50.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.0 p -96.58 147.66 23.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.923 . . . . 0.0 109.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.86 153.6 38.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.46 158.65 24.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.74 -148.29 7.02 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -127.17 -43.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.561 -0.964 . . . . 0.0 109.499 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -70.93 120.54 16.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.641 -0.662 . . . . 0.0 109.481 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -124.93 170.12 11.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -89.45 142.59 27.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 pt -62.49 165.96 8.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.585 -0.697 . . . . 0.0 109.54 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.08 96.96 1.03 Allowed 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.057 3.838 . . . . 0.0 109.865 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -94.97 156.86 16.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -89.42 113.23 24.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -90.1 -26.01 20.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.567 -0.708 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -60.32 -27.01 67.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 109.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.76 35.97 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.51 -0.744 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -147.35 172.37 13.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.9 m -145.11 157.14 44.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -91.82 136.9 32.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.3 t -118.02 -65.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.575 -0.703 . . . . 0.0 109.464 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 m -107.3 144.16 34.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.55 -0.719 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.5 t -148.2 108.49 4.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 115.01 27.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -84.46 149.07 26.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.692 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 153' ' ' HIS . 27.8 t -138.33 109.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.474 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.6 tm-20 -89.06 123.08 33.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.33 -174.48 3.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.647 -0.658 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 p -62.68 -42.29 99.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.59 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -102.54 166.56 11.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.74 -30.24 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.144 3.896 . . . . 0.0 109.765 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.3 -24.21 50.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.649 -0.657 . . . . 0.0 109.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.95 26.49 4.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.1 m -84.07 140.57 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.424 -0.797 . . . . 0.0 109.128 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HE2' HG11 ' A' ' 144' ' ' VAL . 32.7 p-80 -143.49 151.93 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 109.801 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.671 HG23 ' HA ' ' A' ' 143' ' ' THR . 46.3 m -132.22 112.63 12.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.659 . . . . 0.0 109.335 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -65.74 98.57 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.8 129.69 40.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -114.32 90.41 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.614 -0.679 . . . . 0.0 109.55 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -83.07 140.23 32.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -130.26 147.83 52.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -72.57 125.88 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.59 156.92 35.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.473 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.511 ' C12' HD21 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.83 138.88 32.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -105.63 117.24 33.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.732 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.614 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.9 tp -132.99 115.95 15.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.541 -0.724 . . . . 0.0 109.28 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.44 163.64 39.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.73 . . . . 0.0 109.728 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.67 132.72 56.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -144.25 173.41 11.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.57 -0.706 . . . . 0.0 109.691 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -114.0 -173.71 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.414 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -64.36 -26.97 68.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.57 -37.66 62.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 109.538 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.34 30.52 3.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 tp -94.72 151.18 19.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.617 -0.931 . . . . 0.0 109.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 126' ' ' THR . 14.8 pt -145.96 31.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.17 11.09 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -162.39 121.65 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.964 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.55 27.26 16.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.14 -44.14 2.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -97.96 176.15 5.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.991 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.64 151.27 64.58 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.43 -30.66 2.42 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 124.875 3.717 . . . . 0.0 109.992 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 24.9 p90 -109.39 -175.44 2.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.63 -0.669 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -140.21 109.93 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.232 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' ND1' ' A' ' 153' ' ' HIS . 15.3 tp -134.2 108.25 11.4 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.701 . . . . 0.0 109.538 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' HD12 ' A' ' 27' ' ' LEU . 8.1 Cg_endo -77.17 -29.59 4.92 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 124.76 3.64 . . . . 0.0 109.782 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.67 -37.51 87.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.707 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.5 t0 -72.3 -30.39 64.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 24' ' ' PRO . 15.9 mt -65.9 -34.21 77.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -63.08 -45.09 93.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.522 -0.736 . . . . 0.0 109.601 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -64.18 -31.07 72.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 109.457 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -66.21 -29.87 70.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.704 -0.622 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -79.97 -36.48 36.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.1 -28.91 67.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.703 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -102.0 42.69 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -150.0 -45.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -59.75 114.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.5 8.3 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -153.34 -173.67 4.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -1.008 . . . . 0.0 109.368 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.51 106.32 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ttp -82.56 125.89 31.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.634 -0.666 . . . . 0.0 109.581 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 t -115.92 119.02 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.609 -0.682 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.4 m -132.95 163.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.08 -163.13 38.91 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.607 ' HD3' HG21 ' A' ' 63' ' ' THR . 18.7 ttp85 -85.39 -41.61 15.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.621 -0.929 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -64.53 -36.19 83.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' HE1' ' A' ' 49' ' ' PHE . 25.7 m -76.11 -51.52 12.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.447 -0.783 . . . . 0.0 109.483 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 49' ' ' PHE . 25.8 t80 -60.04 -26.32 66.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.565 -0.709 . . . . 0.0 110.047 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -74.19 -21.73 59.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 p -95.72 26.31 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.301 -0.874 . . . . 0.0 109.935 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 46' ' ' TYR . 3.2 m-85 -85.99 155.06 58.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.298 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -79.62 -61.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 124.93 3.753 . . . . 0.0 109.848 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -120.56 93.13 3.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -87.47 137.16 32.49 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -84.6 -173.21 10.13 Favored 'Cis proline' 0 N--CA 1.506 2.252 0 O-C-N 123.115 1.061 . . . . 0.0 109.825 -0.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 54' ' ' LEU . 19.9 mt -101.85 117.96 60.48 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.77 172.7 13.85 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.763 3.642 . . . . 0.0 109.984 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 61.33 27.9 17.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -178.6 173.65 1.29 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.597 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -104.52 147.44 27.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.427 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -123.6 137.05 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.536 -0.728 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -137.05 111.66 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 76' ' ' VAL . 30.0 t -90.27 137.55 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.676 HD12 HG23 ' A' ' 76' ' ' VAL . 6.2 tp -133.35 97.93 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 43' ' ' ARG . 4.1 t -131.17 4.1 4.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.619 -0.676 . . . . 0.0 110.609 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 56.78 32.6 21.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.053 -1.03 . . . . 0.0 110.061 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -124.82 130.26 52.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.457 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.73 31.76 2.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.73 -41.56 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.701 . . . . 0.0 109.485 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.86 120.59 16.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 109.376 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.08 109.5 18.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.2 129.41 35.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -96.65 118.72 33.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.653 -0.654 . . . . 0.0 109.475 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -43.84 1.63 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.71 18.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -1.008 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 75' ' ' VAL . 32.0 t -76.29 160.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.366 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' NE2' ' A' ' 77' ' ' HIS . 27.7 t -134.69 123.27 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.541 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG23 HD12 ' A' ' 62' ' ' LEU . 20.8 m -111.26 166.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.269 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' NE2' HG12 ' A' ' 75' ' ' VAL . 51.2 m-70 -149.88 32.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.433 -0.792 . . . . 0.0 109.518 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 m-20 -162.36 139.67 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.478 -0.764 . . . . 0.0 109.604 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.18 -43.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 -35.45 80.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.73 81.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.332 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 78' ' ' ASP . 44.2 t -63.54 -40.88 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -77.5 -30.71 53.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -36.1 82.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.705 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -74.6 -37.05 62.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.509 -0.745 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.97 62.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.573 -0.704 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -63.26 -40.05 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -63.96 -30.58 71.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.478 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.96 93.19 46.36 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.666 -0.646 . . . . 0.0 109.458 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -76.29 -29.06 6.6 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.832 3.688 . . . . 0.0 109.882 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.84 -31.89 73.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.606 -0.684 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -98.29 151.38 20.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.518 -0.739 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -112.37 161.98 16.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.78 121.41 34.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.27 126.39 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.703 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -96.2 130.37 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.674 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -112.93 -32.26 6.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.8 -172.98 35.1 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.65 -156.93 9.99 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 120.389 -1.653 . . . . 0.0 109.629 -0.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.34 80.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -62.71 -33.13 74.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 62' ' ' LEU . 42.6 mm -76.11 -36.31 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.552 -0.718 . . . . 0.0 109.423 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -65.67 -35.23 80.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.705 . . . . 0.0 109.576 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 m -73.04 -33.41 65.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.527 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.18 92.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -101.71 45.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -84.57 -30.62 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.444 -0.785 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.02 35.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.524 -0.735 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.99 73.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.48 141.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.52 -42.79 2.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -94.68 127.53 40.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 3' ' ' PHE . 63.6 mt -116.85 98.34 6.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.587 -0.695 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.614 ' CB ' HD12 ' A' ' 4' ' ' LEU . 7.9 mt -94.29 127.39 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.99 148.6 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -110.17 99.36 8.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.44 126.76 31.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.592 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 152' ' ' THR . 0.2 OUTLIER -103.68 144.72 31.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.649 -0.657 . . . . 0.0 109.296 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.35 37.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.612 -0.68 . . . . 0.0 109.519 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.51 135.07 35.94 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 p -90.96 143.9 26.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.527 -0.984 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -145.05 151.58 38.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.685 . . . . 0.0 109.398 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -120.49 149.38 42.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.99 -155.31 11.33 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.34 -36.97 5.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.603 -0.939 . . . . 0.0 109.497 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 13' ' ' ILE . 2.5 m -72.77 108.06 5.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -120.23 159.92 23.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.444 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -90.11 149.33 22.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.636 -0.665 . . . . 0.0 109.48 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.3 pt -75.33 160.39 79.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.567 -0.708 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.57 113.38 3.09 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 125.086 3.858 . . . . 0.0 109.873 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.0 mt -102.49 148.59 25.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.643 -0.661 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.9 118.09 12.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.723 . . . . 0.0 109.462 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -101.62 8.22 41.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.484 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -88.33 -29.91 19.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.82 36.98 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -144.74 162.88 35.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -141.88 150.82 42.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -95.57 130.36 42.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.3 -30.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.411 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.0 m -135.84 148.95 48.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.693 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.2 t -158.23 101.9 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -102.41 136.0 43.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.495 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.3 m -101.61 133.18 46.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.429 HG11 ' HE2' ' A' ' 153' ' ' HIS . 31.6 t -129.3 118.94 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.584 -0.697 . . . . 0.0 109.595 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' A' ' 152' ' ' THR . 2.9 mp0 -96.27 158.2 15.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.51 -170.77 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.561 -0.712 . . . . 0.0 109.432 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.2 p -62.59 -44.42 96.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.545 -0.722 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -102.58 165.87 12.99 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.602 -0.686 . . . . 0.0 109.295 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.66 -29.56 3.54 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.071 3.847 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.31 -21.95 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.042 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.92 26.3 4.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.322 -0.862 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.621 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.0 m -85.28 135.11 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 108.946 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.707 ' ND1' HD21 ' A' ' 23' ' ' LEU . 37.3 p-80 -134.53 159.19 41.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 109.895 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.608 HG22 ' OE1' ' A' ' 156' ' ' GLU . 29.5 m -139.51 126.26 20.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -82.91 111.73 19.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.546 -0.721 . . . . 0.0 109.612 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -106.74 122.32 46.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.631 -0.668 . . . . 0.0 109.368 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -104.08 85.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.391 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -78.24 131.41 37.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -115.43 150.93 35.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -88.29 145.5 25.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.584 -0.697 . . . . 0.0 109.401 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -62.06 -178.47 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.479 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 2.2 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.62 128.9 4.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.695 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.607 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -70.37 158.75 35.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.647 -0.658 . . . . 0.0 109.353 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.56 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.6 tp -161.32 109.74 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.529 -0.732 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.2 p90 -154.29 169.56 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.471 -0.768 . . . . 0.0 109.798 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.61 125.67 47.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.7 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.27 178.34 7.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.563 -0.71 . . . . 0.0 109.734 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -123.36 -171.65 2.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.607 -0.683 . . . . 0.0 109.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.75 -37.56 76.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -0.752 . . . . 0.0 110.052 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.55 -47.62 63.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.576 -0.702 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.08 39.02 0.71 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HG3' ' A' ' 20' ' ' PRO . 5.2 tp -98.86 135.53 40.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.671 -0.899 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 pt -130.37 31.89 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.03 159.35 9.52 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -151.97 113.22 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 28.14 17.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.54 -0.725 . . . . 0.0 109.86 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.25 -44.16 2.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -94.9 168.25 10.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.49 -1.006 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD12 ' HM2' ' A' ' 170' ' ' MTX . 17.5 mt -78.2 149.19 75.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 0.0 109.415 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -78.37 -40.27 0.36 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 124.836 3.691 . . . . 0.0 109.948 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.2 p90 -101.65 -174.92 2.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.63 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -142.08 94.82 2.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.64 -0.662 . . . . 0.0 109.343 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 26' ' ' ASP . 9.0 tp -118.31 118.07 34.32 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.648 -0.658 . . . . 0.0 109.42 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 27' ' ' LEU . 9.4 Cg_endo -79.08 -30.46 2.71 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 124.728 3.618 . . . . 0.0 109.854 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.45 -40.09 95.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.576 -0.703 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.5 t0 -69.67 -29.67 67.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.536 -0.727 . . . . 0.0 109.465 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 24' ' ' PRO . 57.6 mt -71.82 -35.51 69.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.414 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -62.62 -39.84 95.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -68.52 -35.34 77.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.642 -0.661 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 34' ' ' THR . 47.3 t80 -62.82 -44.78 95.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.587 -0.695 . . . . 0.0 109.502 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -66.05 -33.48 75.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.566 -0.709 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.14 -30.07 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -98.35 35.7 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.6 p -144.05 -45.34 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.37 132.63 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.53 30.46 62.18 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -151.34 -176.56 5.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.609 -0.936 . . . . 0.0 109.469 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -107.52 102.21 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.588 -0.695 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttp -80.4 108.13 13.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.591 -0.693 . . . . 0.0 109.433 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 94' ' ' LEU . 30.9 t -94.61 119.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.4 m -139.33 154.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.622 -0.674 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.14 -160.81 36.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -83.96 -32.81 24.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.96 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -69.88 -30.04 67.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.608 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.89 -32.98 16.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.575 -0.703 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -64.2 -35.3 80.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.509 -0.744 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -78.99 -24.89 43.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.695 -0.628 . . . . 0.0 109.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -62.87 -31.57 72.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.83 155.06 87.59 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.765 . . . . 0.0 109.375 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -80.75 -59.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 125.064 3.843 . . . . 0.0 109.785 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -99.67 114.07 26.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.661 -0.649 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -116.42 133.52 22.97 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.8 Cg_endo -84.08 163.36 67.52 Favored 'Cis proline' 0 N--CA 1.507 2.298 0 O-C-N 123.083 1.044 . . . . 0.0 109.796 -0.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.12 122.2 85.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.94 174.32 12.35 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.709 3.606 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 61.08 28.81 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.622 -0.674 . . . . 0.0 109.776 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -178.41 156.81 0.97 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 109.48 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 m -87.8 138.62 31.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.456 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.52 146.88 43.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.706 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 t -140.89 102.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.55 131.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD12 HG23 ' A' ' 76' ' ' VAL . 19.6 tp -113.17 103.5 11.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.531 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -120.85 170.59 9.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.541 -0.724 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -107.85 37.67 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -145.84 141.89 28.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -99.55 28.29 4.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.563 -0.711 . . . . 0.0 109.506 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.47 -29.36 7.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.505 -0.747 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.94 137.06 58.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.463 -0.773 . . . . 0.0 109.597 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -128.06 146.85 50.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.67 129.08 16.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.562 -0.711 . . . . 0.0 109.439 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.45 102.59 12.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 109.497 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.93 -34.13 2.5 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -113.16 152.78 29.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.916 . . . . 0.0 109.507 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 t -83.96 128.26 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.67 116.6 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 HD12 ' A' ' 62' ' ' LEU . 26.9 m -108.54 156.6 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -136.19 33.58 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.4 t70 -153.53 129.32 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.37 -39.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.615 -0.678 . . . . 0.0 109.436 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.13 73.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.702 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.57 76.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.722 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' ASP . 31.1 t -63.54 -46.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -70.06 -36.16 74.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.82 74.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.568 -0.707 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -62.61 -33.95 76.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.495 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.79 -30.26 65.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.662 -0.649 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -66.89 -42.0 86.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -62.9 -30.22 71.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.503 -0.748 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -116.48 92.22 36.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.16 -30.1 4.56 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.912 3.741 . . . . 0.0 109.872 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.641 -0.662 . . . . 0.0 109.417 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.1 160.94 14.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -122.53 151.93 40.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.492 HD11 HG21 ' A' ' 40' ' ' VAL . 10.0 tp -84.17 129.63 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.639 -0.663 . . . . 0.0 109.446 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.54 132.36 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.7 mm -105.72 115.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 109.399 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.48 -28.22 10.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.673 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.4 -170.03 35.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.89 -158.36 12.5 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 120.365 -1.668 . . . . 0.0 109.505 0.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.81 88.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.619 -0.93 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.22 -33.65 76.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -72.19 -36.67 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 13.8 m-85 -62.94 -41.45 99.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 m -62.34 -30.05 70.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.639 -0.663 . . . . 0.0 109.554 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.84 72.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.595 -0.691 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.82 36.08 2.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.68 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -79.3 -32.33 43.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.595 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -104.67 37.31 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.605 -0.684 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 3.5 m-20 -157.09 64.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.741 . . . . 0.0 109.387 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -155.15 147.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -117.44 -54.58 2.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -89.79 134.37 34.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.676 . . . . 0.0 109.301 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.3 mt -121.33 105.74 10.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.8 mt -95.35 124.08 39.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.783 . . . . 0.0 109.233 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -141.59 146.1 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.637 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.2 m -109.91 105.68 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -82.16 124.12 29.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.29 -173.57 3.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.75 -45.71 2.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.24 149.19 51.35 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -85.96 147.95 25.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.933 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -146.86 145.5 29.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.632 -0.668 . . . . 0.0 109.464 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -117.34 155.71 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.629 -0.669 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.64 -164.5 32.13 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.03 -31.31 7.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.557 -0.967 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -73.63 126.33 30.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -139.51 152.62 47.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.566 -0.709 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.91 148.14 28.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.7 pt -73.16 152.73 90.52 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.554 -0.716 . . . . 0.0 109.448 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.65 131.83 9.97 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.135 3.89 . . . . 0.0 110.233 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -120.94 141.45 50.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.721 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -93.3 109.92 21.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.621 -0.674 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -94.22 8.24 42.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.447 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.24 -30.72 38.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.27 36.23 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.654 -0.654 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -152.25 154.92 36.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.2 m -139.02 145.45 39.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.603 -0.686 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -94.14 114.04 26.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.587 -0.696 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.41 -30.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.589 -0.694 . . . . 0.0 109.457 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.4 m -120.31 130.62 54.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.537 -0.727 . . . . 0.0 109.387 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.3 t -161.91 138.91 8.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -125.64 126.34 44.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.426 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 154' ' ' THR . 1.5 m -87.9 132.36 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -132.06 114.95 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.596 ' HA ' HG23 ' A' ' 152' ' ' THR . 15.2 mp0 -94.89 149.71 20.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 109.405 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.93 -171.47 1.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p -62.84 -41.13 99.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -105.41 166.25 11.71 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.497 -0.752 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.82 -30.26 3.01 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 125.055 3.837 . . . . 0.0 109.909 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.24 -23.73 54.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.626 -0.671 . . . . 0.0 109.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.7 mt -95.49 25.36 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 110.065 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 145' ' ' GLU . 2.9 m -85.87 140.88 30.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.492 ' ND1' HD21 ' A' ' 23' ' ' LEU . 24.3 p-80 -142.72 163.31 33.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.2 m -146.3 124.6 12.27 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -78.5 129.48 34.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.722 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -121.56 129.69 53.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.642 . . . . 0.0 109.334 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 t -114.27 84.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -80.49 120.49 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.735 . . . . 0.0 109.392 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -110.03 162.65 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 109.519 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -84.24 129.74 34.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 32.3 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.704 . . . . 0.0 109.59 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.412 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.515 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.0 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.17 120.69 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.637 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -74.04 147.25 43.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.208 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.4 tp -152.65 111.52 3.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.438 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.2 p90 -151.32 159.61 44.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.552 -0.718 . . . . 0.0 109.819 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 127.22 54.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.239 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -136.22 173.67 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.491 -0.755 . . . . 0.0 109.749 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.18 -172.54 2.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.374 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -61.0 -39.42 89.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 109.88 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -63.53 -40.86 98.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.763 . . . . 0.0 109.633 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.91 30.21 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 124' ' ' GLY . 9.0 tp -96.65 128.91 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.568 -0.96 . . . . 0.0 109.218 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.672 HD11 HG22 ' A' ' 126' ' ' THR . 25.1 pt -102.17 -28.94 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.553 -0.717 . . . . 0.0 109.821 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.97 177.34 40.51 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -144.98 115.23 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.604 -0.939 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.35 27.07 14.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.536 -0.728 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.09 2.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -89.86 161.03 16.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.954 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.572 HD12 ' HM2' ' A' ' 170' ' ' MTX . 41.7 mt -83.54 147.51 52.77 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -79.65 -40.85 0.22 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 124.891 3.727 . . . . 0.0 109.819 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -93.64 174.36 7.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -124.98 98.46 5.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.297 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.7 tp -119.73 99.76 49.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.625 -0.672 . . . . 0.0 109.595 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.0 Cg_endo -75.13 -28.8 8.65 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.699 3.599 . . . . 0.0 109.838 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.47 -38.52 91.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.2 t0 -67.54 -32.23 72.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.597 -0.689 . . . . 0.0 109.378 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 24' ' ' PRO . 16.3 mt -63.08 -38.02 89.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.56 -0.712 . . . . 0.0 109.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -63.31 -38.14 89.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CD2' ' NE2' ' A' ' 33' ' ' GLN . 23.2 t80 -76.37 -30.29 57.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.46 -36.86 83.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ttp85 -67.05 -32.74 74.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 109.31 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.5 68.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' A' ' 29' ' ' TYR . 15.0 mt-30 -98.02 36.37 1.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.443 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.6 p -149.51 -46.24 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.702 . . . . 0.0 109.461 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -62.09 123.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.55 -0.718 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.25 31.06 35.4 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -156.98 -177.81 6.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.975 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.96 131.88 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.1 ttp -104.63 103.27 12.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HB ' HD13 ' A' ' 96' ' ' ILE . 31.2 t -94.87 115.05 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.633 -0.667 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -138.27 161.28 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.664 -0.647 . . . . 0.0 109.451 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.74 -165.32 38.35 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.89 -32.12 27.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.995 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -31.04 69.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.37 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -89.49 -31.52 17.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.657 -0.652 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 41.3 t80 -63.36 -34.95 78.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -76.96 -24.49 52.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.611 -0.681 . . . . 0.0 109.952 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.3 p -62.55 -29.3 70.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.875 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.86 155.56 82.62 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.14 -61.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 125.132 3.888 . . . . 0.0 109.762 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -108.42 106.28 16.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 4.2 mtt180 -104.23 142.82 25.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -84.27 165.44 62.94 Favored 'Cis proline' 0 N--CA 1.507 2.296 0 O-C-N 123.264 1.139 . . . . 0.0 109.777 -0.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 54' ' ' LEU . 96.1 mt -78.65 124.56 85.19 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.79 173.03 14.16 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 124.685 3.59 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 61.32 29.65 18.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -177.62 166.03 2.15 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 m -92.94 135.14 34.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.565 -0.709 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -106.06 129.62 54.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.724 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -133.43 105.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.645 -0.659 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.0 135.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 76' ' ' VAL . 6.5 tp -123.67 107.5 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.67 . . . . 0.0 109.454 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -139.02 177.25 8.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -110.86 29.79 7.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.677 -0.64 . . . . 0.0 109.509 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -115.82 135.52 53.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.5 30.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.555 -0.716 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.48 27.93 4.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 0.0 109.634 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.27 129.89 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -125.66 74.53 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.707 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.62 91.05 3.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -0.763 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -66.73 159.66 27.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.99 11.37 81.47 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.38 179.77 6.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.124 -1.221 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -113.63 94.62 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 109.524 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.33 115.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.633 -0.667 . . . . 0.0 109.392 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 62' ' ' LEU . 28.1 m -117.69 170.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -143.55 34.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 82' ' ' VAL . 40.8 m-20 -156.99 121.9 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.81 -34.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.5 -0.75 . . . . 0.0 109.551 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.92 -34.8 73.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -37.49 87.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.601 -0.687 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -63.31 -33.2 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.505 -0.747 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 106' ' ' PHE . 24.9 m-85 -72.47 -33.46 67.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.71 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.66 72.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.85 -38.53 91.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.602 -0.686 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.17 -32.03 62.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.569 -0.707 . . . . 0.0 109.499 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -64.67 -38.71 91.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.717 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.48 -30.31 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.422 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -117.57 92.19 40.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.31 -28.52 5.62 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 124.971 3.781 . . . . 0.0 109.959 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.89 -30.43 71.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.715 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -96.01 160.14 14.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -120.24 151.89 38.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 0.0 109.6 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 106' ' ' PHE . 5.4 tp -84.94 129.92 34.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -121.07 126.0 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 109.441 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -102.3 117.73 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.568 -0.707 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.654 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.61 -27.77 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.48 -169.14 31.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.79 -155.76 7.82 Favored Glycine 0 N--CA 1.501 2.975 0 O-C-N 120.34 -1.682 . . . . 0.0 109.527 -0.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.17 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.596 -0.943 . . . . 0.0 109.483 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.31 -36.61 84.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' CD1' HD23 ' A' ' 62' ' ' LEU . 42.2 mm -71.64 -37.79 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 96' ' ' ILE . 14.8 m-85 -62.25 -37.55 85.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.57 -0.706 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -71.04 -30.64 66.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.569 -0.707 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.7 92.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 83' ' ' PHE . 19.2 m-85 -98.21 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.596 -0.69 . . . . 0.0 109.495 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -79.3 -30.43 42.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.575 -0.703 . . . . 0.0 109.578 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -99.19 33.06 2.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.636 -0.665 . . . . 0.0 109.567 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -163.21 77.09 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.34 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -158.12 147.11 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.499 -0.751 . . . . 0.0 109.558 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.53 -58.73 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -88.36 136.23 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 0.0 109.359 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 3' ' ' PHE . 71.3 mt -120.7 98.45 6.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.535 -0.728 . . . . 0.0 109.616 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.547 ' CB ' HD12 ' A' ' 4' ' ' LEU . 11.3 mt -90.15 124.51 34.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -138.07 148.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.0 109.637 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.0 m -111.87 99.36 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.624 -0.673 . . . . 0.0 109.328 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -78.03 120.84 23.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.609 -0.682 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.88 -173.45 4.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.613 -0.679 . . . . 0.0 109.475 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.71 -51.06 2.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.595 -0.691 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.84 149.31 46.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -83.49 160.57 21.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.963 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -149.2 159.15 44.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -107.18 152.36 24.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 178.34 -174.95 47.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -118.58 -38.54 3.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.925 . . . . 0.0 109.504 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.672 HG22 HD11 ' A' ' 13' ' ' ILE . 13.9 m -70.89 129.74 39.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.541 -0.724 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -129.38 163.77 25.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.678 . . . . 0.0 109.496 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.5 tpt -81.06 143.21 32.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.86 165.76 46.69 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.493 -0.754 . . . . 0.0 109.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.17 99.89 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 125.023 3.815 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.04 174.63 7.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.631 -0.668 . . . . 0.0 109.504 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.69 124.06 37.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -107.03 -24.94 11.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.19 -28.32 66.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.398 -0.814 . . . . 0.0 109.847 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 29.74 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.403 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -147.83 164.8 32.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.717 . . . . 0.0 109.398 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.0 m -150.0 156.69 42.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -79.48 150.52 31.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.526 -0.734 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 t -128.14 -64.79 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -119.29 151.01 39.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.1 t -147.47 141.66 26.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.554 -0.716 . . . . 0.0 109.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -135.43 110.84 9.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.655 ' HA ' HG23 ' A' ' 154' ' ' THR . 17.4 m -83.88 136.96 33.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.404 HG11 ' NE2' ' A' ' 153' ' ' HIS . 31.1 t -130.6 115.76 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 5.1 tm-20 -91.98 117.32 29.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.89 -172.02 3.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.614 -0.679 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.6 p -62.82 -35.91 81.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.48 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -109.27 163.64 16.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.29 -30.15 2.19 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 125.111 3.874 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.78 -24.53 41.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.1 mt -97.13 30.0 2.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 0.0 109.817 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.2 m -83.01 153.61 24.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.485 -0.76 . . . . 0.0 109.342 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' CG ' HD21 ' A' ' 23' ' ' LEU . 23.7 p-80 -147.91 148.02 30.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 109.68 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 143' ' ' THR . 35.0 m -133.71 117.41 16.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -73.78 129.87 38.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.554 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -125.66 124.95 42.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.716 . . . . 0.0 109.323 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.53 102.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -93.32 150.65 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 0.0 109.392 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -137.7 150.45 47.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -78.65 144.66 35.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -74.6 -43.1 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.483 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.572 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.23 115.27 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.2 m-85 -76.07 140.31 41.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.515 -0.741 . . . . 0.0 109.42 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.0 tp -150.23 113.42 4.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 109.414 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.4 p90 -153.17 158.64 42.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.698 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.63 131.98 55.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.699 . . . . 0.0 109.311 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.24 166.54 24.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.672 . . . . 0.0 109.615 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.63 -172.94 2.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -60.34 -31.39 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.609 -0.682 . . . . 0.0 109.881 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.9 -40.06 65.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.586 -0.696 . . . . 0.0 109.369 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.11 34.51 2.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.0 tp -99.14 134.77 41.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.622 -0.928 . . . . 0.0 109.433 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -110.63 -30.13 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.66 -168.56 13.22 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -169.6 101.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.932 . . . . 0.0 109.548 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.1 27.68 16.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.62 2.26 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -90.04 155.71 18.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.509 -0.995 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD11 ' HM2' ' A' ' 170' ' ' MTX . 34.6 mt -74.53 150.97 87.16 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.692 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.3 Cg_endo -79.7 -33.56 1.21 Allowed 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 125.009 3.806 . . . . 0.0 109.962 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 16.2 p90 -111.67 -173.89 2.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.527 -0.733 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -139.31 87.44 2.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.66 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -114.2 110.22 48.41 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.571 -0.705 . . . . 0.0 109.444 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.73 -29.3 4.59 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 124.663 3.575 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.2 -36.78 84.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.562 -0.711 . . . . 0.0 109.447 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.625 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.8 t0 -70.49 -32.48 70.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.499 -0.751 . . . . 0.0 109.384 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.13 -32.54 72.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.591 -0.693 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -67.66 -37.7 82.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.552 -0.717 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -69.19 -30.7 68.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 34' ' ' THR . 61.4 t80 -65.07 -37.42 87.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.06 -33.55 76.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.699 . . . . 0.0 109.606 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.04 63.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.522 -0.737 . . . . 0.0 109.617 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -97.6 39.47 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.461 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.401 HG21 ' CE2' ' A' ' 30' ' ' PHE . 18.5 p -149.23 -44.77 0.14 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.662 . . . . 0.0 109.654 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.86 128.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.33 28.08 68.62 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -143.25 -178.46 5.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 93' ' ' GLU . 44.4 mt -106.81 97.39 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.0 109.432 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 54' ' ' LEU . 21.2 ttp -72.58 106.26 4.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 109.495 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 94' ' ' LEU . 30.6 t -99.78 122.14 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.3 m -136.8 162.41 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.45 -163.03 38.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -81.66 -43.47 18.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.591 -0.946 . . . . 0.0 109.482 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -65.55 -32.29 73.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 m -80.96 -30.87 35.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.418 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -67.38 -33.89 76.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.702 -0.624 . . . . 0.0 109.447 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.89 -22.46 36.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.712 . . . . 0.0 109.935 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -62.57 -29.4 70.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 109.617 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -64.53 148.52 96.48 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -78.3 -57.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 124.788 3.659 . . . . 0.0 109.882 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -108.65 103.16 12.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.566 -0.709 . . . . 0.0 109.462 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -107.41 144.62 29.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.715 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.0 Cg_endo -82.46 157.58 77.79 Favored 'Cis proline' 0 N--CA 1.508 2.357 0 O-C-N 123.265 1.139 . . . . 0.0 109.841 -0.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.504 HD12 ' CE ' ' A' ' 39' ' ' MET . 83.0 mt -74.58 121.25 84.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.15 174.32 12.24 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 124.801 3.667 . . . . 0.0 109.997 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 61.84 28.74 17.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.58 -0.7 . . . . 0.0 109.758 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.9 170.54 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 109.496 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 m -99.65 139.27 35.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.561 -0.712 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -115.12 136.48 53.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -132.39 107.66 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.66 117.3 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD12 HG23 ' A' ' 76' ' ' VAL . 27.1 tp -106.63 114.08 27.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.666 -0.646 . . . . 0.0 109.521 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -150.14 173.19 14.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -111.92 45.69 1.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.349 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -136.36 136.96 40.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -98.81 29.06 3.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.703 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.69 -38.95 2.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.611 -0.68 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.98 128.88 38.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.522 -0.736 . . . . 0.0 109.75 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -135.29 162.41 32.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.58 -0.7 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.03 25.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.99 108.7 20.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 109.538 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.8 -38.51 3.3 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -85.25 147.15 26.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.952 . . . . 0.0 109.45 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.7 t -79.59 146.84 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.352 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.52 114.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 HD12 ' A' ' 62' ' ' LEU . 26.2 m -111.44 171.52 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.35 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -150.16 38.32 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.0 t0 -169.54 136.11 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.8 -38.07 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.29 77.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.63 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.93 83.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.411 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' LEU . 32.3 t -62.4 -34.44 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -77.54 -30.24 52.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.09 96.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -62.87 -40.97 99.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.61 -44.43 64.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.554 -0.716 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -63.1 -47.24 83.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 109.404 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.72 -27.07 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.586 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 11.2 m-70 -115.03 94.52 38.81 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 109.418 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.5 -29.17 4.91 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.887 3.725 . . . . 0.0 109.758 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.4 -33.88 76.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.591 -0.693 . . . . 0.0 109.365 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -101.4 160.18 14.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' O ' HD12 ' A' ' 38' ' ' ILE . 47.6 mt-10 -114.91 -177.06 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 40' ' ' VAL . 15.6 tp -112.53 119.51 38.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.62 -0.675 . . . . 0.0 109.525 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.02 139.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.673 . . . . 0.0 109.428 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.561 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -113.06 121.55 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.687 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.422 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -27.92 9.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.54 -170.75 36.57 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.52 -156.05 12.67 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.369 -1.665 . . . . 0.0 109.502 0.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.73 81.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.22 -33.23 74.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.518 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 62' ' ' LEU . 43.2 mm -72.33 -35.86 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.579 -0.701 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 96' ' ' ILE . 15.8 m-85 -63.35 -36.97 85.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.66 -0.65 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 m -66.05 -35.85 81.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.712 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.38 -39.49 92.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.03 36.59 2.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.566 -0.709 . . . . 0.0 109.411 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -82.81 -31.26 28.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.66 33.55 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -159.34 72.46 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.3 p -161.85 141.84 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.57 -47.02 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.514 -0.742 . . . . 0.0 109.369 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.9 m -90.21 125.23 35.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 3' ' ' PHE . 81.3 mt -112.62 97.7 6.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.598 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.0 mt -88.56 121.25 30.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -137.42 144.58 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.581 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.4 m -104.76 109.58 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.672 . . . . 0.0 109.265 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.35 107.92 16.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.599 -0.688 . . . . 0.0 109.617 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -170.75 3.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.581 -0.699 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.23 -49.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.37 146.7 49.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 56.0 m -86.21 151.42 23.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.515 -0.991 . . . . 0.0 109.388 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -150.01 117.91 6.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.93 145.73 25.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.53 -131.07 1.18 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -146.77 -46.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.65 -0.912 . . . . 0.0 109.464 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 13' ' ' ILE . 7.3 m -72.36 113.83 9.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -114.3 162.48 16.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -80.37 150.13 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.552 -0.717 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.3 pt -66.17 164.27 31.23 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.738 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.9 100.42 1.28 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 125.044 3.829 . . . . 0.0 109.926 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.71 143.99 25.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -79.61 117.66 20.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.551 -0.718 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.05 8.21 42.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.472 -0.767 . . . . 0.0 110.484 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.93 -29.58 21.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 109.526 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -97.19 38.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.478 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -150.4 166.0 31.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.526 -0.733 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 m -145.31 161.26 40.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.695 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -95.8 131.27 42.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.455 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 140' ' ' SER . 8.9 p -122.28 -41.42 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.626 -0.671 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 139' ' ' VAL . 61.1 m -134.88 149.16 50.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -166.62 136.89 3.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.565 -0.709 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.19 132.4 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.553 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.5 m -101.07 126.82 47.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 t -120.0 115.91 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 152' ' ' THR . 27.8 mt-10 -93.8 124.78 38.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 109.415 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.13 -173.89 3.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.562 -0.711 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -62.79 -44.69 95.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.572 -0.705 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.36 166.4 13.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.569 -0.707 . . . . 0.0 109.57 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.47 -29.05 2.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.188 3.925 . . . . 0.0 109.941 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.49 -22.34 44.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.568 -0.708 . . . . 0.0 109.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.61 23.4 5.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -84.41 137.74 33.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 0.0 109.141 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -139.28 155.68 47.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -0.753 . . . . 0.0 109.71 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 143' ' ' THR . 44.4 m -140.77 114.05 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.627 -0.671 . . . . 0.0 109.328 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -73.79 125.9 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -123.71 135.55 53.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.743 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 114' ' ' LEU . 32.1 t -115.68 93.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.543 -0.723 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -84.24 128.29 34.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.469 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -113.22 157.83 21.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -78.27 147.53 34.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.437 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -103.23 -27.42 12.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 109.761 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.531 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.473 ' HM2' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.06 105.78 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.629 -0.669 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.8 m-85 -70.28 145.28 51.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.392 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 114' ' ' LEU . 9.1 tp -149.77 112.25 4.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.8 p90 -154.31 168.5 26.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -0.784 . . . . 0.0 109.669 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.47 131.64 48.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.342 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.02 -177.23 4.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.561 -0.712 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -124.32 -170.99 2.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -58.66 -38.92 79.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.173 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.83 -39.14 87.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.548 -0.72 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.46 29.44 3.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 20' ' ' PRO . 6.3 tp -91.64 132.03 36.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.992 . . . . 0.0 109.368 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.736 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -108.22 -29.66 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.99 -169.03 18.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -162.73 105.16 1.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.586 -0.949 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 59.37 28.37 17.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.436 -0.79 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 -42.91 2.28 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -89.95 154.56 19.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.98 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -76.5 153.42 83.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.1 Cg_endo -80.73 -40.56 0.18 Allowed 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.948 3.765 . . . . 0.0 109.988 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 19.6 p90 -104.03 -173.53 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.588 -0.695 . . . . 0.0 109.729 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -136.92 91.5 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.663 -0.648 . . . . 0.0 109.274 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 26' ' ' ASP . 3.1 tp -114.22 108.89 49.68 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.531 -0.731 . . . . 0.0 109.529 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -77.46 -28.92 5.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 124.7 3.6 . . . . 0.0 109.938 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -67.05 -34.47 77.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.714 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.0 t0 -71.7 -31.22 66.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.45 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.576 -0.703 . . . . 0.0 109.475 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -65.49 -33.35 75.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.698 . . . . 0.0 109.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.08 -29.96 62.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.32 -32.09 68.18 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -77.08 -35.75 56.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.523 -0.736 . . . . 0.0 109.659 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.02 66.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -97.86 39.64 1.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 p -148.79 -44.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.711 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 56' ' ' GLU . 27.5 m -59.06 141.42 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.49 -0.756 . . . . 0.0 109.79 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.13 65.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -145.61 -179.09 6.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.436 -1.038 . . . . 0.0 109.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 86' ' ' ALA . 53.9 mt -106.74 113.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -93.02 116.89 29.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 t -98.57 108.5 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.64 -0.662 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 97' ' ' ALA . 25.7 m -126.3 150.97 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.41 -157.74 31.72 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -86.03 -31.69 21.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.524 -0.986 . . . . 0.0 109.476 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -70.11 -32.78 70.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.727 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.691 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 m -86.57 -32.97 20.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 51.2 t80 -62.17 -38.76 90.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.88 -26.57 40.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.3 m -62.86 -34.26 76.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.48 -0.762 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.3 m-85 -62.91 157.68 58.92 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.47 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.84 -50.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.101 3.868 . . . . 0.0 109.474 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -93.49 136.24 33.95 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 7.2 mtp85 -132.94 114.09 13.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.466 -0.772 . . . . 0.0 109.531 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 9.9 Cg_endo -81.14 -164.8 4.06 Favored 'Cis proline' 0 N--CA 1.511 2.501 0 O-C-N 122.937 0.967 . . . . 0.0 109.894 -0.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.5 mt -104.89 126.59 30.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.59 -0.694 . . . . 0.0 109.22 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -80.37 169.82 16.79 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 124.648 3.565 . . . . 0.0 109.913 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 35' ' ' VAL . 6.3 mt-10 61.36 27.4 17.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -178.19 162.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -0.829 . . . . 0.0 109.589 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.1 m -95.63 135.74 36.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.81 130.25 55.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -123.55 108.99 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -85.48 121.38 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 76' ' ' VAL . 20.5 tp -116.09 103.35 10.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.589 -0.694 . . . . 0.0 109.44 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 t -144.08 172.55 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -104.1 31.65 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.527 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -111.42 111.93 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.577 -0.702 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.85 0.63 34.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.644 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.05 -29.22 10.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.3 132.24 49.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -136.76 117.43 13.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -83.31 151.27 25.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.61 100.88 11.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.475 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 11.35 41.54 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.8 144.03 51.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.152 -1.205 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.1 112.4 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.666 -0.647 . . . . 0.0 109.477 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 t -91.5 141.06 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 62' ' ' LEU . 26.1 m -137.07 171.64 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.56 -0.713 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -148.79 37.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.478 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -162.7 128.68 3.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.49 -36.14 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 109.523 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.45 -35.78 81.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.685 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.91 -39.12 83.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.61 -0.681 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.38 -31.45 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -84.14 -35.03 23.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 0.0 109.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.1 72.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.672 -0.643 . . . . 0.0 109.404 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.07 -65.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.325 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . -59.76 -27.37 66.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.916 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -61.19 -28.36 69.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.791 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.76 -31.23 51.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.541 -0.725 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -115.93 77.28 6.65 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -46.21 -34.27 13.33 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.056 3.837 . . . . 0.0 110.14 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -64.64 -27.64 69.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.566 -0.709 . . . . 0.0 109.813 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.64 152.26 21.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.453 -0.78 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.72 168.77 10.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -105.88 125.58 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.619 -0.675 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.88 134.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.61 -0.681 . . . . 0.0 109.4 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.563 HG22 ' CE1' ' A' ' 103' ' ' PHE . 37.8 mm -104.64 121.21 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.365 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.705 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.36 -26.39 13.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.598 -0.689 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 143.26 -169.24 25.88 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.26 -153.45 7.63 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.348 -1.677 . . . . 0.0 109.652 0.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.96 82.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.62 -0.929 . . . . 0.0 109.451 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.59 -29.46 70.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.9 -38.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.6 m-85 -62.41 -34.56 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.544 -0.723 . . . . 0.0 109.429 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -69.13 -30.78 69.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.0 77.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.595 -0.691 . . . . 0.0 109.539 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.67 34.46 2.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -86.71 -27.65 23.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.8 -25.68 32.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.715 . . . . 0.0 110.083 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -116.02 70.88 0.76 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.423 -0.798 . . . . 0.0 109.681 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -143.52 124.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -111.86 -42.8 3.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -90.08 137.04 32.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.491 -0.756 . . . . 0.0 109.193 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 3' ' ' PHE . 61.9 mt -131.47 97.22 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 109.817 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.0 mt -91.23 117.08 29.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.68 150.78 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.446 -0.784 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 m -116.37 102.49 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.684 -0.635 . . . . 0.0 109.328 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 132.24 41.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.631 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -178.92 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -115.63 -47.48 2.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.0 109.544 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.27 146.5 46.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.4 p -87.55 156.13 19.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.615 -0.933 . . . . 0.0 109.379 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -149.87 144.89 26.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -109.43 142.74 39.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -167.05 -150.02 6.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -128.43 -44.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.94 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.736 HG22 HD11 ' A' ' 13' ' ' ILE . 5.4 m -71.98 111.76 7.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.16 162.54 17.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.9 tpt -79.26 144.49 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 13.5 pt -70.41 163.73 60.22 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.576 -0.702 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.69 107.43 2.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.165 3.91 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.0 mt -104.3 169.69 8.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.01 117.8 27.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -105.16 -28.18 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.568 -0.708 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -61.55 -29.06 69.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.433 -0.792 . . . . 0.0 109.704 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -97.6 37.77 1.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.528 -0.732 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -147.46 158.19 43.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -131.55 161.7 32.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.566 -0.708 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -98.31 121.73 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.467 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.54 -51.71 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.2 m -121.34 148.18 44.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.673 . . . . 0.0 109.523 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.6 t -165.89 122.36 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.574 -0.704 . . . . 0.0 109.397 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -115.99 120.74 40.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -84.22 141.34 31.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.659 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 t -140.89 117.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.598 ' HA ' HG23 ' A' ' 152' ' ' THR . 59.4 mt-10 -98.36 147.88 24.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.721 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.83 -171.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.56 -40.44 63.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.576 ' HB2' HD12 ' A' ' 151' ' ' LEU . 6.7 m120 -91.04 161.21 35.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.526 -0.734 . . . . 0.0 109.425 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.91 -27.49 3.82 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.148 3.899 . . . . 0.0 109.952 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.69 34.83 1.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 109.693 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 148' ' ' ASN . 67.7 mt -147.08 29.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 145' ' ' GLU . 20.8 m -88.33 134.61 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.487 ' CG ' HD21 ' A' ' 23' ' ' LEU . 30.2 p-80 -129.6 151.65 49.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.725 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 143' ' ' THR . 50.6 m -140.7 117.35 10.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 109.395 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -76.02 138.99 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.439 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.01 133.68 35.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 114' ' ' LEU . 33.8 t -112.69 92.73 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.633 -0.667 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -84.56 132.67 34.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.386 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -115.06 152.06 33.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.541 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -76.29 148.78 37.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -75.64 -66.82 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.396 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 130.9 5.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.615 -0.678 . . . . 0.0 109.652 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.6 m-85 -73.16 147.27 44.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.687 -0.633 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.6 tp -153.17 112.2 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.0 p90 -152.53 169.39 22.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.732 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.12 45.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.616 -0.678 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -133.23 163.65 28.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.743 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -108.22 -173.68 2.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -62.46 -27.91 69.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.601 -0.687 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.51 -35.91 60.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.01 28.07 4.02 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.9 tp -99.15 131.85 44.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.494 -1.003 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.565 HD11 HG22 ' A' ' 126' ' ' THR . 30.1 pt -104.9 -29.52 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.532 -0.73 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -151.19 -172.8 20.51 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -162.11 116.55 1.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.561 -0.964 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.35 27.36 16.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.37 -44.19 2.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -94.9 170.44 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.576 -0.955 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HG ' ' HM2' ' A' ' 170' ' ' MTX . 86.2 mt -82.39 148.14 58.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.2 Cg_endo -78.92 -29.42 3.37 Favored 'Trans proline' 0 N--CA 1.502 2.002 0 C-N-CA 124.905 3.737 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.4 p90 -111.84 -173.38 2.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.649 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -139.31 91.49 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.63 -0.669 . . . . 0.0 109.331 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 26' ' ' ASP . 27.0 tp -113.9 96.69 42.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.671 -0.643 . . . . 0.0 109.612 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.1 Cg_endo -64.5 -28.98 61.85 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 124.461 3.441 . . . . 0.0 109.783 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -63.4 -35.85 81.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.627 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.5 t0 -73.72 -34.08 64.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 24' ' ' PRO . 51.3 mt -65.98 -34.14 77.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.409 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -63.23 -37.43 87.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -76.35 -30.82 57.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.655 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -68.57 -44.98 73.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.7 . . . . 0.0 109.363 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.554 ' O ' HG22 ' A' ' 35' ' ' VAL . 41.1 ttt-85 -62.45 -29.0 70.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.73 . . . . 0.0 109.565 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.59 52.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -100.22 36.95 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 109.474 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.2 p -149.86 -45.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.457 -0.777 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -60.87 137.18 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.684 . . . . 0.0 109.728 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.75 75.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -149.34 -178.31 6.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.602 -0.94 . . . . 0.0 109.463 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.49 117.34 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.474 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 54' ' ' LEU . 34.8 ttp -99.23 119.38 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.722 . . . . 0.0 109.551 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -107.47 116.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.721 . . . . 0.0 109.381 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.97 149.77 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.529 -0.732 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.95 -164.7 39.66 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -38.79 42.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.533 -0.98 . . . . 0.0 109.459 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -42.73 83.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.582 -0.699 . . . . 0.0 109.197 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -69.84 -31.22 68.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 25.2 t80 -62.54 -45.81 91.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.669 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -67.66 -23.94 65.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.912 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' HM3' ' A' ' 170' ' ' MTX . 32.0 t -62.64 -31.38 72.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 109.766 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CD1' HD11 ' A' ' 54' ' ' LEU . 61.1 m-85 -66.45 153.43 92.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -80.73 -60.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.996 3.797 . . . . 0.0 109.833 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -104.61 93.71 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.38 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 59.4 mtm-85 -87.87 137.25 31.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.628 -0.67 . . . . 0.0 109.45 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -85.23 -174.69 11.62 Favored 'Cis proline' 0 N--CA 1.508 2.343 0 O-C-N 123.19 1.1 . . . . 0.0 109.858 -0.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 49' ' ' PHE . 75.1 mt -101.05 116.54 63.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.468 -0.77 . . . . 0.0 109.029 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -77.33 -179.73 5.71 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.586 3.524 . . . . 0.0 109.966 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 61.33 31.14 19.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.53 -0.731 . . . . 0.0 109.765 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -178.16 166.63 1.95 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.601 -0.687 . . . . 0.0 109.522 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -95.24 105.92 17.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -76.43 138.48 40.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.709 . . . . 0.0 109.627 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.83 87.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.617 -0.677 . . . . 0.0 109.211 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 t -79.08 132.18 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -121.98 113.75 20.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.568 -0.708 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -134.74 173.53 11.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.528 -0.733 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -105.51 30.38 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -137.68 134.05 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.653 -0.655 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -97.97 27.04 4.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.509 -0.745 . . . . 0.0 109.773 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -111.73 -30.94 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.93 140.1 58.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.525 -0.735 . . . . 0.0 109.493 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -129.01 162.25 28.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.599 -0.688 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.14 123.36 1.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.369 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.67 128.6 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.591 -0.693 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.51 -27.71 13.09 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 164.29 14.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -1.002 . . . . 0.0 109.737 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -93.05 145.93 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.382 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 77' ' ' HIS . 30.9 t -115.87 110.0 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -114.63 161.47 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 75' ' ' VAL . 58.6 m-70 -138.03 34.35 2.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 80' ' ' ALA . 20.5 t70 -163.76 131.32 3.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 t -62.38 -39.04 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HB3' ' OD2' ' A' ' 78' ' ' ASP . . . -63.15 -34.19 77.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.678 -0.639 . . . . 0.0 109.308 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.38 -43.07 95.63 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -62.11 -31.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 109.441 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.58 -33.34 62.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.188 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.54 94.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.637 -0.664 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.26 -32.24 73.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.419 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.92 -28.96 55.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.62 -0.675 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -61.23 -36.1 79.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 58.7 mt-30 -98.76 29.62 3.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.603 -0.686 . . . . 0.0 109.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 88' ' ' GLN . 17.1 m-70 -143.37 84.23 10.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.581 -0.7 . . . . 0.0 109.389 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.68 -24.36 5.13 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.183 3.922 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.4 26.35 4.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.506 -0.746 . . . . 0.0 109.978 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -139.81 157.64 45.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.519 -0.738 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -120.49 149.26 42.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -92.0 119.51 31.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.581 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.27 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.639 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.0 mm -101.66 122.17 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.33 -27.31 11.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.71 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 154.9 -170.19 33.11 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.21 -149.6 7.83 Favored Glycine 0 N--CA 1.499 2.87 0 O-C-N 120.312 -1.699 . . . . 0.0 109.622 0.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.37 -40.64 77.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.565 -0.962 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -62.69 -29.7 70.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.489 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.87 -38.61 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.8 m-85 -63.95 -36.61 84.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.592 -0.693 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 m -61.98 -34.02 75.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.522 -0.736 . . . . 0.0 109.654 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -44.15 66.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.523 -0.736 . . . . 0.0 109.434 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -97.28 52.33 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.695 . . . . 0.0 109.421 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' HD12 ' A' ' 129' ' ' ILE . 22.0 tptp -96.49 -29.26 14.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.667 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.1 31.31 2.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -158.75 76.3 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.471 -0.768 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.1 p -167.74 142.71 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.563 -0.711 . . . . 0.0 109.427 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -128.34 -43.19 1.46 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 109.484 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 m -93.52 125.29 38.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.725 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 3' ' ' PHE . 28.4 mt -117.97 104.76 11.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.637 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 4' ' ' LEU . 34.6 mt -94.18 121.09 35.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.617 -0.677 . . . . 0.0 109.335 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -133.73 146.36 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -110.85 103.59 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.611 -0.68 . . . . 0.0 109.257 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -80.78 122.29 26.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.636 -0.665 . . . . 0.0 109.542 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.6 mp -97.25 -175.18 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.665 . . . . 0.0 109.507 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.08 -42.85 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.575 -0.703 . . . . 0.0 109.55 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 122' ' ' PHE . . . -62.95 140.98 46.08 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.9 p -86.5 147.88 25.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.955 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 120' ' ' GLY . 79.7 m-85 -150.01 142.15 24.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.66 145.24 40.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.44 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -166.05 -154.15 8.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.05 -40.17 2.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.904 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.565 HG22 HD11 ' A' ' 13' ' ' ILE . 2.4 m -72.08 111.83 7.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -118.84 168.64 10.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -93.7 143.38 26.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD12 ' HE2' ' A' ' 107' ' ' LYS . 10.5 pt -64.0 165.67 12.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.579 -0.701 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.54 98.28 1.14 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 125.103 3.869 . . . . 0.0 109.789 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.02 149.31 22.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.382 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.57 109.8 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.635 -0.666 . . . . 0.0 109.504 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -87.57 -28.86 21.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.612 -0.68 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -60.04 -22.28 62.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.46 -0.775 . . . . 0.0 109.955 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -97.06 28.93 3.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.792 . . . . 0.0 109.813 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -148.77 177.66 9.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.487 -0.758 . . . . 0.0 109.245 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.3 m -149.99 135.73 18.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.521 -0.737 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -76.79 121.58 23.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.664 -0.647 . . . . 0.0 109.318 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.25 -30.29 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.61 -0.681 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 m -132.82 152.2 51.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -164.63 142.24 6.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.652 -0.655 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -137.78 118.11 13.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.595 -0.69 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -90.73 131.93 36.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 t -137.93 123.57 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -101.33 140.85 35.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -168.05 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.68 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.4 p -68.62 -58.16 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 151' ' ' LEU . 85.2 m-20 -73.57 162.02 76.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.616 -0.677 . . . . 0.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.28 -27.14 3.73 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 125.183 3.922 . . . . 0.0 110.14 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.94 30.58 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.483 -0.761 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 148' ' ' ASN . 20.7 mt -136.39 30.45 2.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.8 m -83.16 158.97 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.596 ' CG ' HD21 ' A' ' 23' ' ' LEU . 36.5 p-80 -158.16 140.98 14.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.1 m -129.16 112.8 14.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.21 102.79 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.38 129.92 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 t -111.18 110.18 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.61 121.78 42.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.81 153.52 22.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -87.85 119.87 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.718 . . . . 0.0 109.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -79.65 -28.13 40.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.726 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.468 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.513 ' HM3' ' OG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.89 113.32 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 110' ' ' VAL . 4.5 m-85 -75.55 150.84 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.318 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 114' ' ' LEU . 11.5 tp -159.57 111.6 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 5.5 p90 -156.73 170.15 23.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.2 143.38 47.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.547 -0.721 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -149.47 172.51 14.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.521 -0.737 . . . . 0.0 109.624 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -117.95 -173.77 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.395 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -66.98 -26.29 66.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 109.85 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.89 -47.64 51.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.51 -21.98 3.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 126' ' ' THR . 7.4 tp -57.88 140.95 50.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.287 -1.125 . . . . 0.0 109.899 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 7' ' ' GLN . 32.5 pt -114.52 -32.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 109.629 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.15 -168.49 19.08 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -155.24 116.22 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.952 . . . . 0.0 109.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.45 26.98 16.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.733 . . . . 0.0 109.986 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.96 -42.95 2.32 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -89.83 159.6 16.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.42 151.56 72.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.535 -0.728 . . . . 0.0 109.471 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.4 Cg_endo -80.22 -27.04 3.83 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.924 3.749 . . . . 0.0 110.055 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.0 p90 -114.1 -173.53 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.465 -0.772 . . . . 0.0 109.815 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -138.82 105.51 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.9 tp -113.72 85.11 9.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.491 -0.756 . . . . 0.0 109.577 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 Cg_exo -47.52 -35.7 22.7 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 124.971 3.781 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.0 -43.06 79.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -62.52 -29.3 70.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.562 -0.711 . . . . 0.0 109.591 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 24' ' ' PRO . 21.1 mt -65.31 -34.63 78.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -68.83 -40.16 79.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.677 . . . . 0.0 109.434 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.25 -31.78 72.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.652 -0.655 . . . . 0.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -66.8 -42.09 86.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 ttp85 -65.11 -33.77 76.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.586 -0.696 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.09 66.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -100.31 37.16 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.514 -0.741 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.7 p -148.55 -46.15 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.7 m -61.93 116.15 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.78 36.55 10.25 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -157.37 -178.02 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.943 . . . . 0.0 109.477 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG2' HG21 ' A' ' 60' ' ' VAL . 60.7 mt -100.13 113.87 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 ttp -92.33 112.32 24.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.529 -0.732 . . . . 0.0 109.476 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 t -103.5 122.66 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.423 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.6 m -143.95 149.24 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 109.51 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 -166.92 42.18 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -77.95 -34.93 50.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.951 . . . . 0.0 109.392 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -29.79 70.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.582 -0.699 . . . . 0.0 109.602 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -92.87 -32.02 14.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.89 -32.7 74.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.461 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.0 2.17 44.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.47 -0.769 . . . . 0.0 110.642 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.9 m -99.63 26.02 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.03 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.86 160.6 31.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.76 . . . . 0.0 109.419 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.79 -63.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.163 3.909 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 97.23 6.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.588 -0.695 . . . . 0.0 109.404 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -94.48 141.88 24.06 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 109.568 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.55 176.99 34.02 Favored 'Cis proline' 0 N--CA 1.507 2.318 0 O-C-N 123.248 1.131 . . . . 0.0 109.711 -0.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.32 118.77 68.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.584 -0.698 . . . . 0.0 109.364 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.26 177.79 8.19 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.698 3.598 . . . . 0.0 109.976 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 61.26 30.59 19.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.73 151.62 0.73 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.525 -0.734 . . . . 0.0 109.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 m -79.91 115.9 19.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.577 -0.702 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -84.89 140.53 31.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.63 -0.669 . . . . 0.0 109.575 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.596 HG21 ' CG2' ' A' ' 38' ' ' ILE . 34.3 t -142.91 95.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.688 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -88.07 136.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD12 HG23 ' A' ' 76' ' ' VAL . 23.2 tp -117.16 109.98 17.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.613 -0.679 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.16 159.85 40.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -90.87 -16.64 27.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.579 -0.7 . . . . 0.0 110.106 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -89.5 135.79 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -98.61 30.29 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.62 -0.675 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.02 -26.56 9.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.602 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -59.86 123.44 17.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.442 -0.786 . . . . 0.0 109.726 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -108.32 138.47 44.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.59 118.01 12.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.728 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.25 114.06 26.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.4 -28.77 12.43 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.86 154.26 18.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -1.023 . . . . 0.0 109.534 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 t -96.0 119.04 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 t -99.4 131.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.604 -0.685 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HD12 ' A' ' 62' ' ' LEU . 27.1 m -123.08 170.7 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.584 -0.698 . . . . 0.0 109.505 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -149.54 33.77 0.71 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.678 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -160.93 131.97 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.28 -42.27 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.565 -0.709 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.17 75.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.417 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.645 -0.659 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 76' ' ' VAL . 29.8 t -63.25 -36.35 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.97 -38.29 76.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.74 83.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.695 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -72.7 -31.38 64.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -75.18 -43.99 49.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -62.92 -42.45 99.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.453 -0.78 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.66 -24.96 67.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.638 -0.664 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 9.6 m-70 -113.27 97.11 41.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.385 -0.822 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.24 -36.17 1.07 Allowed 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 124.891 3.727 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.33 -35.82 81.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.575 -0.703 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -98.41 160.23 14.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.562 -0.711 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.31 161.16 27.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.467 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 86' ' ' ALA . 9.3 tp -82.03 123.65 29.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.02 126.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' PHE . 38.7 mm -101.8 116.09 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.622 -0.674 . . . . 0.0 109.266 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.484 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.56 -27.93 13.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.0 109.562 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.13 -168.88 27.59 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.74 -154.43 6.75 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.36 -1.67 . . . . 0.0 109.533 0.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.13 -33.28 75.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.943 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.19 -34.53 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.561 -0.712 . . . . 0.0 109.581 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.9 mm -77.31 -36.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.564 -0.71 . . . . 0.0 109.391 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.3 m-85 -63.96 -35.59 81.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.665 -0.647 . . . . 0.0 109.566 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -69.56 -31.31 69.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.14 -41.14 82.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 96' ' ' ILE . 65.4 m-85 -104.5 38.96 1.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.713 . . . . 0.0 109.562 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -84.75 -29.82 25.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.712 . . . . 0.0 109.556 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.41 -29.49 59.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.7 67.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -132.52 112.51 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.412 -0.805 . . . . 0.0 109.323 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.08 -42.96 3.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.718 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -95.57 132.75 40.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.491 -0.755 . . . . 0.0 109.187 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 3' ' ' PHE . 25.9 mt -125.94 95.3 4.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.544 -0.722 . . . . 0.0 109.791 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.816 HD23 HG22 ' A' ' 157' ' ' VAL . 4.8 mt -89.78 97.95 11.49 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 10.3 p -117.59 140.85 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 109.783 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.9 m -102.41 102.64 12.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.174 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -75.74 125.14 28.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.32 -173.23 2.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.603 -0.686 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 -51.19 1.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.618 -0.676 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.66 144.22 48.79 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.9 m -80.64 162.13 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.983 . . . . 0.0 109.443 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -149.93 170.0 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.571 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.34 146.52 48.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.525 -0.734 . . . . 0.0 109.485 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.91 -173.93 46.41 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -115.06 -33.88 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.592 -0.946 . . . . 0.0 109.689 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 m -71.2 135.36 47.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.499 -0.751 . . . . 0.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -139.18 170.01 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.404 ' HB2' HG21 ' A' ' 13' ' ' ILE . 14.2 tpt -88.65 153.02 21.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 131' ' ' LEU . 16.5 pt -71.93 165.96 45.02 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.644 -0.66 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.88 91.57 1.17 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 125.067 3.845 . . . . 0.0 109.908 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 129' ' ' ILE . 61.1 mt -91.52 154.28 19.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.11 122.93 30.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -102.61 8.37 39.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.555 -0.716 . . . . 0.0 110.518 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.54 -29.8 25.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.94 34.37 2.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.635 -0.665 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -140.73 136.16 32.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.578 -0.702 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 138' ' ' LYS . 18.3 m -113.86 162.49 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' N ' HG22 ' A' ' 137' ' ' THR . 4.6 ttpm? -94.21 137.82 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.538 -0.726 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.2 t -124.76 -63.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.544 -0.723 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.4 m -100.11 144.09 29.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.512 -0.742 . . . . 0.0 109.446 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 t -156.24 102.44 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.682 -0.636 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 122.82 48.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 154' ' ' THR . 15.9 m -93.09 142.47 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.708 . . . . 0.0 109.445 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.0 t -143.53 119.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.615 -0.678 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.7 tt0 -105.38 136.47 44.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.715 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.26 -168.75 1.7 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.609 -0.682 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -63.33 -31.91 73.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -112.04 161.15 27.16 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.471 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -80.51 -30.27 2.01 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 125.105 3.87 . . . . 0.0 109.818 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.81 60.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.683 . . . . 0.0 109.749 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.38 32.34 2.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 109.752 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 145' ' ' GLU . 17.6 m -87.62 147.17 25.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.641 ' CG ' HD21 ' A' ' 23' ' ' LEU . 22.3 p-80 -146.42 155.24 42.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 143' ' ' THR . 12.5 m -139.92 108.42 5.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.685 . . . . 0.0 109.274 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.25 125.71 26.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.546 -0.721 . . . . 0.0 109.559 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 154' ' ' THR . 49.1 mm-40 -129.44 134.77 47.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.642 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.816 HG22 HD23 ' A' ' 114' ' ' LEU . 30.0 t -117.05 107.92 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.611 -0.681 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -96.37 146.23 24.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.724 . . . . 0.0 109.395 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.33 151.66 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.454 -0.779 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -78.86 153.87 30.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.494 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -73.64 138.01 44.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.608 -0.682 . . . . 0.0 109.461 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.707 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.46 ' HM2' ' H7 ' ' A' ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 121.55 8.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB2' HD23 ' A' ' 113' ' ' LEU . 4.1 m-85 -80.32 142.46 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.696 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.0 tp -154.86 114.27 3.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 7.6 p90 -152.45 163.75 38.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.499 -0.751 . . . . 0.0 109.793 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.17 138.29 51.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.59 178.72 8.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -120.15 -171.33 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.534 -0.729 . . . . 0.0 109.623 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.45 -41.98 95.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.256 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.04 -39.69 90.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.838 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.82 29.51 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.37 134.0 38.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.994 . . . . 0.0 109.206 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 pt -105.21 -28.71 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.562 -0.711 . . . . 0.0 109.862 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 -179.62 37.42 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -144.89 110.23 5.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.666 -0.902 . . . . 0.0 109.382 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.44 29.26 18.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.482 -0.761 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.98 -44.07 2.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -89.93 155.23 19.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.53 -0.982 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD12 ' HM2' ' A' ' 170' ' ' MTX . 13.1 mt -80.17 150.7 71.75 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.604 -0.685 . . . . 0.0 109.437 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.51 -35.5 0.8 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.93 3.754 . . . . 0.0 109.86 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -103.59 -172.6 2.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -147.83 109.29 4.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 26' ' ' ASP . 8.9 tp -130.31 116.93 17.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.388 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.9 -29.59 2.66 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 124.73 3.62 . . . . 0.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.02 -35.82 82.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.2 t0 -72.25 -31.68 66.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.664 -0.648 . . . . 0.0 109.428 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.39 -31.81 72.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.612 -0.68 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -65.15 -37.09 86.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -73.07 -31.74 64.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.578 -0.702 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 34' ' ' THR . 68.1 t80 -64.06 -42.08 97.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.621 -0.675 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -63.47 -30.62 71.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.621 -0.674 . . . . 0.0 109.586 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.88 64.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.625 -0.672 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -101.76 40.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' CE2' ' A' ' 30' ' ' PHE . 11.9 p -150.12 -45.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.516 -0.74 . . . . 0.0 109.639 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.2 m -60.24 123.48 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.8 20.55 57.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -143.12 -177.0 5.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.343 -1.092 . . . . 0.0 109.257 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.04 102.74 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 49' ' ' PHE . 18.6 ttp -76.68 107.83 9.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.607 -0.683 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 96' ' ' ILE . 33.2 t -97.72 125.34 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.631 -0.668 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.2 m -147.21 155.58 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.98 -163.4 34.0 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -84.32 -32.12 24.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.601 -0.94 . . . . 0.0 109.508 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -66.72 -30.93 71.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -90.44 -31.42 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.717 . . . . 0.0 109.576 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 48.9 t80 -63.19 -33.74 76.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.17 -26.03 33.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.746 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.554 ' OG ' ' HM3' ' A' ' 170' ' ' MTX . 12.6 t -62.81 -30.0 71.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 0.0 109.696 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 39.8 m-85 -63.92 153.22 85.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.96 -59.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 124.948 3.765 . . . . 0.0 109.804 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.56 96.74 7.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.646 -0.659 . . . . 0.0 109.451 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -99.08 131.74 24.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.332 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.2 Cg_endo -83.19 169.85 56.54 Favored 'Cis proline' 0 N--CA 1.507 2.32 0 O-C-N 123.077 1.04 . . . . 0.0 109.832 -0.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.52 126.14 74.44 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.712 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.06 170.56 17.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 124.682 3.588 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.68 29.05 17.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.694 . . . . 0.0 109.667 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -178.17 159.63 1.3 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 109.596 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -92.58 142.46 27.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.3 137.8 52.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.732 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.78 98.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.696 -0.627 . . . . 0.0 109.337 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 t -78.87 126.05 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.72 HD12 HG23 ' A' ' 76' ' ' VAL . 12.2 tp -115.22 114.19 24.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.592 -0.693 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -151.22 163.39 38.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.703 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -97.52 36.4 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 0.0 109.513 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -123.68 126.28 46.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.561 -0.712 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -99.26 34.94 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -135.48 26.69 3.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.73 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -93.26 173.13 7.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.76 86.21 1.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.506 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.06 99.56 11.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.691 . . . . 0.0 109.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -84.45 112.74 20.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.86 -39.9 2.71 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -92.6 150.43 20.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.972 . . . . 0.0 109.49 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -80.7 141.24 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.629 -0.669 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.27 135.94 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.64 -0.663 . . . . 0.0 109.513 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 62' ' ' LEU . 25.8 m -132.36 168.51 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 109.503 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -150.02 32.59 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.666 -0.646 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -176.94 143.56 0.42 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.45 -30.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.568 -0.708 . . . . 0.0 109.339 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.28 77.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.677 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.23 62.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.627 -0.671 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t -63.13 -37.31 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.398 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.18 -31.0 38.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.62 75.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.638 -0.664 . . . . 0.0 109.492 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -69.85 -36.09 75.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 109.426 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.41 67.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.693 -0.629 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -63.27 -42.06 99.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.46 -31.01 70.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.667 -0.646 . . . . 0.0 109.426 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -118.11 94.01 45.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.428 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -76.77 -28.83 6.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.898 3.732 . . . . 0.0 109.887 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.03 -31.2 70.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.584 -0.698 . . . . 0.0 109.467 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -96.44 137.55 35.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.602 -0.686 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -99.88 178.78 4.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tp -106.32 124.74 50.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.34 131.66 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.595 -0.691 . . . . 0.0 109.392 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.474 HD13 ' HB ' ' A' ' 40' ' ' VAL . 35.9 mm -107.44 116.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.533 -0.729 . . . . 0.0 109.387 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.588 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -99.38 -27.49 13.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.61 -0.681 . . . . 0.0 109.825 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.8 -170.5 31.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.11 -152.11 8.64 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.573 -0.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.89 87.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -1.02 . . . . 0.0 109.479 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -62.53 -31.16 71.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.39 -38.9 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.389 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -61.72 -39.11 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.545 -0.722 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -35.88 82.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.542 -0.724 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.95 85.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.665 . . . . 0.0 109.529 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -103.08 44.24 1.03 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 110' ' ' VAL . 22.2 tptp -94.23 -30.26 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.67 -29.5 64.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.625 -0.672 . . . . 0.0 109.67 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.73 70.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 109.418 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -137.29 123.76 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.46 -42.63 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.576 -0.702 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 m -90.89 143.11 27.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 3' ' ' PHE . 54.7 mt -135.73 95.09 3.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.608 -0.682 . . . . 0.0 109.585 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 4' ' ' LEU . 8.1 mt -93.84 132.53 38.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.689 . . . . 0.0 109.369 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -147.51 150.69 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 109.757 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -115.77 99.63 7.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -76.26 132.35 39.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.622 -0.674 . . . . 0.0 109.684 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -100.43 173.82 6.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.45 -44.88 4.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.462 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 135.33 38.41 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -78.98 150.33 32.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.567 -0.961 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -147.86 148.83 31.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.693 . . . . 0.0 109.497 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.82 149.83 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.624 -0.672 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.63 -163.42 24.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.58 -37.89 3.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.935 . . . . 0.0 109.533 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -70.84 114.88 9.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.725 . . . . 0.0 109.525 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -113.79 170.12 8.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.685 . . . . 0.0 109.579 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HD11 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -95.2 149.13 21.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.457 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 pt -63.4 165.48 11.28 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.57 103.15 1.56 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.079 3.853 . . . . 0.0 109.892 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' CE ' ' A' ' 128' ' ' MET . 27.0 mt -94.81 156.03 16.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.519 -0.738 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -97.06 126.72 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -104.48 8.3 35.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.629 -0.669 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.27 -30.86 20.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.55 35.32 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -146.67 165.89 28.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.6 m -144.05 150.73 38.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.489 -0.757 . . . . 0.0 109.367 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -82.38 143.98 30.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.563 -0.711 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.37 -64.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.577 -0.702 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -111.75 131.7 55.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.545 -0.722 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.0 t -142.77 93.54 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.598 -0.689 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -89.27 132.61 34.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.702 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.4 m -104.36 131.78 51.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.4 t -136.54 134.48 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.536 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HA ' HG23 ' A' ' 152' ' ' THR . 9.8 pt-20 -121.49 143.04 49.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.19 -165.12 1.23 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 79.5 p -62.55 -29.79 70.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.565 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -112.67 161.13 27.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.497 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -32.83 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 125.213 3.942 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.49 -25.92 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.598 -0.689 . . . . 0.0 109.803 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.48 29.44 3.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.426 -0.796 . . . . 0.0 109.725 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.4 m -87.77 141.51 28.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.344 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -139.43 158.5 44.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -0.764 . . . . 0.0 109.692 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 HG22 ' OE2' ' A' ' 156' ' ' GLU . 17.0 m -140.85 116.22 10.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.611 -0.68 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.13 135.98 46.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.573 -0.704 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' OE2' HG22 ' A' ' 154' ' ' THR . 7.4 mp0 -128.41 120.83 27.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.48 92.82 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.58 -0.7 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -87.47 141.41 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -132.3 149.25 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -74.8 154.27 38.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -72.38 165.31 24.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.462 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.554 ' HM3' ' OG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.41 132.6 19.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.734 ' HB2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -76.74 145.39 38.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.546 -0.721 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 114' ' ' LEU . 23.5 tp -152.17 113.07 4.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.431 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.7 p90 -154.01 169.76 22.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.77 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.17 137.28 54.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.598 -0.689 . . . . 0.0 109.223 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.22 174.08 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.5 -0.75 . . . . 0.0 109.721 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -115.55 -169.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.41 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -58.03 -36.1 72.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.449 -0.782 . . . . 0.0 110.072 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -60.57 2.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.524 -0.735 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.74 45.01 0.1 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 20' ' ' PRO . 10.6 tp -98.9 134.35 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.928 . . . . 0.0 109.423 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 126' ' ' THR . 30.8 pt -108.26 -29.7 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.601 -0.687 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.5 -175.37 25.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -156.46 107.24 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.976 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.42 26.62 15.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.533 -0.729 . . . . 0.0 109.971 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.73 -40.65 2.59 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -89.88 159.29 17.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.531 -0.982 . . . . 0.0 109.592 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.1 145.97 98.9 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.603 -0.686 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' CG ' HD23 ' A' ' 12' ' ' LEU . 12.3 Cg_endo -80.03 -34.18 0.95 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.903 3.735 . . . . 0.0 109.948 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 10.2 p90 -116.11 -173.5 2.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.55 -0.719 . . . . 0.0 109.528 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.408 ' CD2' ' HD3' ' A' ' 24' ' ' PRO . 37.6 t60 -139.45 94.68 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.677 . . . . 0.0 109.385 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD21 ' ND1' ' A' ' 153' ' ' HIS . 14.9 tp -125.15 83.28 60.88 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.723 . . . . 0.0 109.607 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 22' ' ' HIS . 6.3 Cg_exo -46.53 -33.86 13.81 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 125.061 3.841 . . . . 0.0 110.165 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.52 -40.11 93.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.619 -0.676 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' HD23 ' A' ' 23' ' ' LEU . 24.7 t70 -65.82 -30.13 70.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.688 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.2 -31.13 65.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -68.99 -42.25 76.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.627 -0.671 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.88 -32.01 72.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 109.411 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD1' ' C4 ' ' A' ' 170' ' ' MTX . 42.3 t80 -66.37 -42.41 88.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 109.338 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.41 -30.57 71.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.565 -0.709 . . . . 0.0 109.567 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -29.61 46.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.6 -0.688 . . . . 0.0 109.717 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.73 37.18 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.506 -0.747 . . . . 0.0 109.591 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 p -150.15 -45.84 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.572 -0.705 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -61.16 119.42 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.592 -0.692 . . . . 0.0 109.716 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.28 12.84 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -107.42 -179.04 3.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.479 -1.012 . . . . 0.0 109.563 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mt -94.86 111.45 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.685 -0.634 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.0 ttp -78.86 103.75 9.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.595 -0.691 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 t -96.27 129.09 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.63 . . . . 0.0 109.365 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.706 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.0 m -148.07 -179.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.38 -169.34 30.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.07 49.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.976 . . . . 0.0 109.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -63.35 -46.59 85.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.588 -0.695 . . . . 0.0 109.479 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.494 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 7.2 m -68.39 -30.48 69.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 31.4 t80 -62.45 -50.51 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.698 . . . . 0.0 109.544 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -71.03 -22.12 62.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.636 -0.665 . . . . 0.0 110.003 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 t -62.47 -28.6 69.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.411 -0.806 . . . . 0.0 109.756 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG22 ' A' ' 45' ' ' THR . 20.5 m-85 -68.65 158.49 85.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.02 -61.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.024 3.816 . . . . 0.0 109.857 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -104.48 105.09 15.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.373 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -106.01 137.11 19.27 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 11.7 Cg_endo -83.67 167.55 61.39 Favored 'Cis proline' 0 N--CA 1.507 2.28 0 O-C-N 123.192 1.101 . . . . 0.0 109.692 -0.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD12 ' CE ' ' A' ' 39' ' ' MET . 41.1 mt -79.04 130.19 70.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.497 -0.752 . . . . 0.0 109.228 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -79.36 170.09 17.88 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 124.63 3.553 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 60.62 26.95 16.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.686 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -177.79 157.63 1.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.8 145.28 26.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -116.82 111.55 19.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -111.09 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.21 133.69 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD12 HG23 ' A' ' 76' ' ' VAL . 10.5 tp -120.17 116.72 26.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 109.374 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -134.05 175.06 9.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.715 . . . . 0.0 109.567 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -106.1 30.07 6.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.542 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -128.48 142.43 51.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.18 33.43 3.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -134.33 27.17 3.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.661 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.3 156.07 17.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -146.93 100.2 3.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.583 -0.698 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -90.3 147.61 23.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.687 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.85 91.49 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 109.567 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.49 -29.95 11.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -83.37 156.74 22.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.522 -0.987 . . . . 0.0 109.445 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 t -89.67 149.39 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.6 t -123.87 109.07 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.384 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.659 HG23 HD12 ' A' ' 62' ' ' LEU . 26.4 m -114.48 157.75 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.612 -0.68 . . . . 0.0 109.485 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -138.83 34.38 2.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.1 m-20 -151.11 135.4 16.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.1 t -62.62 -38.09 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.651 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.71 75.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.586 -0.696 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.05 74.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.437 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 78' ' ' ASP . 41.6 t -68.16 -37.61 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.658 . . . . 0.0 109.318 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.65 -32.16 41.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.584 -0.698 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.26 83.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.419 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -64.05 -36.49 84.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.54 -0.725 . . . . 0.0 109.441 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.85 -33.02 57.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.638 -0.664 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -64.14 -43.53 94.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -64.58 -29.64 70.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -116.09 93.01 37.4 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.39 -29.78 5.83 Favored 'Trans proline' 0 N--CA 1.504 2.145 0 C-N-CA 124.861 3.708 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.95 -33.03 74.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 109.35 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -100.59 160.29 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 174.14 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tp -95.99 133.46 40.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -123.31 124.84 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.688 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.624 HG22 ' CE1' ' A' ' 103' ' ' PHE . 35.9 mm -101.74 116.0 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.646 -0.659 . . . . 0.0 109.4 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.706 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -102.68 -28.68 11.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.58 -173.58 29.33 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -151.22 20.37 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 120.358 -1.672 . . . . 0.0 109.604 0.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.75 -30.21 71.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.576 -0.955 . . . . 0.0 109.648 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -62.85 -29.61 70.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.4 mm -85.15 -37.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 96' ' ' ILE . 26.4 m-85 -65.89 -38.96 90.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.528 -0.733 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -62.96 -31.36 72.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.33 -37.11 63.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.752 . . . . 0.0 109.601 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.81 37.85 2.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.531 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -62.62 -54.55 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 109.595 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -101.41 52.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.565 -0.709 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.01 39.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 3' ' ' PHE . 9.5 p -147.37 146.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.66 -47.67 3.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 0.0 109.392 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 m -91.62 143.31 26.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.0 109.329 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 3' ' ' PHE . 20.1 mt -133.21 107.09 7.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.719 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 4' ' ' LEU . 7.0 mt -94.73 127.38 40.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 109.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -139.47 146.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.5 m -115.11 103.19 10.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.679 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -79.68 134.72 36.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.558 -0.714 . . . . 0.0 109.604 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -103.67 170.74 7.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.633 -0.667 . . . . 0.0 109.335 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.68 -39.27 6.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.57 -0.706 . . . . 0.0 109.494 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.62 140.72 33.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 84.6 p -81.25 143.66 32.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.674 -0.897 . . . . 0.0 109.403 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -142.09 139.22 32.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -112.26 141.91 45.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.92 -168.92 27.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.18 -34.94 6.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.613 -0.933 . . . . 0.0 109.484 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.793 HG22 HD11 ' A' ' 13' ' ' ILE . 1.5 m -73.77 118.37 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.714 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -122.46 168.13 12.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.7 tpt -91.22 145.91 24.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.645 -0.659 . . . . 0.0 109.463 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.1 pt -66.8 164.74 31.19 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.73 111.43 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.222 3.948 . . . . 0.0 109.91 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.05 157.26 19.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.541 -0.725 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.75 122.87 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -100.0 -25.98 14.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.683 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -26.13 65.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.94 37.79 1.28 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.367 -0.833 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -152.76 169.57 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.75 . . . . 0.0 109.337 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 m -149.93 149.24 30.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.497 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -88.37 140.04 29.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.619 -0.676 . . . . 0.0 109.401 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 140' ' ' SER . 26.5 m -129.09 -43.03 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.622 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 139' ' ' VAL . 62.2 m -120.22 158.71 26.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -169.71 154.83 5.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -145.62 113.44 6.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.713 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.7 m -85.96 124.2 32.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.79 123.75 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.612 -0.68 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 152' ' ' THR . 62.0 mt-10 -106.25 120.25 41.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.555 -0.715 . . . . 0.0 109.557 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.25 -172.54 4.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.391 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.3 p -63.07 -40.28 97.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.562 -0.711 . . . . 0.0 109.441 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -98.77 164.35 17.1 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.577 -0.702 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.1 -31.66 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.089 3.86 . . . . 0.0 109.844 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.13 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.3 mt -79.26 -8.21 58.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.9 m -59.14 134.81 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.691 ' ND1' HD21 ' A' ' 23' ' ' LEU . 34.3 p-80 -143.41 170.72 15.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.517 -0.74 . . . . 0.0 109.489 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 143' ' ' THR . 6.3 m -150.0 123.8 9.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.504 -0.747 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -78.72 151.43 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -139.77 132.6 29.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.725 . . . . 0.0 109.483 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 114' ' ' LEU . 28.9 t -111.07 81.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.486 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.78 145.07 45.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.623 -0.673 . . . . 0.0 109.5 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.81 150.82 51.43 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.652 . . . . 0.0 109.46 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -78.42 138.79 38.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -102.08 -28.2 12.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.592 -0.693 . . . . 0.0 109.63 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.487 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.425 ' C4 ' ' CD1' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.08 99.89 2.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.0 m-85 -69.98 140.19 52.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.671 . . . . 0.0 109.47 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -152.55 112.37 3.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p90 -153.0 167.07 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.792 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.53 133.91 55.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.768 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.05 163.32 36.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.589 -0.694 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -108.95 -171.56 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.51 -30.8 70.86 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.886 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -69.54 -41.95 75.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.475 -0.766 . . . . 0.0 109.478 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.51 30.82 2.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD23 ' HG3' ' A' ' 20' ' ' PRO . 11.6 tp -97.15 132.27 43.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.546 -0.973 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -106.65 -29.96 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.576 -0.703 . . . . 0.0 109.624 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.36 -178.0 30.07 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -159.66 112.33 2.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.638 -0.919 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.91 27.02 15.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.496 -0.752 . . . . 0.0 109.963 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.47 -44.14 2.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -91.74 164.58 13.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.626 -0.926 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.68 154.78 62.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.557 -0.715 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HG3' HD23 ' A' ' 12' ' ' LEU . 11.2 Cg_endo -80.54 -44.23 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 125.042 3.828 . . . . 0.0 109.999 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 27.7 p90 -92.62 -173.18 3.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.659 -0.651 . . . . 0.0 109.708 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -140.2 89.14 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 26' ' ' ASP . 4.1 tp -113.82 112.63 47.73 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.705 . . . . 0.0 109.492 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -78.63 -29.06 3.85 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 124.795 3.664 . . . . 0.0 109.883 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.47 -31.75 71.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.503 -0.748 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.664 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.6 t0 -73.07 -31.19 64.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.42 -33.47 71.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.658 -0.651 . . . . 0.0 109.495 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.61 -36.08 78.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.43 -30.63 66.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.5 -45.0 81.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.705 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 35' ' ' VAL . 24.6 ttp85 -62.12 -29.26 70.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.21 52.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.77 37.65 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.8 p -149.98 -45.38 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' ARG . 27.6 m -61.54 120.67 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.498 -0.751 . . . . 0.0 109.638 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.0 29.73 19.55 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -154.34 -178.97 7.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.936 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.08 116.36 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.665 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HE3' HD12 ' A' ' 54' ' ' LEU . 16.7 ttp -93.18 116.39 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.561 -0.712 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.47 114.55 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 109.369 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 97' ' ' ALA . 24.4 m -135.12 144.22 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.59 -0.694 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 -164.17 14.6 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -79.69 -41.98 25.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.568 -0.96 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -65.72 -40.19 91.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -72.9 -31.49 64.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 55.6 t80 -65.95 -37.46 86.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.604 -0.685 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -75.08 -23.92 58.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.678 . . . . 0.0 109.971 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -62.68 -28.68 70.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.714 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -63.2 157.32 63.78 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.447 -0.783 . . . . 0.0 109.484 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -80.42 -62.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.079 3.852 . . . . 0.0 109.808 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -108.4 106.58 16.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.687 -0.633 . . . . 0.0 109.321 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 32.1 mtm-85 -104.71 141.37 22.41 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.35 157.9 73.7 Favored 'Cis proline' 0 N--CA 1.508 2.329 0 O-C-N 123.181 1.095 . . . . 0.0 109.817 -0.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.401 HD12 ' HE3' ' A' ' 39' ' ' MET . 68.0 mt -75.64 124.46 88.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.501 -0.749 . . . . 0.0 109.208 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.23 173.78 12.88 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 124.685 3.59 . . . . 0.0 109.973 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.23 29.0 18.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.52 -0.737 . . . . 0.0 109.754 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -177.92 160.09 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.58 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 m -91.59 129.21 37.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.511 -0.743 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.63 111.74 24.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 t -105.18 96.59 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.0 109.369 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 t -79.89 130.48 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 0.0 109.416 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 76' ' ' VAL . 11.5 tp -117.71 112.34 20.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 170.21 19.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.517 -0.739 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -104.65 30.16 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -113.9 138.18 50.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.573 -0.705 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -102.57 29.29 5.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.725 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.46 19.21 3.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.51 -0.744 . . . . 0.0 110.147 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -93.55 126.47 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -133.27 134.81 44.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -150.52 129.58 12.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.69 . . . . 0.0 109.451 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -75.49 113.51 12.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.738 . . . . 0.0 109.524 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.02 11.44 46.09 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.35 118.78 18.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -1.174 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.4 t -79.57 114.07 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.662 -0.649 . . . . 0.0 109.482 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.84 107.46 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.601 -0.687 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 62' ' ' LEU . 29.7 m -91.96 175.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -148.72 36.08 0.78 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -172.59 133.56 0.61 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.564 -0.71 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.04 -35.25 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 109.577 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.62 83.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.656 -0.653 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.44 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.592 -0.692 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 76' ' ' VAL . 25.3 t -62.04 -30.62 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -81.12 -30.74 34.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.6 -0.687 . . . . 0.0 109.5 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.56 94.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.435 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -63.49 -36.51 84.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.78 87.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.416 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -44.19 94.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.639 -0.663 . . . . 0.0 109.454 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -67.36 -28.77 68.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 89' ' ' HIS . 10.2 m-70 -115.84 93.68 38.6 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.537 -0.727 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.43 -31.35 2.75 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 124.973 3.782 . . . . 0.0 109.8 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.29 -30.47 67.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.645 -0.659 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.64 -174.4 2.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.577 -0.702 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -126.84 108.19 10.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.61 -0.681 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.57 133.03 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.598 -0.688 . . . . 0.0 109.469 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.6 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.2 mm -100.46 124.54 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.27 -29.05 10.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.543 -0.723 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 152.57 -168.59 31.62 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.86 -155.08 8.43 Favored Glycine 0 N--CA 1.5 2.954 0 O-C-N 120.409 -1.642 . . . . 0.0 109.581 0.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.6 84.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.613 -0.934 . . . . 0.0 109.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -64.5 -30.74 71.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.435 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.503 ' CD1' HD23 ' A' ' 62' ' ' LEU . 43.7 mm -75.7 -37.14 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.674 -0.641 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.6 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.7 m-85 -64.15 -39.69 94.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.58 -0.7 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 m -62.98 -34.37 77.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.562 -0.711 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.19 84.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.509 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.71 37.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.686 . . . . 0.0 109.551 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -81.98 -34.64 29.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.81 -30.19 56.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.487 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.55 65.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -129.49 139.43 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -70.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.69 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 m -72.52 102.94 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.65 -0.656 . . . . 0.0 109.346 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 136' ' ' PHE . 23.1 mt -95.5 86.33 4.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.735 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 6.2 mt -83.41 129.05 34.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.534 -0.728 . . . . 0.0 109.226 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.8 p -149.33 148.47 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 109.669 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -107.79 107.12 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -80.68 120.6 24.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.49 174.75 6.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.587 -0.695 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.36 -36.16 4.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.509 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.36 142.21 45.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.7 p -87.11 144.79 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.656 -0.908 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 80.0 m-85 -148.34 135.74 20.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -105.44 145.07 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.48 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.08 -147.61 5.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -128.35 -44.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.614 -0.933 . . . . 0.0 109.462 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.602 HG22 HD11 ' A' ' 13' ' ' ILE . 1.4 m -72.11 120.1 17.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.519 -0.738 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -125.73 162.17 25.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.64 150.17 31.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 pt -69.7 164.01 54.61 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.82 102.18 1.44 Allowed 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 125.114 3.876 . . . . 0.0 109.822 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.4 155.06 17.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.619 -0.675 . . . . 0.0 109.493 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -89.05 96.16 10.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.603 -0.686 . . . . 0.0 109.386 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -71.55 -24.93 62.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.79 -27.48 65.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.342 -0.849 . . . . 0.0 109.95 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 1.2 m-20 -98.51 33.1 2.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 109.518 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 113' ' ' LEU . 29.7 m-85 -145.38 174.89 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 m -150.24 150.09 31.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -90.3 137.85 32.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.609 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.4 t -113.38 -62.85 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.49 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -109.45 164.12 12.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.5 -0.75 . . . . 0.0 109.484 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -168.03 139.01 2.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -136.79 123.81 21.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.8 m -96.94 135.2 39.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.28 123.09 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.646 -0.659 . . . . 0.0 109.498 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.55 140.05 38.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.686 . . . . 0.0 109.429 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.82 -165.73 1.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 p -62.38 -29.34 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.546 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -120.47 164.99 19.73 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.565 -0.709 . . . . 0.0 109.45 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.87 -29.66 2.64 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.215 3.943 . . . . 0.0 109.855 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.0 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.574 -0.703 . . . . 0.0 109.717 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 23' ' ' LEU . 19.0 mt -97.35 32.67 2.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 109.751 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.5 m -90.11 142.89 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CG ' HD21 ' A' ' 23' ' ' LEU . 26.3 p-80 -142.51 154.43 44.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.5 m -139.54 107.7 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -65.22 114.64 4.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.512 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -112.96 127.74 56.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -105.63 100.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.588 -0.695 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -92.67 141.77 28.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -136.13 144.51 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -76.97 146.43 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.662 -0.649 . . . . 0.0 109.453 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -76.65 -49.54 15.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.727 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.728 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.86 120.92 13.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 110' ' ' VAL . 4.1 m-85 -80.17 143.22 34.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.667 -0.646 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.6 tp -154.41 112.71 3.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 109.386 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.6 p90 -152.72 157.18 40.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.534 -0.729 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.63 136.26 48.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.683 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -149.78 164.56 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.668 -0.645 . . . . 0.0 109.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -109.63 -171.67 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.727 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -62.53 -27.98 69.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.636 -0.665 . . . . 0.0 109.847 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.72 -42.32 61.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.38 33.37 1.78 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tp -98.97 131.14 45.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.491 -1.005 . . . . 0.0 109.348 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 126' ' ' THR . 28.4 pt -104.77 -29.03 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.59 -0.694 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -158.51 -171.84 24.89 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -164.71 115.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.612 -0.934 . . . . 0.0 109.438 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.68 27.54 14.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.41 -44.16 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.59 169.01 10.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.593 -0.945 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 ' HA2' ' A' ' 14' ' ' GLY . 42.7 mt -89.29 153.97 48.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.552 -0.718 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.9 -31.99 1.2 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 125.028 3.819 . . . . 0.0 110.014 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -103.96 -178.51 3.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -137.91 87.62 2.26 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.5 tp -113.93 101.87 54.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.21 -27.66 13.44 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.642 3.561 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -34.63 77.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.442 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HB2' HD23 ' A' ' 23' ' ' LEU . 14.8 t0 -70.58 -31.4 68.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.328 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 27' ' ' LEU . 68.4 mt -62.77 -34.82 78.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -64.39 -38.41 90.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.661 -0.65 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.35 -34.13 70.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.547 -0.721 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -64.31 -41.18 96.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 109.44 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.8 ttp85 -64.19 -36.77 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.98 65.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.579 -0.701 . . . . 0.0 109.551 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -97.65 37.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.636 -0.665 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -148.12 -46.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.0 142.35 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.602 -0.686 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.38 30.65 76.99 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -157.23 -178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.998 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' HG21 ' A' ' 60' ' ' VAL . 46.0 mt -102.58 135.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 54' ' ' LEU . 25.3 ttp -106.71 116.25 31.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -106.01 119.64 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.555 -0.716 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.32 153.32 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.01 -155.43 25.9 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -81.71 -51.66 7.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.556 -0.967 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.42 -32.92 73.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.601 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -76.4 -36.27 58.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.603 -0.686 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 30.3 t80 -68.04 -44.55 76.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.92 -23.98 60.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.942 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -62.86 -29.85 71.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.41 -0.806 . . . . 0.0 109.604 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 46' ' ' TYR . 23.3 m-85 -66.49 148.04 98.75 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.454 -0.779 . . . . 0.0 109.452 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.67 -56.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 124.895 3.73 . . . . 0.0 109.782 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -98.4 106.51 18.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -114.35 138.38 23.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.591 -0.693 . . . . 0.0 109.396 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.67 178.05 32.31 Favored 'Cis proline' 0 N--CA 1.508 2.354 0 O-C-N 123.221 1.116 . . . . 0.0 109.807 -0.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 39' ' ' MET . 95.0 mt -97.72 117.92 64.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.681 . . . . 0.0 109.309 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -77.73 179.74 6.22 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 124.669 3.579 . . . . 0.0 109.98 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 60.87 30.95 19.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.546 -0.721 . . . . 0.0 109.722 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -177.59 170.96 1.96 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m -96.39 117.86 31.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.588 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.81 125.17 30.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.524 -0.735 . . . . 0.0 109.56 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 ' CG2' ' A' ' 38' ' ' ILE . 32.4 t -133.74 94.25 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 t -87.26 140.0 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.575 -0.703 . . . . 0.0 109.646 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' HG23 ' A' ' 76' ' ' VAL . 15.0 tp -140.05 107.98 5.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.4 t -133.35 12.57 4.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.656 -0.653 . . . . 0.0 110.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 57.64 27.75 14.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.81 134.66 43.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -102.3 29.54 5.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.657 -0.652 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -111.38 -27.8 8.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.575 -0.703 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.96 118.45 7.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -111.91 125.75 54.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.548 -0.72 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.75 114.28 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.0 109.531 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.62 145.85 30.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.656 -0.652 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.93 11.37 61.7 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.19 29.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.611 -0.681 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.15 129.66 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.665 -0.647 . . . . 0.0 109.374 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.658 HG21 HG22 ' A' ' 82' ' ' VAL . 24.2 m -115.87 165.22 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.574 -0.704 . . . . 0.0 109.313 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -133.84 37.02 3.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' VAL . 15.9 t0 -159.26 129.67 5.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.86 -39.37 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.81 81.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.685 -0.634 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.23 82.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.643 -0.661 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 76' ' ' VAL . 41.4 t -63.07 -37.74 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.564 -0.71 . . . . 0.0 109.266 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -76.0 -34.64 59.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.59 70.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.384 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -62.2 -36.65 82.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.547 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.4 63.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.629 -0.669 . . . . 0.0 109.367 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.79 -42.12 82.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.31 -29.3 70.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.591 -0.693 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -110.5 99.75 42.29 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.575 -0.703 . . . . 0.0 109.456 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.34 -25.28 21.92 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 124.694 3.596 . . . . 0.0 110.11 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.69 26.25 4.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.466 -0.771 . . . . 0.0 109.833 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -143.11 142.28 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 109.37 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -112.25 165.16 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.69 124.92 46.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.0 133.4 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.563 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.632 HG22 ' CE1' ' A' ' 103' ' ' PHE . 38.8 mm -105.15 118.6 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.698 . . . . 0.0 109.254 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.47 -31.9 8.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.744 . . . . 0.0 109.677 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.26 -172.98 38.5 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 -152.37 23.04 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.335 -1.685 . . . . 0.0 109.607 0.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.61 83.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.582 -0.952 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -65.61 -30.9 71.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 mm -76.69 -35.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 109.396 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.4 m-85 -65.53 -34.16 77.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -69.34 -31.98 70.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.99 -40.23 75.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.12 36.16 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.501 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -78.72 -29.8 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.583 -0.698 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.51 32.79 2.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 109.567 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 1' ' ' THR . 5.8 m-20 -159.17 75.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.575 -0.703 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -158.53 140.08 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.748 . . . . 0.0 109.432 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.82 -42.3 2.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.678 -0.639 . . . . 0.0 109.346 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 m -99.07 112.54 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.552 -0.718 . . . . 0.0 109.428 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.98 96.28 7.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.591 ' CB ' HD12 ' A' ' 4' ' ' LEU . 10.7 mt -89.97 126.26 35.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 109.506 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -145.25 148.59 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.3 m -108.72 104.51 13.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.94 123.48 28.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.531 -0.731 . . . . 0.0 109.687 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 mp -99.85 174.31 6.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.623 -0.673 . . . . 0.0 109.45 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.3 -41.01 4.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 142.12 47.22 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 p -87.63 150.65 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.934 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -149.93 146.88 27.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.29 140.71 49.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.701 -0.625 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.07 -154.12 7.39 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -121.07 -41.07 2.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.977 . . . . 0.0 109.512 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.787 HG22 HD11 ' A' ' 13' ' ' ILE . 2.8 m -73.78 125.98 29.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 109.463 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -132.81 167.45 20.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.4 tpt -84.24 147.65 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.702 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.9 pt -66.32 165.62 22.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.77 98.54 1.07 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.228 3.952 . . . . 0.0 109.851 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.13 159.4 15.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.594 -0.691 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -84.41 128.24 34.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -104.77 -26.32 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.575 -0.703 . . . . 0.0 109.72 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -59.59 -26.17 65.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 109.917 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.03 37.08 1.34 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.451 -0.781 . . . . 0.0 109.539 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -150.41 157.64 43.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 m -136.53 147.88 47.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.596 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -85.17 117.79 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.582 -0.699 . . . . 0.0 109.417 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.6 t -104.54 -36.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.44 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 t -128.55 152.46 48.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.596 -0.69 . . . . 0.0 109.598 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -160.93 143.38 12.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.625 -0.672 . . . . 0.0 109.425 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -141.07 116.45 10.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.542 -0.724 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 19.8 m -88.89 132.27 34.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.654 -0.654 . . . . 0.0 109.391 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 t -133.97 126.13 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.558 -0.714 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -105.7 133.96 49.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.72 -165.75 1.36 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.602 -0.686 . . . . 0.0 109.39 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 p -62.66 -44.5 96.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.505 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -105.12 166.09 12.04 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.368 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.89 -29.31 4.43 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 124.968 3.779 . . . . 0.0 109.873 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.29 60.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.613 -0.68 . . . . 0.0 109.865 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -96.88 28.75 3.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.516 -0.74 . . . . 0.0 109.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.9 m -85.76 140.41 30.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.509 ' ND1' HD21 ' A' ' 23' ' ' LEU . 39.7 p-80 -141.69 156.63 45.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.52 -0.737 . . . . 0.0 109.785 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -137.52 112.49 9.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.568 -0.707 . . . . 0.0 109.326 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -69.58 107.53 3.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.61 -0.681 . . . . 0.0 109.415 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.7 134.17 51.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -116.06 108.52 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -99.15 117.62 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.91 164.05 12.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.67 -0.644 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -73.57 153.28 40.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -68.05 -64.78 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.748 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.486 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 94' ' ' LEU . 3.1 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.76 122.72 2.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.504 -0.748 . . . . 0.0 109.659 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.5 m-85 -80.89 139.58 35.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.3 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.2 tp -146.19 112.64 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.535 -0.728 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 6.4 p90 -152.55 160.38 43.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.513 -0.742 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 130.62 55.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 109.464 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.6 170.95 14.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.57 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -121.97 -172.26 2.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 0.0 109.417 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -59.42 -42.54 92.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.49 -0.756 . . . . 0.0 110.021 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.97 -40.41 97.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 109.519 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.89 3.39 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.705 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.1 tp -94.77 143.4 26.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.991 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 126' ' ' THR . 29.6 pt -111.76 -31.8 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.738 . . . . 0.0 109.629 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.78 36.88 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -146.79 115.89 6.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.666 -0.902 . . . . 0.0 109.439 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.13 28.24 17.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.576 -0.702 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.04 2.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -89.84 154.13 20.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.561 -0.964 . . . . 0.0 109.51 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' C7 ' ' A' ' 170' ' ' MTX . 33.8 mt -71.92 147.45 91.38 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.418 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.8 Cg_endo -79.02 -28.9 3.56 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 124.891 3.727 . . . . 0.0 110.067 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 23.7 p90 -114.09 -172.62 2.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.684 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -138.02 99.86 4.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.618 -0.676 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.7 tp -114.01 76.63 3.44 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 0.0 109.63 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.7 Cg_exo -48.39 -33.62 23.22 Favored 'Trans proline' 0 N--CA 1.506 2.213 0 C-N-CA 124.898 3.732 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 2.7 t70 -62.33 -36.34 81.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.693 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.612 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.6 t0 -65.87 -29.84 70.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.629 -0.67 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' PRO . 18.3 mt -64.98 -30.59 71.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.524 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 25' ' ' ASP . 23.6 m-70 -66.9 -31.01 71.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.552 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.36 -29.83 25.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 34' ' ' THR . 65.8 t80 -68.03 -36.36 79.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -65.27 -43.08 92.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.614 -0.679 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.62 -28.48 67.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 109.755 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -97.66 37.76 1.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.647 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 30' ' ' PHE . 17.5 p -149.2 -48.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 109.532 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG11 ' OE2' ' A' ' 56' ' ' GLU . 27.2 m -62.33 125.01 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.535 -0.728 . . . . 0.0 109.653 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.56 29.22 27.57 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -156.69 -178.6 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.973 . . . . 0.0 109.446 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.68 106.99 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.689 . . . . 0.0 109.395 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 54' ' ' LEU . 23.5 ttp -83.51 136.74 34.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.685 . . . . 0.0 109.582 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -121.87 137.07 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.675 . . . . 0.0 109.404 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.49 161.11 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.72 -157.43 33.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -84.83 -40.78 16.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.644 -0.915 . . . . 0.0 109.504 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -31.93 70.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.669 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -80.97 -35.56 31.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -65.26 -45.34 84.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.603 -0.686 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -70.58 -24.92 62.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.563 -0.711 . . . . 0.0 109.929 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 t -62.67 -28.66 70.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.467 -0.771 . . . . 0.0 109.728 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -66.9 149.75 98.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 109.471 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -78.74 -58.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.869 3.713 . . . . 0.0 109.819 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -102.13 101.87 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.684 . . . . 0.0 109.374 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -100.07 138.15 20.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.374 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -85.37 -179.18 18.97 Favored 'Cis proline' 0 N--CA 1.506 2.23 0 O-C-N 123.169 1.089 . . . . 0.0 109.785 -0.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' CE ' ' A' ' 39' ' ' MET . 72.2 mt -91.82 117.99 68.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 109.185 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.12 -179.67 5.67 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 124.658 3.572 . . . . 0.0 110.154 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE2' HG11 ' A' ' 35' ' ' VAL . 20.5 tt0 62.27 22.56 13.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.687 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 179.71 166.48 1.16 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.39 -0.819 . . . . 0.0 109.415 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -96.13 139.65 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.32 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -113.67 141.45 47.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.573 -0.705 . . . . 0.0 109.554 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.3 t -130.64 93.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.704 -0.622 . . . . 0.0 109.371 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -78.9 128.24 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 0.0 109.45 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD12 HG23 ' A' ' 76' ' ' VAL . 21.9 tp -110.55 122.33 47.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.723 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -153.44 176.76 11.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.412 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -119.26 50.84 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -145.5 139.08 26.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.467 -0.771 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.93 30.0 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.42 -29.18 7.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.613 -0.679 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -62.35 132.69 53.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -132.25 91.67 2.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.565 -0.709 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -84.77 122.21 28.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.586 -0.696 . . . . 0.0 109.486 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -90.5 108.98 20.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.662 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.02 -35.1 5.05 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . . . -89.34 174.8 7.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.62 -0.93 . . . . 0.0 109.494 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.88 106.16 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.643 -0.66 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 t -91.92 119.04 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.708 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 HD12 ' A' ' 62' ' ' LEU . 24.1 m -104.84 173.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.643 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 76' ' ' VAL . 27.5 m170 -149.13 34.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.585 -0.697 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.8 m-20 -164.26 134.5 4.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.73 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.15 -46.3 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.07 -29.06 69.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.595 -0.691 . . . . 0.0 109.381 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 78' ' ' ASP . . . -61.75 -47.41 85.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 109.395 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 76' ' ' VAL . 29.3 t -62.66 -30.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.306 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -76.21 -31.75 58.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.91 -35.92 69.83 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.57 -42.11 92.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.67 -0.644 . . . . 0.0 109.294 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.68 69.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.691 -0.63 . . . . 0.0 109.332 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -38.46 71.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -65.63 -29.56 70.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 109.657 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -115.43 93.93 38.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.734 . . . . 0.0 109.504 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -74.81 -13.89 21.76 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.916 3.744 . . . . 0.0 110.585 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.89 26.24 4.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.891 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -144.95 153.32 41.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.426 -0.796 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.13 157.67 26.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.56 -0.713 . . . . 0.0 109.508 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HG22 ' A' ' 1' ' ' THR . 7.8 tp -91.09 119.61 31.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.3 113.2 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.547 -0.721 . . . . 0.0 109.548 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.591 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.6 mm -90.35 118.06 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.678 . . . . 0.0 109.232 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.65 -27.74 13.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.67 . . . . 0.0 109.75 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.75 -168.9 26.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.36 -153.48 6.73 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.279 -1.718 . . . . 0.0 109.566 -0.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.93 -31.09 72.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.59 -0.947 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -63.1 -30.68 71.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.626 -0.671 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -81.78 -38.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.666 . . . . 0.0 109.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.6 m-85 -63.64 -41.05 98.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 0.0 109.511 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 m -62.64 -36.66 83.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.89 98.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -103.66 38.85 1.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 109.436 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -74.13 -37.62 64.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.511 -0.743 . . . . 0.0 109.601 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.34 34.54 1.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -152.25 66.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.547 -0.721 . . . . 0.0 109.46 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -161.18 141.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.528 -0.732 . . . . 0.0 109.283 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -116.26 -42.69 3.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.719 . . . . 0.0 109.405 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 m -96.88 132.86 42.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 3' ' ' PHE . 34.6 mt -118.89 101.93 8.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.609 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.63 ' CB ' HD12 ' A' ' 4' ' ' LEU . 12.2 mt -93.69 128.13 39.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.552 -0.717 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -147.38 147.07 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.541 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -107.3 112.73 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 109.286 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -83.91 116.96 23.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 109.602 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.79 -39.73 2.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.514 -0.741 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.04 142.8 48.02 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 t -90.19 152.79 20.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.951 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 21' ' ' TRP . 79.1 m-85 -150.03 163.75 37.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.485 -0.76 . . . . 0.0 109.53 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -116.55 149.53 39.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.412 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.705 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -179.58 -177.16 47.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -111.55 -30.95 7.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.971 . . . . 0.0 109.546 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -74.84 124.88 27.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -129.6 169.83 14.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 109.421 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 tpt -89.33 148.07 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.598 -0.689 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.61 165.14 38.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.487 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.76 100.76 1.32 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.12 3.88 . . . . 0.0 109.862 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.82 150.25 23.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.697 . . . . 0.0 109.432 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -89.59 125.87 35.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.523 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -102.26 8.26 40.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.58 -30.71 41.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.18 37.26 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.56 162.92 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -144.16 147.63 33.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -83.54 125.68 32.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.616 -0.678 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.42 -30.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -145.12 159.03 43.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.659 -0.651 . . . . 0.0 109.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -169.97 137.83 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.431 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -132.79 133.2 43.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.452 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.659 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.0 m -100.89 149.52 23.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.5 t -145.52 117.18 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.76 126.44 41.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.01 -172.38 3.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -63.47 -42.95 98.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.589 -0.694 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.92 166.78 12.46 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -33.25 1.35 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 125.031 3.82 . . . . 0.0 109.64 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.28 61.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.559 -0.713 . . . . 0.0 109.869 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.1 mt -95.06 24.07 5.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.373 -0.829 . . . . 0.0 110.164 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.9 m -83.32 127.93 34.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 109.051 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.511 ' CG ' HD21 ' A' ' 23' ' ' LEU . 33.7 p-80 -136.22 156.27 48.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.775 . . . . 0.0 109.957 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 143' ' ' THR . 29.7 m -137.13 110.56 7.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -62.58 128.49 36.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.574 -0.704 . . . . 0.0 109.674 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -119.17 125.54 49.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.41 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.47 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -84.42 158.02 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -147.44 137.06 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -65.97 161.59 21.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 109.523 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -73.77 101.59 3.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.49 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.433 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.42 124.87 8.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 110' ' ' VAL . 3.7 m-85 -78.16 151.53 33.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.463 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 114' ' ' LEU . 14.3 tp -158.85 112.52 2.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.544 -0.722 . . . . 0.0 109.456 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 5.4 p90 -158.09 170.05 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.554 -0.716 . . . . 0.0 109.996 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.8 134.59 52.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -145.57 169.48 18.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.478 -0.764 . . . . 0.0 109.815 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -113.32 -170.69 1.73 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 109.287 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -39.3 82.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.025 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.7 -42.99 99.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.75 . . . . 0.0 109.59 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.39 3.22 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.8 HD12 ' HG2' ' A' ' 127' ' ' LYS . 13.0 tp -94.42 143.72 26.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.453 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' O ' HD21 ' A' ' 19' ' ' LEU . 28.8 pt -117.19 -32.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.651 -0.655 . . . . 0.0 109.778 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.68 -165.7 12.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -170.85 109.56 0.33 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.912 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 57.9 28.82 16.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.713 . . . . 0.0 109.922 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.56 -43.96 2.15 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -92.99 166.98 12.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.955 . . . . 0.0 109.533 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.825 HD12 ' HM2' ' A' ' 170' ' ' MTX . 4.4 mt -91.49 156.44 43.27 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.61 -0.681 . . . . 0.0 109.511 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -81.04 -34.02 0.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.034 3.823 . . . . 0.0 109.948 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 21.9 p90 -108.54 -173.23 2.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.716 . . . . 0.0 109.668 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -149.75 99.35 2.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.605 -0.685 . . . . 0.0 109.234 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 26' ' ' ASP . 7.6 tp -115.83 116.32 40.72 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.618 -0.676 . . . . 0.0 109.346 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.89 -31.31 1.91 Allowed 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.762 3.642 . . . . 0.0 109.894 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.45 -43.62 89.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB2' HD23 ' A' ' 23' ' ' LEU . 9.4 t0 -67.49 -31.88 72.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.557 -0.714 . . . . 0.0 109.497 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.78 -34.41 77.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -66.32 -35.17 79.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -73.59 -30.64 63.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.657 -0.652 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 34' ' ' THR . 69.8 t80 -67.19 -30.72 70.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.656 -0.653 . . . . 0.0 109.505 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -69.77 -37.43 76.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.587 -0.695 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.18 67.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.546 -0.721 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -97.13 40.19 1.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.677 . . . . 0.0 109.446 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.8 p -148.38 -45.4 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.6 144.57 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.43 30.53 77.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -154.99 -178.83 7.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.965 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.6 mt -104.34 119.09 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.7 ttp -91.94 110.97 22.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.14 117.82 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 97' ' ' ALA . 26.4 m -136.45 158.39 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.589 -0.695 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.4 -164.94 32.09 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -75.9 -33.26 59.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.963 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -72.37 -29.58 63.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.637 -0.664 . . . . 0.0 109.581 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.4 m -90.97 -32.04 16.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.556 -0.715 . . . . 0.0 109.541 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.22 -37.84 88.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.18 -24.75 51.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 109.782 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.643 ' HB3' ' HM3' ' A' ' 170' ' ' MTX . 50.5 m -62.78 -29.15 70.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 109.608 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 54' ' ' LEU . 50.6 m-85 -62.85 151.2 85.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.58 -59.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 124.883 3.722 . . . . 0.0 109.707 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -108.77 99.37 8.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.607 -0.683 . . . . 0.0 109.281 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -95.51 140.52 22.4 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.449 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.68 179.47 26.35 Favored 'Cis proline' 0 N--CA 1.507 2.288 0 O-C-N 123.197 1.104 . . . . 0.0 109.77 -0.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 49' ' ' PHE . 89.0 mt -92.97 119.28 67.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.687 . . . . 0.0 109.256 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.15 175.68 10.6 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 124.751 3.634 . . . . 0.0 110.024 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.28 28.29 17.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.66 -0.65 . . . . 0.0 110.002 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -177.49 161.69 1.76 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 109.511 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -85.5 146.16 27.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.614 -0.679 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -121.88 133.72 54.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.578 -0.701 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.38 101.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 109.312 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -87.09 133.75 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.689 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 76' ' ' VAL . 13.2 tp -121.59 102.62 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.661 -0.649 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -121.13 174.69 6.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -106.27 -17.63 14.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.646 -0.659 . . . . 0.0 110.036 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -89.43 145.47 25.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.35 31.42 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.532 -0.73 . . . . 0.0 109.605 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.85 14.72 7.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.5 117.8 30.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.36 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -98.42 134.14 41.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.82 110.12 5.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 109.495 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.13 120.81 30.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.56 -0.713 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.99 1.82 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.36 138.69 38.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.947 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.01 150.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 t -128.21 101.32 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.598 -0.689 . . . . 0.0 109.409 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 62' ' ' LEU . 29.4 m -103.62 -179.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -150.2 38.82 0.73 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.632 -0.667 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.6 t0 -154.54 127.24 8.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.58 -37.79 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 109.607 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.44 -32.84 74.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.76 83.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.423 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 62' ' ' LEU . 31.4 t -63.01 -32.64 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.627 -0.67 . . . . 0.0 109.398 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -76.86 -34.07 57.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.28 -35.03 73.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.01 -35.63 81.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.407 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.08 70.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.594 -0.691 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -67.11 -36.59 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.55 -0.719 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -29.94 70.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.625 -0.672 . . . . 0.0 109.532 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -116.15 94.6 42.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -76.05 -28.73 7.26 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 124.874 3.716 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -73.07 -29.88 63.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.562 -0.711 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -96.68 160.23 14.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.37 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 tp -104.76 119.84 39.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.537 -0.727 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 t -114.87 122.54 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.663 -0.648 . . . . 0.0 109.4 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 103' ' ' PHE . 36.9 mm -94.56 119.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.616 -0.678 . . . . 0.0 109.482 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -105.58 -27.28 11.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 149.04 -169.72 29.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.15 -150.52 5.53 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 120.314 -1.697 . . . . 0.0 109.593 0.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.97 76.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.61 -0.935 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.24 -35.16 79.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.707 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.435 ' CD1' HD23 ' A' ' 62' ' ' LEU . 44.1 mm -75.37 -36.07 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 109.312 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.604 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.2 m-85 -66.71 -41.44 87.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.7 m -61.93 -34.28 75.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.677 -0.64 . . . . 0.0 109.548 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.99 83.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 40.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.696 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -85.0 -29.15 25.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.69 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -100.24 30.99 3.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.0 77.23 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.618 -0.676 . . . . 0.0 109.592 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG21 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -160.08 143.37 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.782 . . . . 0.0 109.412 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.36 -58.9 1.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -81.17 128.0 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 0.0 109.334 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 3' ' ' PHE . 97.7 mt -117.66 107.1 13.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.63 -0.668 . . . . 0.0 109.61 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' ' 4' ' ' LEU . 9.9 mt -103.02 119.25 38.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.598 -0.689 . . . . 0.0 109.279 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -140.6 146.48 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -0.763 . . . . 0.0 109.654 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 153' ' ' HIS . 5.6 m -108.94 107.77 18.27 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -81.66 127.16 32.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.579 -0.701 . . . . 0.0 109.469 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.57 -175.37 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.699 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.28 -43.98 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.36 144.75 44.82 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -88.62 155.67 19.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.968 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -150.16 153.75 36.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -119.6 153.32 35.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.565 -0.709 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.58 -133.33 1.73 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -148.08 -46.09 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.591 -0.946 . . . . 0.0 109.587 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.0 m -73.98 103.52 4.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.566 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.8 ' HG2' HD12 ' A' ' 12' ' ' LEU . 10.5 mtmm -114.21 166.77 11.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.598 -0.689 . . . . 0.0 109.516 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.12 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.578 -0.701 . . . . 0.0 109.376 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.6 pt -69.11 166.53 27.71 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.607 -0.683 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.7 102.01 1.44 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 125.005 3.803 . . . . 0.0 109.669 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.62 161.78 15.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.334 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.83 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 0.0 109.513 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -107.16 -27.93 10.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.634 -0.666 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -61.12 -27.17 68.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.445 -0.784 . . . . 0.0 109.883 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.52 33.77 1.96 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -0.808 . . . . 0.0 109.633 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -150.54 160.86 43.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.352 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.4 m -137.49 155.69 49.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.516 -0.74 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -97.44 119.36 35.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.44 -30.65 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 m -124.63 135.9 53.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.663 -0.648 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.1 t -150.96 95.86 2.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -101.05 118.44 37.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.586 ' HA ' HG23 ' A' ' 154' ' ' THR . 2.9 m -86.59 139.47 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' HE2' ' A' ' 153' ' ' HIS . 28.5 t -134.66 118.85 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.518 -0.739 . . . . 0.0 109.518 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' HA ' HG23 ' A' ' 152' ' ' THR . 39.5 tt0 -92.37 129.19 38.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.639 -0.663 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.0 -169.93 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.0 p -62.6 -48.31 79.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.36 166.1 13.95 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.381 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.31 -30.72 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.055 3.836 . . . . 0.0 109.669 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.69 -22.43 43.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.644 -0.66 . . . . 0.0 109.913 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 mt -96.03 26.68 4.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.32 -0.863 . . . . 0.0 110.127 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 145' ' ' GLU . 22.5 m -80.86 152.26 28.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.514 -0.741 . . . . 0.0 109.051 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 116' ' ' THR . 30.7 p-80 -147.27 154.22 40.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 143' ' ' THR . 34.6 m -137.21 115.2 11.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.535 -0.728 . . . . 0.0 109.245 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.93 109.69 5.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.21 127.0 56.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.64 -0.663 . . . . 0.0 109.358 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 114' ' ' LEU . 29.7 t -108.21 103.67 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.663 -0.648 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -92.92 122.54 35.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.572 -0.705 . . . . 0.0 109.383 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.25 164.48 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -75.36 149.28 38.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.68 . . . . 0.0 109.489 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -70.32 -67.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.546 179.992 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' MTX . . . . . 0.825 ' HM2' HD12 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_